id	sid	tid	token	lemma	pos
dpc-5083	1	1	dermatology	dermatology	NOUN
dpc-5083	1	2	:	:	PUNCT
dpc-5083	1	3	practical	practical	ADJ
dpc-5083	1	4	and	and	CCONJ
dpc-5083	1	5	conceptual	conceptual	ADJ
dpc-5083	1	6	review	review	NOUN
dpc-5083	1	7	|	|	ADV
dpc-5083	1	8	dermatol	dermatol	ADJ
dpc-5083	1	9	pract	pract	NOUN
dpc-5083	1	10	concept	concept	NOUN
dpc-5083	1	11	.	.	PUNCT
dpc-5083	2	1	2025;15(3):5083	2025;15(3):5083	NUM
dpc-5083	2	2	1	1	NUM
dpc-5083	2	3	reactive	reactive	ADJ
dpc-5083	2	4	infectious	infectious	ADJ
dpc-5083	2	5	mucocutaneous	mucocutaneous	ADJ
dpc-5083	2	6	eruption	eruption	NOUN
dpc-5083	2	7	(	(	PUNCT
dpc-5083	2	8	rime	rime	NOUN
dpc-5083	2	9	):	):	PUNCT
dpc-5083	2	10	narrative	narrative	NOUN
dpc-5083	2	11	review	review	NOUN
dpc-5083	2	12	and	and	CCONJ
dpc-5083	2	13	proposed	propose	VERB
dpc-5083	2	14	management	management	NOUN
dpc-5083	2	15	algorithm	algorithm	NOUN
dpc-5083	2	16	víctor	víctor	NOUN
dpc-5083	2	17	garcía	garcía	NOUN
dpc-5083	2	18	-	-	PUNCT
dpc-5083	2	19	rodríguez1	rodríguez1	NOUN
dpc-5083	2	20	,	,	PUNCT
dpc-5083	2	21	maribel	maribel	PROPN
dpc-5083	2	22	iglesias	iglesias	PROPN
dpc-5083	2	23	-	-	PUNCT
dpc-5083	2	24	sancho1	sancho1	PROPN
dpc-5083	2	25	,	,	PUNCT
dpc-5083	2	26	albert	albert	PROPN
dpc-5083	2	27	martin	martin	PROPN
dpc-5083	2	28	-	-	PUNCT
dpc-5083	2	29	poch1	poch1	PROPN
dpc-5083	2	30	,	,	PUNCT
dpc-5083	2	31	maria	maria	PROPN
dpc-5083	2	32	teresa	teresa	PROPN
dpc-5083	2	33	fernández	fernández	PROPN
dpc-5083	2	34	-	-	PUNCT
dpc-5083	2	35	figueras2	figueras2	PROPN
dpc-5083	2	36	,	,	PUNCT
dpc-5083	2	37	montserrat	montserrat	PROPN
dpc-5083	2	38	salleras	salleras	PROPN
dpc-5083	2	39	-	-	PROPN
dpc-5083	2	40	redonnet1	redonnet1	NOUN
dpc-5083	2	41	1	1	NUM
dpc-5083	2	42	dermatology	dermatology	NOUN
dpc-5083	2	43	department	department	NOUN
dpc-5083	2	44	,	,	PUNCT
dpc-5083	2	45	hospital	hospital	NOUN
dpc-5083	2	46	universitari	universitari	PROPN
dpc-5083	2	47	sagrat	sagrat	PROPN
dpc-5083	2	48	cor	cor	PROPN
dpc-5083	2	49	,	,	PUNCT
dpc-5083	2	50	grupo	grupo	PROPN
dpc-5083	2	51	hospitalario	hospitalario	PROPN
dpc-5083	2	52	quirónsalud	quirónsalud	PROPN
dpc-5083	2	53	,	,	PUNCT
dpc-5083	2	54	barcelona	barcelona	PROPN
dpc-5083	2	55	,	,	PUNCT
dpc-5083	2	56	spain	spain	PROPN
dpc-5083	2	57	2	2	NUM
dpc-5083	2	58	pathology	pathology	PROPN
dpc-5083	2	59	department	department	NOUN
dpc-5083	2	60	,	,	PUNCT
dpc-5083	2	61	hospital	hospital	NOUN
dpc-5083	2	62	universitari	universitari	PROPN
dpc-5083	2	63	general	general	PROPN
dpc-5083	2	64	de	de	PROPN
dpc-5083	2	65	catalunya	catalunya	PROPN
dpc-5083	2	66	,	,	PUNCT
dpc-5083	2	67	grupo	grupo	PROPN
dpc-5083	2	68	hospitalario	hospitalario	PROPN
dpc-5083	2	69	quirónsalud	quirónsalud	PROPN
dpc-5083	2	70	,	,	PUNCT
dpc-5083	2	71	sant	sant	PROPN
dpc-5083	2	72	cugat	cugat	PROPN
dpc-5083	2	73	del	del	PROPN
dpc-5083	2	74	vallés	vallés	PROPN
dpc-5083	2	75	,	,	PUNCT
dpc-5083	2	76	barcelona	barcelona	PROPN
dpc-5083	2	77	,	,	PUNCT
dpc-5083	2	78	spain	spain	PROPN
dpc-5083	2	79	key	key	ADJ
dpc-5083	2	80	words	word	NOUN
dpc-5083	2	81	:	:	PUNCT
dpc-5083	2	82	reactive	reactive	ADJ
dpc-5083	2	83	infectious	infectious	ADJ
dpc-5083	2	84	mucocutaneous	mucocutaneous	ADJ
dpc-5083	2	85	eruption	eruption	NOUN
dpc-5083	2	86	,	,	PUNCT
dpc-5083	2	87	mucocutaneous	mucocutaneous	ADJ
dpc-5083	2	88	eruptions	eruption	NOUN
dpc-5083	2	89	,	,	PUNCT
dpc-5083	2	90	mycoplasma	mycoplasma	NOUN
dpc-5083	2	91	-	-	PUNCT
dpc-5083	2	92	induced	induce	VERB
dpc-5083	2	93	rash	rash	NOUN
dpc-5083	2	94	and	and	CCONJ
dpc-5083	2	95	mucositis	mucositis	NOUN
dpc-5083	2	96	,	,	PUNCT
dpc-5083	2	97	rime	rime	NOUN
dpc-5083	2	98	,	,	PUNCT
dpc-5083	2	99	mirm	mirm	ADJ
dpc-5083	2	100	citation	citation	NOUN
dpc-5083	2	101	:	:	PUNCT
dpc-5083	2	102	garcía	garcía	ADJ
dpc-5083	2	103	-	-	PUNCT
dpc-5083	2	104	rodríguez	rodríguez	NOUN
dpc-5083	2	105	v	v	NOUN
dpc-5083	2	106	,	,	PUNCT
dpc-5083	2	107	iglesias	iglesias	PROPN
dpc-5083	2	108	-	-	PUNCT
dpc-5083	2	109	sancho	sancho	PROPN
dpc-5083	2	110	m	m	PROPN
dpc-5083	2	111	,	,	PUNCT
dpc-5083	2	112	martin	martin	PROPN
dpc-5083	2	113	-	-	PUNCT
dpc-5083	2	114	poch	poch	PROPN
dpc-5083	2	115	a	a	PROPN
dpc-5083	2	116	,	,	PUNCT
dpc-5083	2	117	fernández	fernández	PROPN
dpc-5083	2	118	-	-	PUNCT
dpc-5083	2	119	figueras	figueras	PROPN
dpc-5083	2	120	mt	mt	PROPN
dpc-5083	2	121	,	,	PUNCT
dpc-5083	2	122	salleras	sallera	NOUN
dpc-5083	2	123	-	-	ADJ
dpc-5083	2	124	redonnet	redonnet	ADJ
dpc-5083	2	125	m.	m.	NOUN
dpc-5083	2	126	reactive	reactive	ADJ
dpc-5083	2	127	infectious	infectious	ADJ
dpc-5083	2	128	mucocutaneous	mucocutaneous	ADJ
dpc-5083	2	129	eruption	eruption	NOUN
dpc-5083	2	130	(	(	PUNCT
dpc-5083	2	131	rime	rime	NOUN
dpc-5083	2	132	):	):	PUNCT
dpc-5083	2	133	narrative	narrative	NOUN
dpc-5083	2	134	review	review	NOUN
dpc-5083	2	135	and	and	CCONJ
dpc-5083	2	136	proposed	propose	VERB
dpc-5083	2	137	management	management	NOUN
dpc-5083	2	138	algorithm	algorithm	NOUN
dpc-5083	2	139	.	.	PUNCT
dpc-5083	3	1	dermatol	dermatol	NOUN
dpc-5083	3	2	pract	pract	PROPN
dpc-5083	3	3	concept	concept	NOUN
dpc-5083	3	4	.	.	PUNCT
dpc-5083	4	1	2025;15(3):5083	2025;15(3):5083	X
dpc-5083	4	2	.	.	PUNCT
dpc-5083	5	1	doi	doi	NOUN
dpc-5083	5	2	:	:	PUNCT
dpc-5083	5	3	https://doi.org/10.5826/dpc.1503a5083	https://doi.org/10.5826/dpc.1503a5083	PUNCT
dpc-5083	5	4	accepted	accept	VERB
dpc-5083	5	5	:	:	PUNCT
dpc-5083	5	6	january	january	PROPN
dpc-5083	5	7	11	11	NUM
dpc-5083	5	8	,	,	PUNCT
dpc-5083	5	9	2025	2025	NUM
dpc-5083	5	10	;	;	PUNCT
dpc-5083	5	11	published	publish	VERB
dpc-5083	5	12	:	:	PUNCT
dpc-5083	6	1	july	july	PROPN
dpc-5083	6	2	2025	2025	NUM
dpc-5083	6	3	copyright	copyright	NOUN
dpc-5083	6	4	:	:	PUNCT
dpc-5083	6	5	©	©	PROPN
dpc-5083	6	6	2025	2025	NUM
dpc-5083	6	7	garcía	garcía	ADJ
dpc-5083	6	8	-	-	PUNCT
dpc-5083	6	9	rodríguez	rodríguez	NOUN
dpc-5083	6	10	et	et	NOUN
dpc-5083	6	11	al	al	PROPN
dpc-5083	6	12	.	.	PUNCT
dpc-5083	7	1	this	this	PRON
dpc-5083	7	2	is	be	AUX
dpc-5083	7	3	an	an	DET
dpc-5083	7	4	open	open	ADJ
dpc-5083	7	5	-	-	PUNCT
dpc-5083	7	6	access	access	NOUN
dpc-5083	7	7	article	article	NOUN
dpc-5083	7	8	distributed	distribute	VERB
dpc-5083	7	9	under	under	ADP
dpc-5083	7	10	the	the	DET
dpc-5083	7	11	terms	term	NOUN
dpc-5083	7	12	of	of	ADP
dpc-5083	7	13	the	the	DET
dpc-5083	7	14	creative	creative	ADJ
dpc-5083	7	15	commons	common	NOUN
dpc-5083	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-5083	7	17	license	license	NOUN
dpc-5083	7	18	(	(	PUNCT
dpc-5083	7	19	by	by	ADP
dpc-5083	7	20	-	-	PUNCT
dpc-5083	7	21	nc-4.0	nc-4.0	NOUN
dpc-5083	7	22	)	)	PUNCT
dpc-5083	7	23	,	,	PUNCT
dpc-5083	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-5083	7	25	,	,	PUNCT
dpc-5083	7	26	which	which	PRON
dpc-5083	7	27	permits	permit	VERB
dpc-5083	7	28	unrestricted	unrestricted	ADJ
dpc-5083	7	29	noncommercial	noncommercial	ADJ
dpc-5083	7	30	use	use	NOUN
dpc-5083	7	31	,	,	PUNCT
dpc-5083	7	32	distribution	distribution	NOUN
dpc-5083	7	33	,	,	PUNCT
dpc-5083	7	34	and	and	CCONJ
dpc-5083	7	35	reproduction	reproduction	NOUN
dpc-5083	7	36	in	in	ADP
dpc-5083	7	37	any	any	DET
dpc-5083	7	38	medium	medium	NOUN
dpc-5083	7	39	,	,	PUNCT
dpc-5083	7	40	provided	provide	VERB
dpc-5083	7	41	the	the	DET
dpc-5083	7	42	original	original	ADJ
dpc-5083	7	43	authors	author	NOUN
dpc-5083	7	44	and	and	CCONJ
dpc-5083	7	45	source	source	NOUN
dpc-5083	7	46	are	be	AUX
dpc-5083	7	47	credited	credit	VERB
dpc-5083	7	48	.	.	PUNCT
dpc-5083	8	1	funding	funding	NOUN
dpc-5083	8	2	:	:	PUNCT
dpc-5083	8	3	none	none	NOUN
dpc-5083	8	4	.	.	PUNCT
dpc-5083	9	1	competing	compete	VERB
dpc-5083	9	2	interests	interest	NOUN
dpc-5083	9	3	:	:	PUNCT
dpc-5083	9	4	none	none	NOUN
dpc-5083	9	5	.	.	PUNCT
dpc-5083	10	1	authorship	authorship	NOUN
dpc-5083	10	2	:	:	PUNCT
dpc-5083	10	3	all	all	DET
dpc-5083	10	4	authors	author	NOUN
dpc-5083	10	5	have	have	AUX
dpc-5083	10	6	contributed	contribute	VERB
dpc-5083	10	7	significantly	significantly	ADV
dpc-5083	10	8	to	to	ADP
dpc-5083	10	9	this	this	DET
dpc-5083	10	10	publication	publication	NOUN
dpc-5083	10	11	.	.	PUNCT
dpc-5083	11	1	corresponding	correspond	VERB
dpc-5083	11	2	author	author	NOUN
dpc-5083	11	3	:	:	PUNCT
dpc-5083	11	4	víctor	víctor	NOUN
dpc-5083	11	5	garcía	garcía	NOUN
dpc-5083	11	6	-	-	PUNCT
dpc-5083	11	7	rodríguez	rodríguez	NOUN
dpc-5083	11	8	,	,	PUNCT
dpc-5083	11	9	md	md	PROPN
dpc-5083	11	10	,	,	PUNCT
dpc-5083	11	11	dermatology	dermatology	NOUN
dpc-5083	11	12	department	department	NOUN
dpc-5083	11	13	,	,	PUNCT
dpc-5083	11	14	hospital	hospital	NOUN
dpc-5083	11	15	universitari	universitari	PROPN
dpc-5083	11	16	sagrat	sagrat	PROPN
dpc-5083	11	17	cor	cor	PROPN
dpc-5083	11	18	,	,	PUNCT
dpc-5083	11	19	grupo	grupo	PROPN
dpc-5083	11	20	hospitalario	hospitalario	PROPN
dpc-5083	11	21	quirónsalud	quirónsalud	PROPN
dpc-5083	11	22	,	,	PUNCT
dpc-5083	11	23	barcelona	barcelona	PROPN
dpc-5083	11	24	(	(	PUNCT
dpc-5083	11	25	barcelona	barcelona	PROPN
dpc-5083	11	26	)	)	PUNCT
dpc-5083	11	27	,	,	PUNCT
dpc-5083	11	28	spain	spain	PROPN
dpc-5083	11	29	.	.	PUNCT
dpc-5083	12	1	viladomat	viladomat	PROPN
dpc-5083	12	2	street	street	PROPN
dpc-5083	12	3	,	,	PUNCT
dpc-5083	12	4	288	288	NUM
dpc-5083	12	5	,	,	PUNCT
dpc-5083	12	6	e-08029	e-08029	PROPN
dpc-5083	12	7	barcelona	barcelona	PROPN
dpc-5083	12	8	,	,	PUNCT
dpc-5083	12	9	spain	spain	PROPN
dpc-5083	12	10	.	.	PUNCT
dpc-5083	13	1	orcid	orcid	PROPN
dpc-5083	14	1	i	i	PRON
dpc-5083	14	2	d	d	NOUN
dpc-5083	14	3	:	:	PUNCT
dpc-5083	14	4	0000	0000	NUM
dpc-5083	14	5	-	-	PUNCT
dpc-5083	14	6	0001	0001	NUM
dpc-5083	14	7	-	-	PUNCT
dpc-5083	14	8	5079	5079	NUM
dpc-5083	14	9	-	-	SYM
dpc-5083	14	10	4775	4775	NUM
dpc-5083	14	11	.	.	PUNCT
dpc-5083	15	1	e	e	X
dpc-5083	15	2	-	-	NOUN
dpc-5083	15	3	mail	mail	NOUN
dpc-5083	15	4	:	:	PUNCT
dpc-5083	15	5	derma.vgr@gmail.com	derma.vgr@gmail.com	PROPN
dpc-5083	15	6	introduction	introduction	NOUN
dpc-5083	15	7	:	:	PUNCT
dpc-5083	15	8	rime	rime	NOUN
dpc-5083	15	9	is	be	AUX
dpc-5083	15	10	an	an	DET
dpc-5083	15	11	emerging	emerge	VERB
dpc-5083	15	12	dermatologic	dermatologic	ADJ
dpc-5083	15	13	condition	condition	NOUN
dpc-5083	15	14	marked	mark	VERB
dpc-5083	15	15	by	by	ADP
dpc-5083	15	16	prominent	prominent	ADJ
dpc-5083	15	17	mucositis	mucositis	NOUN
dpc-5083	15	18	with	with	ADP
dpc-5083	15	19	minimal	minimal	ADJ
dpc-5083	15	20	skin	skin	NOUN
dpc-5083	15	21	involvement	involvement	NOUN
dpc-5083	15	22	,	,	PUNCT
dpc-5083	15	23	often	often	ADV
dpc-5083	15	24	mimicking	mimic	VERB
dpc-5083	15	25	stevens	stevens	PROPN
dpc-5083	15	26	-	-	PUNCT
dpc-5083	15	27	johnson	johnson	PROPN
dpc-5083	15	28	syndrome	syndrome	NOUN
dpc-5083	15	29	.	.	PUNCT
dpc-5083	16	1	while	while	SCONJ
dpc-5083	16	2	initially	initially	ADV
dpc-5083	16	3	linked	link	VERB
dpc-5083	16	4	to	to	PART
dpc-5083	16	5	mycoplasma	mycoplasma	VERB
dpc-5083	16	6	pneumoniae	pneumoniae	NOUN
dpc-5083	16	7	,	,	PUNCT
dpc-5083	16	8	a	a	DET
dpc-5083	16	9	broader	broad	ADJ
dpc-5083	16	10	range	range	NOUN
dpc-5083	16	11	of	of	ADP
dpc-5083	16	12	infectious	infectious	ADJ
dpc-5083	16	13	triggers	trigger	NOUN
dpc-5083	16	14	is	be	AUX
dpc-5083	16	15	now	now	ADV
dpc-5083	16	16	recognized	recognize	VERB
dpc-5083	16	17	.	.	PUNCT
dpc-5083	17	1	objectives	objective	NOUN
dpc-5083	17	2	:	:	PUNCT
dpc-5083	17	3	we	we	PRON
dpc-5083	17	4	present	present	VERB
dpc-5083	17	5	a	a	DET
dpc-5083	17	6	narrative	narrative	NOUN
dpc-5083	17	7	review	review	NOUN
dpc-5083	17	8	of	of	ADP
dpc-5083	17	9	this	this	DET
dpc-5083	17	10	entity	entity	NOUN
dpc-5083	17	11	.	.	PUNCT
dpc-5083	18	1	a	a	DET
dpc-5083	18	2	proposed	propose	VERB
dpc-5083	18	3	diagnostic	diagnostic	ADJ
dpc-5083	18	4	and	and	CCONJ
dpc-5083	18	5	therapeutic	therapeutic	ADJ
dpc-5083	18	6	algorithm	algorithm	NOUN
dpc-5083	18	7	is	be	AUX
dpc-5083	18	8	also	also	ADV
dpc-5083	18	9	provided	provide	VERB
dpc-5083	18	10	to	to	PART
dpc-5083	18	11	aid	aid	VERB
dpc-5083	18	12	clinicians	clinician	NOUN
dpc-5083	18	13	in	in	ADP
dpc-5083	18	14	clinical	clinical	ADJ
dpc-5083	18	15	practice	practice	NOUN
dpc-5083	18	16	.	.	PUNCT
dpc-5083	19	1	methods	method	NOUN
dpc-5083	19	2	:	:	PUNCT
dpc-5083	19	3	we	we	PRON
dpc-5083	19	4	performed	perform	VERB
dpc-5083	19	5	a	a	DET
dpc-5083	19	6	narrative	narrative	NOUN
dpc-5083	19	7	review	review	NOUN
dpc-5083	19	8	of	of	ADP
dpc-5083	19	9	english	english	ADJ
dpc-5083	19	10	-	-	PUNCT
dpc-5083	19	11	language	language	NOUN
dpc-5083	19	12	literature	literature	NOUN
dpc-5083	19	13	on	on	ADP
dpc-5083	19	14	rime	rime	NOUN
dpc-5083	19	15	and	and	CCONJ
dpc-5083	19	16	mirm	mirm	PROPN
dpc-5083	19	17	indexed	index	VERB
dpc-5083	19	18	in	in	ADP
dpc-5083	19	19	pubmed	pubmed	PROPN
dpc-5083	19	20	through	through	ADP
dpc-5083	19	21	2024	2024	NUM
dpc-5083	19	22	,	,	PUNCT
dpc-5083	19	23	supplemented	supplement	VERB
dpc-5083	19	24	by	by	ADP
dpc-5083	19	25	clinical	clinical	ADJ
dpc-5083	19	26	insights	insight	NOUN
dpc-5083	19	27	from	from	ADP
dpc-5083	19	28	the	the	DET
dpc-5083	19	29	experience	experience	NOUN
dpc-5083	19	30	of	of	ADP
dpc-5083	19	31	our	our	PRON
dpc-5083	19	32	centre	centre	NOUN
dpc-5083	19	33	.	.	PUNCT
dpc-5083	20	1	results	result	NOUN
dpc-5083	20	2	:	:	PUNCT
dpc-5083	20	3	evidence	evidence	NOUN
dpc-5083	20	4	regarding	regard	VERB
dpc-5083	20	5	treatment	treatment	NOUN
dpc-5083	20	6	is	be	AUX
dpc-5083	20	7	lacking	lack	VERB
dpc-5083	20	8	,	,	PUNCT
dpc-5083	20	9	with	with	ADP
dpc-5083	20	10	systemic	systemic	ADJ
dpc-5083	20	11	steroids	steroid	NOUN
dpc-5083	20	12	and/or	and/or	CCONJ
dpc-5083	20	13	cyclosporine	cyclosporine	VERB
dpc-5083	20	14	a	a	DET
dpc-5083	20	15	showing	show	VERB
dpc-5083	20	16	the	the	DET
dpc-5083	20	17	most	most	ADJ
dpc-5083	20	18	benefit	benefit	NOUN
dpc-5083	20	19	.	.	PUNCT
dpc-5083	21	1	rime	rime	NOUN
dpc-5083	21	2	usually	usually	ADV
dpc-5083	21	3	portends	portend	VERB
dpc-5083	21	4	a	a	DET
dpc-5083	21	5	good	good	ADJ
dpc-5083	21	6	prognosis	prognosis	NOUN
dpc-5083	21	7	,	,	PUNCT
dpc-5083	21	8	with	with	ADP
dpc-5083	21	9	recovery	recovery	NOUN
dpc-5083	21	10	within	within	ADP
dpc-5083	21	11	seven	seven	NUM
dpc-5083	21	12	to	to	PART
dpc-5083	21	13	21	21	NUM
dpc-5083	21	14	days	day	NOUN
dpc-5083	21	15	,	,	PUNCT
dpc-5083	21	16	although	although	SCONJ
dpc-5083	21	17	complications	complication	NOUN
dpc-5083	21	18	can	can	AUX
dpc-5083	21	19	occur	occur	VERB
dpc-5083	21	20	.	.	PUNCT
dpc-5083	22	1	recurrences	recurrence	NOUN
dpc-5083	22	2	are	be	AUX
dpc-5083	22	3	rare	rare	ADJ
dpc-5083	22	4	,	,	PUNCT
dpc-5083	22	5	and	and	CCONJ
dpc-5083	22	6	subsequent	subsequent	ADJ
dpc-5083	22	7	episodes	episode	NOUN
dpc-5083	22	8	can	can	AUX
dpc-5083	22	9	be	be	AUX
dpc-5083	22	10	triggered	trigger	VERB
dpc-5083	22	11	by	by	ADP
dpc-5083	22	12	different	different	ADJ
dpc-5083	22	13	microorganisms	microorganism	NOUN
dpc-5083	22	14	.	.	PUNCT
dpc-5083	23	1	conclusions	conclusion	NOUN
dpc-5083	23	2	:	:	PUNCT
dpc-5083	23	3	rime	rime	NOUN
dpc-5083	23	4	represents	represent	VERB
dpc-5083	23	5	a	a	DET
dpc-5083	23	6	distinct	distinct	ADJ
dpc-5083	23	7	clinical	clinical	ADJ
dpc-5083	23	8	entity	entity	NOUN
dpc-5083	23	9	with	with	ADP
dpc-5083	23	10	a	a	DET
dpc-5083	23	11	broadening	broaden	VERB
dpc-5083	23	12	range	range	NOUN
dpc-5083	23	13	of	of	ADP
dpc-5083	23	14	infectious	infectious	ADJ
dpc-5083	23	15	triggers	trigger	NOUN
dpc-5083	23	16	beyond	beyond	ADP
dpc-5083	23	17	mycoplasma	mycoplasma	NOUN
dpc-5083	23	18	pneumoniae	pneumoniae	NOUN
dpc-5083	23	19	.	.	PUNCT
dpc-5083	24	1	prompt	prompt	ADJ
dpc-5083	24	2	recognition	recognition	NOUN
dpc-5083	24	3	,	,	PUNCT
dpc-5083	24	4	accurate	accurate	ADJ
dpc-5083	24	5	differentiation	differentiation	NOUN
dpc-5083	24	6	from	from	ADP
dpc-5083	24	7	mimickers	mimicker	NOUN
dpc-5083	24	8	,	,	PUNCT
dpc-5083	24	9	and	and	CCONJ
dpc-5083	24	10	a	a	DET
dpc-5083	24	11	structured	structured	ADJ
dpc-5083	24	12	diagnostic	diagnostic	ADJ
dpc-5083	24	13	and	and	CCONJ
dpc-5083	24	14	therapeutic	therapeutic	ADJ
dpc-5083	24	15	approach	approach	NOUN
dpc-5083	24	16	are	be	AUX
dpc-5083	24	17	essential	essential	ADJ
dpc-5083	24	18	for	for	ADP
dpc-5083	24	19	effective	effective	ADJ
dpc-5083	24	20	management	management	NOUN
dpc-5083	24	21	and	and	CCONJ
dpc-5083	24	22	improved	improve	VERB
dpc-5083	24	23	patient	patient	ADJ
dpc-5083	24	24	outcomes	outcome	NOUN
dpc-5083	24	25	.	.	PUNCT
dpc-5083	25	1	abstract	abstract	ADJ
dpc-5083	25	2	2	2	NUM
dpc-5083	25	3	review	review	NOUN
dpc-5083	25	4	|	|	ADV
dpc-5083	25	5	dermatol	dermatol	ADJ
dpc-5083	25	6	pract	pract	NOUN
dpc-5083	25	7	concept	concept	NOUN
dpc-5083	25	8	.	.	PUNCT
dpc-5083	26	1	2025;15(3):5083	2025;15(3):5083	NUM
dpc-5083	26	2	introduction	introduction	NOUN
dpc-5083	26	3	rime	rime	NOUN
dpc-5083	26	4	is	be	AUX
dpc-5083	26	5	a	a	DET
dpc-5083	26	6	parainfectious	parainfectious	ADJ
dpc-5083	26	7	inflammatory	inflammatory	ADJ
dpc-5083	26	8	syndrome	syndrome	NOUN
dpc-5083	26	9	that	that	PRON
dpc-5083	26	10	primarily	primarily	ADV
dpc-5083	26	11	affects	affect	VERB
dpc-5083	26	12	multiple	multiple	ADJ
dpc-5083	26	13	mucous	mucous	ADJ
dpc-5083	26	14	membranes	membrane	NOUN
dpc-5083	26	15	,	,	PUNCT
dpc-5083	26	16	with	with	ADP
dpc-5083	26	17	minimal	minimal	ADJ
dpc-5083	26	18	(	(	PUNCT
dpc-5083	26	19	<	<	X
dpc-5083	26	20	10	10	NUM
dpc-5083	26	21	%	%	NOUN
dpc-5083	26	22	body	body	NOUN
dpc-5083	26	23	surface	surface	NOUN
dpc-5083	26	24	area	area	NOUN
dpc-5083	26	25	[	[	X
dpc-5083	26	26	bsa	bsa	X
dpc-5083	26	27	]	]	X
dpc-5083	26	28	)	)	PUNCT
dpc-5083	26	29	or	or	CCONJ
dpc-5083	26	30	no	no	DET
dpc-5083	26	31	cutaneous	cutaneous	ADJ
dpc-5083	26	32	involvement	involvement	NOUN
dpc-5083	26	33	.	.	PUNCT
dpc-5083	27	1	initially	initially	ADV
dpc-5083	27	2	identified	identify	VERB
dpc-5083	27	3	as	as	ADP
dpc-5083	27	4	mycoplasma	mycoplasma	NOUN
dpc-5083	27	5	-	-	PUNCT
dpc-5083	27	6	induced	induce	VERB
dpc-5083	27	7	rash	rash	NOUN
dpc-5083	27	8	with	with	ADP
dpc-5083	27	9	mucositis	mucositis	PROPN
dpc-5083	27	10	(	(	PUNCT
dpc-5083	27	11	mirm	mirm	NOUN
dpc-5083	27	12	)	)	PUNCT
dpc-5083	27	13	,	,	PUNCT
dpc-5083	27	14	the	the	DET
dpc-5083	27	15	condition	condition	NOUN
dpc-5083	27	16	was	be	AUX
dpc-5083	27	17	renamed	rename	VERB
dpc-5083	27	18	rime	rime	NOUN
dpc-5083	27	19	to	to	PART
dpc-5083	27	20	encompass	encompass	VERB
dpc-5083	27	21	a	a	DET
dpc-5083	27	22	broader	broad	ADJ
dpc-5083	27	23	range	range	NOUN
dpc-5083	27	24	of	of	ADP
dpc-5083	27	25	etiological	etiological	ADJ
dpc-5083	27	26	agents	agent	NOUN
dpc-5083	28	1	[	[	X
dpc-5083	28	2	1	1	NUM
dpc-5083	28	3	]	]	PUNCT
dpc-5083	28	4	.	.	PUNCT
dpc-5083	29	1	rime	rime	NOUN
dpc-5083	29	2	is	be	AUX
dpc-5083	29	3	most	most	ADV
dpc-5083	29	4	frequently	frequently	ADV
dpc-5083	29	5	observed	observe	VERB
dpc-5083	29	6	in	in	ADP
dpc-5083	29	7	pediatric	pediatric	ADJ
dpc-5083	29	8	patients	patient	NOUN
dpc-5083	29	9	and	and	CCONJ
dpc-5083	29	10	young	young	ADJ
dpc-5083	29	11	adults	adult	NOUN
dpc-5083	29	12	,	,	PUNCT
dpc-5083	29	13	with	with	ADP
dpc-5083	29	14	a	a	DET
dpc-5083	29	15	notable	notable	ADJ
dpc-5083	29	16	male	male	ADJ
dpc-5083	29	17	predominance	predominance	NOUN
dpc-5083	29	18	.	.	PUNCT
dpc-5083	30	1	however	however	ADV
dpc-5083	30	2	,	,	PUNCT
dpc-5083	30	3	rime	rime	NOUN
dpc-5083	30	4	has	have	AUX
dpc-5083	30	5	also	also	ADV
dpc-5083	30	6	been	be	AUX
dpc-5083	30	7	reported	report	VERB
dpc-5083	30	8	in	in	ADP
dpc-5083	30	9	older	old	ADJ
dpc-5083	30	10	patients	patient	NOUN
dpc-5083	30	11	[	[	X
dpc-5083	30	12	2,3	2,3	NUM
dpc-5083	30	13	]	]	PUNCT
dpc-5083	30	14	.	.	PUNCT
dpc-5083	31	1	this	this	DET
dpc-5083	31	2	syndrome	syndrome	NOUN
dpc-5083	31	3	tends	tend	VERB
dpc-5083	31	4	to	to	PART
dpc-5083	31	5	occur	occur	VERB
dpc-5083	31	6	more	more	ADV
dpc-5083	31	7	frequently	frequently	ADV
dpc-5083	31	8	during	during	ADP
dpc-5083	31	9	the	the	DET
dpc-5083	31	10	months	month	NOUN
dpc-5083	31	11	from	from	ADP
dpc-5083	31	12	october	october	PROPN
dpc-5083	31	13	to	to	ADP
dpc-5083	31	14	february	february	PROPN
dpc-5083	31	15	[	[	X
dpc-5083	31	16	4	4	NUM
dpc-5083	31	17	]	]	PUNCT
dpc-5083	31	18	.	.	PUNCT
dpc-5083	32	1	the	the	DET
dpc-5083	32	2	diagnosis	diagnosis	NOUN
dpc-5083	32	3	of	of	ADP
dpc-5083	32	4	rime	rime	NOUN
dpc-5083	32	5	is	be	AUX
dpc-5083	32	6	clinical	clinical	ADJ
dpc-5083	32	7	,	,	PUNCT
dpc-5083	32	8	focusing	focus	VERB
dpc-5083	32	9	on	on	ADP
dpc-5083	32	10	the	the	DET
dpc-5083	32	11	characteristic	characteristic	ADJ
dpc-5083	32	12	mucosal	mucosal	NOUN
dpc-5083	32	13	involvement	involvement	NOUN
dpc-5083	32	14	and	and	CCONJ
dpc-5083	32	15	the	the	DET
dpc-5083	32	16	exclusion	exclusion	NOUN
dpc-5083	32	17	of	of	ADP
dpc-5083	32	18	other	other	ADJ
dpc-5083	32	19	potential	potential	ADJ
dpc-5083	32	20	causes	cause	NOUN
dpc-5083	32	21	.	.	PUNCT
dpc-5083	33	1	despite	despite	SCONJ
dpc-5083	33	2	its	its	PRON
dpc-5083	33	3	distinct	distinct	ADJ
dpc-5083	33	4	clinical	clinical	ADJ
dpc-5083	33	5	presentation	presentation	NOUN
dpc-5083	33	6	,	,	PUNCT
dpc-5083	33	7	rime	rime	NOUN
dpc-5083	33	8	is	be	AUX
dpc-5083	33	9	likely	likely	ADV
dpc-5083	33	10	underreported	underreported	ADJ
dpc-5083	33	11	,	,	PUNCT
dpc-5083	33	12	with	with	ADP
dpc-5083	33	13	many	many	ADJ
dpc-5083	33	14	cases	case	NOUN
dpc-5083	33	15	potentially	potentially	ADV
dpc-5083	33	16	misclassified	misclassifie	VERB
dpc-5083	33	17	as	as	ADP
dpc-5083	33	18	incomplete	incomplete	ADJ
dpc-5083	33	19	stevensjohnson	stevensjohnson	NOUN
dpc-5083	33	20	syndrome	syndrome	NOUN
dpc-5083	33	21	[	[	X
dpc-5083	33	22	5,6	5,6	NUM
dpc-5083	33	23	]	]	PUNCT
dpc-5083	33	24	.	.	PUNCT
dpc-5083	34	1	objectives	objective	NOUN
dpc-5083	34	2	this	this	DET
dpc-5083	34	3	manuscript	manuscript	NOUN
dpc-5083	34	4	aims	aim	VERB
dpc-5083	34	5	to	to	PART
dpc-5083	34	6	provide	provide	VERB
dpc-5083	34	7	an	an	DET
dpc-5083	34	8	updated	update	VERB
dpc-5083	34	9	overview	overview	NOUN
dpc-5083	34	10	of	of	ADP
dpc-5083	34	11	reactive	reactive	ADJ
dpc-5083	34	12	infectious	infectious	ADJ
dpc-5083	34	13	mucocutaneous	mucocutaneous	ADJ
dpc-5083	34	14	eruption	eruption	NOUN
dpc-5083	34	15	(	(	PUNCT
dpc-5083	34	16	rime	rime	NOUN
dpc-5083	34	17	)	)	PUNCT
dpc-5083	34	18	,	,	PUNCT
dpc-5083	34	19	focusing	focus	VERB
dpc-5083	34	20	on	on	ADP
dpc-5083	34	21	its	its	PRON
dpc-5083	34	22	clinical	clinical	ADJ
dpc-5083	34	23	presentation	presentation	NOUN
dpc-5083	34	24	,	,	PUNCT
dpc-5083	34	25	pathophysiology	pathophysiology	NOUN
dpc-5083	34	26	,	,	PUNCT
dpc-5083	34	27	and	and	CCONJ
dpc-5083	34	28	differential	differential	ADJ
dpc-5083	34	29	diagnoses	diagnosis	NOUN
dpc-5083	34	30	.	.	PUNCT
dpc-5083	35	1	it	it	PRON
dpc-5083	35	2	also	also	ADV
dpc-5083	35	3	seeks	seek	VERB
dpc-5083	35	4	to	to	PART
dpc-5083	35	5	identify	identify	VERB
dpc-5083	35	6	infectious	infectious	ADJ
dpc-5083	35	7	triggers	trigger	NOUN
dpc-5083	35	8	beyond	beyond	ADP
dpc-5083	35	9	  	  	SPACE
dpc-5083	35	10	mycoplasma	mycoplasma	NOUN
dpc-5083	35	11	pneumoniae	pneumoniae	NOUN
dpc-5083	35	12	,	,	PUNCT
dpc-5083	35	13	propose	propose	VERB
dpc-5083	35	14	a	a	DET
dpc-5083	35	15	practical	practical	ADJ
dpc-5083	35	16	diagnostic	diagnostic	ADJ
dpc-5083	35	17	and	and	CCONJ
dpc-5083	35	18	therapeutic	therapeutic	ADJ
dpc-5083	35	19	algorithm	algorithm	NOUN
dpc-5083	35	20	,	,	PUNCT
dpc-5083	35	21	and	and	CCONJ
dpc-5083	35	22	highlight	highlight	VERB
dpc-5083	35	23	treatment	treatment	NOUN
dpc-5083	35	24	strategies	strategy	NOUN
dpc-5083	35	25	and	and	CCONJ
dpc-5083	35	26	prognostic	prognostic	ADJ
dpc-5083	35	27	considerations	consideration	NOUN
dpc-5083	35	28	to	to	PART
dpc-5083	35	29	support	support	VERB
dpc-5083	35	30	clinical	clinical	ADJ
dpc-5083	35	31	decision	decision	NOUN
dpc-5083	35	32	-	-	PUNCT
dpc-5083	35	33	making	making	NOUN
dpc-5083	35	34	.	.	PUNCT
dpc-5083	36	1	methods	method	NOUN
dpc-5083	36	2	we	we	PRON
dpc-5083	36	3	conducted	conduct	VERB
dpc-5083	36	4	a	a	DET
dpc-5083	36	5	narrative	narrative	NOUN
dpc-5083	36	6	literature	literature	NOUN
dpc-5083	36	7	review	review	NOUN
dpc-5083	36	8	of	of	ADP
dpc-5083	36	9	english	english	ADJ
dpc-5083	36	10	language	language	NOUN
dpc-5083	36	11	case	case	NOUN
dpc-5083	36	12	reports	report	VERB
dpc-5083	36	13	,	,	PUNCT
dpc-5083	36	14	case	case	NOUN
dpc-5083	36	15	series	series	NOUN
dpc-5083	36	16	,	,	PUNCT
dpc-5083	36	17	and	and	CCONJ
dpc-5083	36	18	systematic	systematic	ADJ
dpc-5083	36	19	reviews	review	NOUN
dpc-5083	36	20	related	relate	VERB
dpc-5083	36	21	to	to	ADP
dpc-5083	36	22	rime	rime	NOUN
dpc-5083	36	23	and	and	CCONJ
dpc-5083	36	24	its	its	PRON
dpc-5083	36	25	former	former	ADJ
dpc-5083	36	26	designation	designation	NOUN
dpc-5083	36	27	,	,	PUNCT
dpc-5083	36	28	mirm	mirm	NOUN
dpc-5083	36	29	,	,	PUNCT
dpc-5083	36	30	published	publish	VERB
dpc-5083	36	31	up	up	ADP
dpc-5083	36	32	to	to	ADP
dpc-5083	36	33	2024	2024	NUM
dpc-5083	36	34	and	and	CCONJ
dpc-5083	36	35	indexed	index	VERB
dpc-5083	36	36	in	in	ADP
dpc-5083	36	37	pubmed	pubmed	PROPN
dpc-5083	36	38	.	.	PUNCT
dpc-5083	37	1	data	datum	NOUN
dpc-5083	37	2	were	be	AUX
dpc-5083	37	3	collected	collect	VERB
dpc-5083	37	4	on	on	ADP
dpc-5083	37	5	clinical	clinical	ADJ
dpc-5083	37	6	features	feature	NOUN
dpc-5083	37	7	,	,	PUNCT
dpc-5083	37	8	histopathology	histopathology	NOUN
dpc-5083	37	9	,	,	PUNCT
dpc-5083	37	10	diagnostic	diagnostic	ADJ
dpc-5083	37	11	workup	workup	NOUN
dpc-5083	37	12	,	,	PUNCT
dpc-5083	37	13	management	management	NOUN
dpc-5083	37	14	strategies	strategy	NOUN
dpc-5083	37	15	,	,	PUNCT
dpc-5083	37	16	and	and	CCONJ
dpc-5083	37	17	outcomes	outcome	NOUN
dpc-5083	37	18	.	.	PUNCT
dpc-5083	38	1	in	in	ADP
dpc-5083	38	2	addition	addition	NOUN
dpc-5083	38	3	,	,	PUNCT
dpc-5083	38	4	we	we	PRON
dpc-5083	38	5	incorporated	incorporate	VERB
dpc-5083	38	6	insights	insight	NOUN
dpc-5083	38	7	from	from	ADP
dpc-5083	38	8	our	our	PRON
dpc-5083	38	9	own	own	ADJ
dpc-5083	38	10	clinical	clinical	ADJ
dpc-5083	38	11	experience	experience	NOUN
dpc-5083	38	12	managing	manage	VERB
dpc-5083	38	13	rime	rime	NOUN
dpc-5083	38	14	cases	case	NOUN
dpc-5083	38	15	to	to	PART
dpc-5083	38	16	complement	complement	VERB
dpc-5083	38	17	and	and	CCONJ
dpc-5083	38	18	contextualize	contextualize	VERB
dpc-5083	38	19	the	the	DET
dpc-5083	38	20	findings	finding	NOUN
dpc-5083	38	21	from	from	ADP
dpc-5083	38	22	the	the	DET
dpc-5083	38	23	literature	literature	NOUN
dpc-5083	38	24	.	.	PUNCT
dpc-5083	39	1	results	result	VERB
dpc-5083	39	2	etiological	etiological	ADJ
dpc-5083	39	3	agents	agent	NOUN
dpc-5083	39	4	originally	originally	ADV
dpc-5083	39	5	thought	think	VERB
dpc-5083	39	6	to	to	PART
dpc-5083	39	7	be	be	AUX
dpc-5083	39	8	exclusively	exclusively	ADV
dpc-5083	39	9	associated	associate	VERB
dpc-5083	39	10	with	with	ADP
dpc-5083	39	11	mp	mp	PROPN
dpc-5083	39	12	,	,	PUNCT
dpc-5083	39	13	rime	rime	NOUN
dpc-5083	39	14	is	be	AUX
dpc-5083	39	15	now	now	ADV
dpc-5083	39	16	known	know	VERB
dpc-5083	39	17	to	to	PART
dpc-5083	39	18	be	be	AUX
dpc-5083	39	19	triggered	trigger	VERB
dpc-5083	39	20	by	by	ADP
dpc-5083	39	21	several	several	ADJ
dpc-5083	39	22	agents	agent	NOUN
dpc-5083	39	23	(	(	PUNCT
dpc-5083	39	24	table	table	NOUN
dpc-5083	39	25	 	 	SPACE
dpc-5083	39	26	1	1	NUM
dpc-5083	39	27	)	)	PUNCT
dpc-5083	39	28	.	.	PUNCT
dpc-5083	40	1	bacterial	bacterial	ADJ
dpc-5083	40	2	agents	agent	NOUN
dpc-5083	40	3	include	include	VERB
dpc-5083	40	4	mp	mp	PROPN
dpc-5083	40	5	,	,	PUNCT
dpc-5083	40	6	chlamydophila	chlamydophila	NOUN
dpc-5083	40	7	pneumoniae	pneumoniae	ADV
dpc-5083	40	8	(	(	PUNCT
dpc-5083	40	9	cp	cp	X
dpc-5083	40	10	)	)	PUNCT
dpc-5083	41	1	[	[	X
dpc-5083	41	2	3,7	3,7	NUM
dpc-5083	41	3	]	]	PUNCT
dpc-5083	41	4	,	,	PUNCT
dpc-5083	41	5	group	group	NOUN
dpc-5083	41	6	a	a	DET
dpc-5083	41	7	beta	beta	ADJ
dpc-5083	41	8	hemolytic	hemolytic	ADJ
dpc-5083	41	9	streptococcus	streptococcus	NOUN
dpc-5083	41	10	[	[	X
dpc-5083	41	11	8	8	NUM
dpc-5083	41	12	]	]	PUNCT
dpc-5083	41	13	,	,	PUNCT
dpc-5083	41	14	and	and	CCONJ
dpc-5083	41	15	chlamydia	chlamydia	NOUN
dpc-5083	41	16	psitacci	psitacci	NOUN
dpc-5083	42	1	[	[	X
dpc-5083	42	2	9	9	NUM
dpc-5083	42	3	]	]	PUNCT
dpc-5083	42	4	.	.	PUNCT
dpc-5083	43	1	regarding	regard	VERB
dpc-5083	43	2	viral	viral	ADJ
dpc-5083	43	3	infection	infection	NOUN
dpc-5083	43	4	,	,	PUNCT
dpc-5083	43	5	influenza	influenza	NOUN
dpc-5083	43	6	a	a	PRON
dpc-5083	44	1	[	[	X
dpc-5083	44	2	10	10	NUM
dpc-5083	44	3	]	]	PUNCT
dpc-5083	44	4	,	,	PUNCT
dpc-5083	44	5	influenza	influenza	NOUN
dpc-5083	44	6	b	b	X
dpc-5083	45	1	[	[	X
dpc-5083	45	2	11	11	NUM
dpc-5083	45	3	]	]	PUNCT
dpc-5083	45	4	,	,	PUNCT
dpc-5083	45	5	sars	sar	NOUN
dpc-5083	45	6	-	-	PUNCT
dpc-5083	45	7	cov-2	cov-2	NOUN
dpc-5083	45	8	[	[	X
dpc-5083	45	9	10,12–19	10,12–19	PROPN
dpc-5083	45	10	]	]	PUNCT
dpc-5083	45	11	,	,	PUNCT
dpc-5083	45	12	common	common	ADJ
dpc-5083	45	13	coronavirus	coronavirus	NOUN
dpc-5083	46	1	[	[	X
dpc-5083	46	2	20	20	NUM
dpc-5083	46	3	]	]	PUNCT
dpc-5083	46	4	,	,	PUNCT
dpc-5083	46	5	norovirus	noroviru	NOUN
dpc-5083	46	6	[	[	X
dpc-5083	46	7	21	21	NUM
dpc-5083	46	8	]	]	PUNCT
dpc-5083	46	9	,	,	PUNCT
dpc-5083	46	10	metapneumovirus	metapneumovirus	NOUN
dpc-5083	46	11	[	[	X
dpc-5083	46	12	6	6	NUM
dpc-5083	46	13	]	]	PUNCT
dpc-5083	46	14	,	,	PUNCT
dpc-5083	46	15	parainfluenza	parainfluenza	ADJ
dpc-5083	46	16	2	2	NUM
dpc-5083	47	1	[	[	X
dpc-5083	47	2	6	6	NUM
dpc-5083	47	3	]	]	PUNCT
dpc-5083	47	4	,	,	PUNCT
dpc-5083	47	5	enterovirus	enterovirus	NOUN
dpc-5083	47	6	,	,	PUNCT
dpc-5083	47	7	rhinovirus	rhinovirus	NOUN
dpc-5083	48	1	[	[	X
dpc-5083	48	2	16	16	NUM
dpc-5083	48	3	]	]	PUNCT
dpc-5083	48	4	,	,	PUNCT
dpc-5083	48	5	herpes	herpe	NOUN
dpc-5083	48	6	simplex	simplex	NOUN
dpc-5083	48	7	virus	virus	NOUN
dpc-5083	48	8	6	6	NUM
dpc-5083	49	1	[	[	X
dpc-5083	49	2	22	22	NUM
dpc-5083	49	3	]	]	PUNCT
dpc-5083	49	4	,	,	PUNCT
dpc-5083	49	5	and	and	CCONJ
dpc-5083	49	6	adenovirus	adenovirus	NOUN
dpc-5083	49	7	[	[	X
dpc-5083	49	8	23	23	NUM
dpc-5083	49	9	]	]	PUNCT
dpc-5083	49	10	have	have	AUX
dpc-5083	49	11	been	be	AUX
dpc-5083	49	12	reported	report	VERB
dpc-5083	49	13	.	.	PUNCT
dpc-5083	50	1	pathophysiology	pathophysiology	NOUN
dpc-5083	50	2	the	the	DET
dpc-5083	50	3	pathophysiology	pathophysiology	NOUN
dpc-5083	50	4	of	of	ADP
dpc-5083	50	5	rime	rime	NOUN
dpc-5083	50	6	remains	remain	VERB
dpc-5083	50	7	unclear	unclear	ADJ
dpc-5083	50	8	.	.	PUNCT
dpc-5083	51	1	b	b	X
dpc-5083	51	2	-	-	PUNCT
dpc-5083	51	3	cell	cell	NOUN
dpc-5083	51	4	proliferation	proliferation	NOUN
dpc-5083	51	5	,	,	PUNCT
dpc-5083	51	6	immune	immune	ADJ
dpc-5083	51	7	complex	complex	ADJ
dpc-5083	51	8	deposition	deposition	NOUN
dpc-5083	51	9	due	due	ADP
dpc-5083	51	10	to	to	ADP
dpc-5083	51	11	antibodies	antibody	NOUN
dpc-5083	51	12	against	against	ADP
dpc-5083	51	13	mp	mp	NOUN
dpc-5083	51	14	,	,	PUNCT
dpc-5083	51	15	and	and	CCONJ
dpc-5083	51	16	other	other	ADJ
dpc-5083	51	17	agents	agent	NOUN
dpc-5083	51	18	have	have	AUX
dpc-5083	51	19	been	be	AUX
dpc-5083	51	20	proposed	propose	VERB
dpc-5083	51	21	,	,	PUNCT
dpc-5083	51	22	as	as	SCONJ
dpc-5083	51	23	has	have	VERB
dpc-5083	51	24	complement	complement	NOUN
dpc-5083	51	25	activation	activation	NOUN
dpc-5083	51	26	.	.	PUNCT
dpc-5083	52	1	resemblance	resemblance	NOUN
dpc-5083	52	2	of	of	ADP
dpc-5083	52	3	an	an	DET
dpc-5083	52	4	unknown	unknown	ADJ
dpc-5083	52	5	keratinocyte	keratinocyte	NOUN
dpc-5083	52	6	antigen	antigen	NOUN
dpc-5083	52	7	and	and	CCONJ
dpc-5083	52	8	mycoplasma	mycoplasma	NOUN
dpc-5083	52	9	p1	p1	NOUN
dpc-5083	52	10	adhesion	adhesion	NOUN
dpc-5083	52	11	molecules	molecule	NOUN
dpc-5083	52	12	in	in	ADP
dpc-5083	52	13	patients	patient	NOUN
dpc-5083	52	14	with	with	ADP
dpc-5083	52	15	a	a	DET
dpc-5083	52	16	genetic	genetic	ADJ
dpc-5083	52	17	predisposition	predisposition	NOUN
dpc-5083	52	18	has	have	AUX
dpc-5083	52	19	also	also	ADV
dpc-5083	52	20	been	be	AUX
dpc-5083	52	21	suggested	suggest	VERB
dpc-5083	52	22	[	[	X
dpc-5083	52	23	7	7	NUM
dpc-5083	52	24	]	]	PUNCT
dpc-5083	52	25	.	.	PUNCT
dpc-5083	53	1	interestingly	interestingly	ADV
dpc-5083	53	2	,	,	PUNCT
dpc-5083	53	3	a	a	DET
dpc-5083	53	4	genetic	genetic	ADJ
dpc-5083	53	5	proneness	proneness	NOUN
dpc-5083	53	6	,	,	PUNCT
dpc-5083	53	7	especially	especially	ADV
dpc-5083	53	8	in	in	ADP
dpc-5083	53	9	human	human	ADJ
dpc-5083	53	10	leukocyte	leukocyte	NOUN
dpc-5083	53	11	antigen	antigen	NOUN
dpc-5083	53	12	(	(	PUNCT
dpc-5083	53	13	hla)-b27	hla)-b27	NOUN
dpc-5083	53	14	and	and	CCONJ
dpc-5083	53	15	b51	b51	ADJ
dpc-5083	53	16	carriers	carrier	NOUN
dpc-5083	53	17	has	have	AUX
dpc-5083	53	18	been	be	AUX
dpc-5083	53	19	hypothesized	hypothesize	VERB
dpc-5083	53	20	[	[	X
dpc-5083	53	21	6,24	6,24	X
dpc-5083	53	22	]	]	PUNCT
dpc-5083	53	23	.	.	PUNCT
dpc-5083	54	1	clinical	clinical	ADJ
dpc-5083	54	2	aspects	aspect	NOUN
dpc-5083	54	3	rime	rime	NOUN
dpc-5083	54	4	predominantly	predominantly	ADV
dpc-5083	54	5	affects	affect	VERB
dpc-5083	54	6	the	the	DET
dpc-5083	54	7	mucous	mucous	ADJ
dpc-5083	54	8	membranes	membrane	NOUN
dpc-5083	54	9	extensively	extensively	ADV
dpc-5083	54	10	,	,	PUNCT
dpc-5083	54	11	while	while	SCONJ
dpc-5083	54	12	causing	cause	VERB
dpc-5083	54	13	minimal	minimal	ADJ
dpc-5083	54	14	involvement	involvement	NOUN
dpc-5083	54	15	of	of	ADP
dpc-5083	54	16	the	the	DET
dpc-5083	54	17	skin	skin	NOUN
dpc-5083	54	18	[	[	X
dpc-5083	54	19	1	1	NUM
dpc-5083	54	20	]	]	PUNCT
dpc-5083	54	21	.	.	PUNCT
dpc-5083	55	1	the	the	DET
dpc-5083	55	2	clinical	clinical	ADJ
dpc-5083	55	3	presentation	presentation	NOUN
dpc-5083	55	4	of	of	ADP
dpc-5083	55	5	rime	rime	NOUN
dpc-5083	55	6	typically	typically	ADV
dpc-5083	55	7	begins	begin	VERB
dpc-5083	55	8	with	with	ADP
dpc-5083	55	9	a	a	DET
dpc-5083	55	10	prodromal	prodromal	ADJ
dpc-5083	55	11	phase	phase	NOUN
dpc-5083	55	12	lasting	last	VERB
dpc-5083	55	13	7–9	7–9	NUM
dpc-5083	55	14	days	day	NOUN
dpc-5083	55	15	(	(	PUNCT
dpc-5083	55	16	1	1	NUM
dpc-5083	55	17	-	-	SYM
dpc-5083	55	18	21	21	NUM
dpc-5083	55	19	days	day	NOUN
dpc-5083	55	20	)	)	PUNCT
dpc-5083	55	21	characterized	characterize	VERB
dpc-5083	55	22	by	by	ADP
dpc-5083	55	23	upper	upper	ADJ
dpc-5083	55	24	respiratory	respiratory	ADJ
dpc-5083	55	25	tract	tract	NOUN
dpc-5083	55	26	infection	infection	NOUN
dpc-5083	55	27	symptoms	symptom	NOUN
dpc-5083	55	28	or	or	CCONJ
dpc-5083	55	29	conjunctivitis	conjunctivitis	NOUN
dpc-5083	55	30	[	[	X
dpc-5083	55	31	21,25	21,25	NUM
dpc-5083	55	32	]	]	PUNCT
dpc-5083	55	33	.	.	PUNCT
dpc-5083	56	1	however	however	ADV
dpc-5083	56	2	,	,	PUNCT
dpc-5083	56	3	the	the	DET
dpc-5083	56	4	prodromal	prodromal	ADJ
dpc-5083	56	5	phase	phase	NOUN
dpc-5083	56	6	can	can	AUX
dpc-5083	56	7	be	be	AUX
dpc-5083	56	8	absent	absent	ADJ
dpc-5083	56	9	[	[	PUNCT
dpc-5083	56	10	21	21	NUM
dpc-5083	56	11	]	]	PUNCT
dpc-5083	56	12	.	.	PUNCT
dpc-5083	57	1	mucosal	mucosal	ADJ
dpc-5083	57	2	involvement	involvement	NOUN
dpc-5083	57	3	is	be	AUX
dpc-5083	57	4	extensive	extensive	ADJ
dpc-5083	57	5	,	,	PUNCT
dpc-5083	57	6	presenting	present	VERB
dpc-5083	57	7	with	with	ADP
dpc-5083	57	8	edema	edema	PROPN
dpc-5083	57	9	,	,	PUNCT
dpc-5083	57	10	erosions	erosion	NOUN
dpc-5083	57	11	,	,	PUNCT
dpc-5083	57	12	friable	friable	ADJ
dpc-5083	57	13	mucosa	mucosa	NOUN
dpc-5083	57	14	,	,	PUNCT
dpc-5083	57	15	and	and	CCONJ
dpc-5083	57	16	hemorrhagic	hemorrhagic	VERB
dpc-5083	57	17	crusts	crust	NOUN
dpc-5083	57	18	[	[	X
dpc-5083	57	19	7	7	NUM
dpc-5083	57	20	]	]	PUNCT
dpc-5083	57	21	.	.	PUNCT
dpc-5083	58	1	the	the	DET
dpc-5083	58	2	oral	oral	ADJ
dpc-5083	58	3	mucosa	mucosa	NOUN
dpc-5083	58	4	is	be	AUX
dpc-5083	58	5	affected	affect	VERB
dpc-5083	58	6	in	in	ADP
dpc-5083	58	7	94–100	94–100	NUM
dpc-5083	58	8	%	%	NOUN
dpc-5083	58	9	of	of	ADP
dpc-5083	58	10	cases	case	NOUN
dpc-5083	58	11	,	,	PUNCT
dpc-5083	58	12	followed	follow	VERB
dpc-5083	58	13	by	by	ADP
dpc-5083	58	14	the	the	DET
dpc-5083	58	15	ocular	ocular	ADJ
dpc-5083	58	16	mucosa	mucosa	NOUN
dpc-5083	58	17	in	in	ADP
dpc-5083	58	18	82	82	NUM
dpc-5083	58	19	%	%	NOUN
dpc-5083	58	20	,	,	PUNCT
dpc-5083	58	21	manifesting	manifest	VERB
dpc-5083	58	22	as	as	ADP
dpc-5083	58	23	bilateral	bilateral	ADJ
dpc-5083	58	24	purulent	purulent	ADJ
dpc-5083	58	25	or	or	CCONJ
dpc-5083	58	26	seromucous	seromucous	ADJ
dpc-5083	58	27	conjunctivitis	conjunctivitis	NOUN
dpc-5083	58	28	and	and	CCONJ
dpc-5083	58	29	eyelid	eyelid	PROPN
dpc-5083	58	30	edema	edema	NOUN
dpc-5083	58	31	.	.	PUNCT
dpc-5083	59	1	urogenital	urogenital	ADJ
dpc-5083	59	2	mucosal	mucosal	NOUN
dpc-5083	59	3	involvement	involvement	NOUN
dpc-5083	59	4	appears	appear	VERB
dpc-5083	59	5	in	in	ADP
dpc-5083	59	6	63	63	NUM
dpc-5083	59	7	%	%	NOUN
dpc-5083	59	8	of	of	ADP
dpc-5083	59	9	cases	case	NOUN
dpc-5083	59	10	and	and	CCONJ
dpc-5083	59	11	can	can	AUX
dpc-5083	59	12	lead	lead	VERB
dpc-5083	59	13	to	to	ADP
dpc-5083	59	14	permanent	permanent	ADJ
dpc-5083	59	15	sequelae	sequelae	NOUN
dpc-5083	59	16	[	[	X
dpc-5083	59	17	1	1	NUM
dpc-5083	59	18	]	]	PUNCT
dpc-5083	59	19	.	.	PUNCT
dpc-5083	60	1	involvement	involvement	NOUN
dpc-5083	60	2	of	of	ADP
dpc-5083	60	3	the	the	DET
dpc-5083	60	4	nasal	nasal	NOUN
dpc-5083	60	5	and	and	CCONJ
dpc-5083	60	6	anal	anal	ADJ
dpc-5083	60	7	mucosa	mucosa	NOUN
dpc-5083	60	8	is	be	AUX
dpc-5083	60	9	rare	rare	ADJ
dpc-5083	60	10	or	or	CCONJ
dpc-5083	60	11	possibly	possibly	ADV
dpc-5083	60	12	underreported	underreported	ADJ
dpc-5083	60	13	,	,	PUNCT
dpc-5083	60	14	warranting	warrant	VERB
dpc-5083	60	15	thorough	thorough	ADJ
dpc-5083	60	16	examination	examination	NOUN
dpc-5083	61	1	[	[	X
dpc-5083	61	2	14,26	14,26	NOUN
dpc-5083	61	3	]	]	PUNCT
dpc-5083	61	4	.	.	PUNCT
dpc-5083	62	1	ocular	ocular	ADJ
dpc-5083	62	2	signs	sign	NOUN
dpc-5083	62	3	include	include	VERB
dpc-5083	62	4	conjunctival	conjunctival	ADJ
dpc-5083	62	5	injection	injection	NOUN
dpc-5083	62	6	,	,	PUNCT
dpc-5083	62	7	conjunctival	conjunctival	NOUN
dpc-5083	62	8	ulcers	ulcer	NOUN
dpc-5083	62	9	,	,	PUNCT
dpc-5083	62	10	erythema	erythema	ADJ
dpc-5083	62	11	and	and	CCONJ
dpc-5083	62	12	ulceration	ulceration	NOUN
dpc-5083	62	13	of	of	ADP
dpc-5083	62	14	the	the	DET
dpc-5083	62	15	eyelid	eyelid	NOUN
dpc-5083	62	16	margin	margin	NOUN
dpc-5083	62	17	,	,	PUNCT
dpc-5083	62	18	pseudomembrane	pseudomembrane	NOUN
dpc-5083	62	19	formation	formation	NOUN
dpc-5083	62	20	,	,	PUNCT
dpc-5083	62	21	corneal	corneal	ADJ
dpc-5083	62	22	epithelial	epithelial	ADJ
dpc-5083	62	23	involvement	involvement	NOUN
dpc-5083	62	24	,	,	PUNCT
dpc-5083	62	25	and	and	CCONJ
dpc-5083	62	26	superficial	superficial	ADJ
dpc-5083	62	27	punctate	punctate	NOUN
dpc-5083	62	28	keratitis	keratitis	NOUN
dpc-5083	62	29	[	[	X
dpc-5083	62	30	27	27	NUM
dpc-5083	62	31	]	]	PUNCT
dpc-5083	62	32	.	.	PUNCT
dpc-5083	63	1	though	though	SCONJ
dpc-5083	63	2	ocular	ocular	ADJ
dpc-5083	63	3	sequelae	sequelae	NOUN
dpc-5083	63	4	are	be	AUX
dpc-5083	63	5	uncommon	uncommon	ADJ
dpc-5083	63	6	,	,	PUNCT
dpc-5083	63	7	they	they	PRON
dpc-5083	63	8	can	can	AUX
dpc-5083	63	9	occur	occur	VERB
dpc-5083	63	10	in	in	ADP
dpc-5083	63	11	up	up	ADP
dpc-5083	63	12	to	to	PART
dpc-5083	63	13	13.3	13.3	NUM
dpc-5083	63	14	%	%	NOUN
dpc-5083	63	15	of	of	ADP
dpc-5083	63	16	cases	case	NOUN
dpc-5083	63	17	[	[	X
dpc-5083	63	18	27	27	NUM
dpc-5083	63	19	]	]	PUNCT
dpc-5083	63	20	.	.	PUNCT
dpc-5083	64	1	cutaneous	cutaneous	ADJ
dpc-5083	64	2	involvement	involvement	NOUN
dpc-5083	64	3	occurs	occur	VERB
dpc-5083	64	4	in	in	ADP
dpc-5083	64	5	34	34	NUM
dpc-5083	64	6	%	%	NOUN
dpc-5083	64	7	of	of	ADP
dpc-5083	64	8	patients	patient	NOUN
dpc-5083	64	9	and	and	CCONJ
dpc-5083	64	10	is	be	AUX
dpc-5083	64	11	characterized	characterize	VERB
dpc-5083	64	12	by	by	ADP
dpc-5083	64	13	erythematous	erythematous	ADJ
dpc-5083	64	14	-	-	PUNCT
dpc-5083	64	15	violaceous	violaceous	NOUN
dpc-5083	64	16	plaques	plaque	NOUN
dpc-5083	64	17	,	,	PUNCT
dpc-5083	64	18	vesiculobullous	vesiculobullous	ADJ
dpc-5083	64	19	lesions	lesion	NOUN
dpc-5083	64	20	(	(	PUNCT
dpc-5083	64	21	77	77	NUM
dpc-5083	64	22	%	%	NOUN
dpc-5083	64	23	)	)	PUNCT
dpc-5083	64	24	,	,	PUNCT
dpc-5083	64	25	atypical	atypical	ADJ
dpc-5083	64	26	targetoid	targetoid	NOUN
dpc-5083	64	27	lesions	lesion	NOUN
dpc-5083	64	28	(	(	PUNCT
dpc-5083	64	29	48	48	NUM
dpc-5083	64	30	%	%	NOUN
dpc-5083	64	31	)	)	PUNCT
dpc-5083	64	32	,	,	PUNCT
dpc-5083	64	33	papules	papule	NOUN
dpc-5083	64	34	(	(	PUNCT
dpc-5083	64	35	14	14	NUM
dpc-5083	64	36	%	%	NOUN
dpc-5083	64	37	)	)	PUNCT
dpc-5083	64	38	,	,	PUNCT
dpc-5083	64	39	macules	macule	NOUN
dpc-5083	64	40	(	(	PUNCT
dpc-5083	64	41	12	12	NUM
dpc-5083	64	42	%	%	NOUN
dpc-5083	64	43	)	)	PUNCT
dpc-5083	64	44	,	,	PUNCT
dpc-5083	64	45	and	and	CCONJ
dpc-5083	64	46	morbilliform	morbilliform	NOUN
dpc-5083	64	47	exanthems	exanthem	NOUN
dpc-5083	64	48	table	table	NOUN
dpc-5083	64	49	1	1	NUM
dpc-5083	64	50	.	.	PUNCT
dpc-5083	64	51	etiological	etiological	ADJ
dpc-5083	64	52	agents	agent	NOUN
dpc-5083	64	53	of	of	ADP
dpc-5083	64	54	rime	rime	NOUN
dpc-5083	64	55	.	.	PUNCT
dpc-5083	65	1	bacteria	bacteria	NOUN
dpc-5083	65	2	mycoplasma	mycoplasma	VERB
dpc-5083	65	3	pneumoniae	pneumoniae	NOUN
dpc-5083	65	4	,	,	PUNCT
dpc-5083	65	5	chlamydophila	chlamydophila	NOUN
dpc-5083	65	6	pneumoniae	pneumoniae	NOUN
dpc-5083	65	7	,	,	PUNCT
dpc-5083	65	8	group	group	NOUN
dpc-5083	65	9	a	a	DET
dpc-5083	65	10	hemolytic	hemolytic	ADJ
dpc-5083	65	11	streptococcus	streptococcus	NOUN
dpc-5083	65	12	,	,	PUNCT
dpc-5083	65	13	chlamydia	chlamydia	NOUN
dpc-5083	65	14	psitacci	psitacci	PROPN
dpc-5083	65	15	.	.	PUNCT
dpc-5083	66	1	virus	virus	NOUN
dpc-5083	66	2	influenza	influenza	PROPN
dpc-5083	66	3	a	a	PRON
dpc-5083	66	4	,	,	PUNCT
dpc-5083	66	5	influenza	influenza	NOUN
dpc-5083	66	6	b	b	NOUN
dpc-5083	66	7	,	,	PUNCT
dpc-5083	66	8	sars	sar	NOUN
dpc-5083	66	9	-	-	PUNCT
dpc-5083	66	10	cov-2	cov-2	NOUN
dpc-5083	66	11	,	,	PUNCT
dpc-5083	66	12	common	common	ADJ
dpc-5083	66	13	coronavirus	coronavirus	NOUN
dpc-5083	66	14	,	,	PUNCT
dpc-5083	66	15	norovirus	noroviru	NOUN
dpc-5083	66	16	,	,	PUNCT
dpc-5083	66	17	metapneumovirus	metapneumovirus	NOUN
dpc-5083	66	18	,	,	PUNCT
dpc-5083	66	19	parainfluenza	parainfluenza	ADJ
dpc-5083	66	20	2	2	NUM
dpc-5083	66	21	,	,	PUNCT
dpc-5083	66	22	enterovirus	enterovirus	NOUN
dpc-5083	66	23	,	,	PUNCT
dpc-5083	66	24	rhinovirus	rhinovirus	NOUN
dpc-5083	66	25	,	,	PUNCT
dpc-5083	66	26	herpes	herpe	NOUN
dpc-5083	66	27	simplex	simplex	NOUN
dpc-5083	66	28	virus	virus	NOUN
dpc-5083	66	29	6	6	NUM
dpc-5083	66	30	,	,	PUNCT
dpc-5083	66	31	adenovirus	adenovirus	NOUN
dpc-5083	66	32	.	.	PUNCT
dpc-5083	67	1	abbreviations	abbreviation	NOUN
dpc-5083	67	2	:	:	PUNCT
dpc-5083	67	3	rime	rime	NOUN
dpc-5083	67	4	:	:	PUNCT
dpc-5083	67	5	reactive	reactive	ADJ
dpc-5083	67	6	infectious	infectious	ADJ
dpc-5083	67	7	mucocutaneous	mucocutaneous	ADJ
dpc-5083	67	8	eruption	eruption	NOUN
dpc-5083	67	9	;	;	PUNCT
dpc-5083	68	1	sars	sar	NOUN
dpc-5083	68	2	-	-	PUNCT
dpc-5083	68	3	cov-2	cov-2	NOUN
dpc-5083	68	4	:	:	PUNCT
dpc-5083	68	5	severe	severe	ADJ
dpc-5083	68	6	acute	acute	ADJ
dpc-5083	68	7	respiratory	respiratory	ADJ
dpc-5083	68	8	syndrome	syndrome	NOUN
dpc-5083	68	9	coronavirus	coronavirus	NOUN
dpc-5083	68	10	2	2	NUM
dpc-5083	68	11	.	.	X
dpc-5083	68	12	review	review	VERB
dpc-5083	68	13	|	|	ADV
dpc-5083	68	14	dermatol	dermatol	ADJ
dpc-5083	68	15	pract	pract	NOUN
dpc-5083	68	16	concept	concept	NOUN
dpc-5083	68	17	.	.	PUNCT
dpc-5083	69	1	2025;15(3):5083	2025;15(3):5083	NUM
dpc-5083	69	2	3	3	NUM
dpc-5083	69	3	(	(	PUNCT
dpc-5083	69	4	9	9	NUM
dpc-5083	69	5	%	%	NOUN
dpc-5083	69	6	)	)	PUNCT
dpc-5083	70	1	[	[	X
dpc-5083	70	2	1	1	NUM
dpc-5083	70	3	]	]	PUNCT
dpc-5083	70	4	.	.	PUNCT
dpc-5083	71	1	the	the	DET
dpc-5083	71	2	palms	palm	NOUN
dpc-5083	71	3	and	and	CCONJ
dpc-5083	71	4	soles	sol	NOUN
dpc-5083	71	5	are	be	AUX
dpc-5083	71	6	typically	typically	ADV
dpc-5083	71	7	spared	spare	VERB
dpc-5083	71	8	.	.	PUNCT
dpc-5083	72	1	in	in	ADP
dpc-5083	72	2	the	the	DET
dpc-5083	72	3	absence	absence	NOUN
dpc-5083	72	4	of	of	ADP
dpc-5083	72	5	cutaneous	cutaneous	ADJ
dpc-5083	72	6	lesions	lesion	NOUN
dpc-5083	72	7	,	,	PUNCT
dpc-5083	72	8	the	the	DET
dpc-5083	72	9	condition	condition	NOUN
dpc-5083	72	10	is	be	AUX
dpc-5083	72	11	referred	refer	VERB
dpc-5083	72	12	to	to	ADP
dpc-5083	72	13	as	as	ADP
dpc-5083	72	14	rime	rime	NOUN
dpc-5083	72	15	sine	sine	ADJ
dpc-5083	72	16	rash	rash	NOUN
dpc-5083	72	17	[	[	X
dpc-5083	72	18	28	28	NUM
dpc-5083	72	19	]	]	PUNCT
dpc-5083	72	20	.	.	PUNCT
dpc-5083	73	1	conversely	conversely	ADV
dpc-5083	73	2	,	,	PUNCT
dpc-5083	73	3	atypical	atypical	ADJ
dpc-5083	73	4	presentations	presentation	NOUN
dpc-5083	73	5	with	with	ADP
dpc-5083	73	6	moderate	moderate	ADJ
dpc-5083	73	7	-	-	PUNCT
dpc-5083	73	8	to	to	ADP
dpc-5083	73	9	-	-	PUNCT
dpc-5083	73	10	severe	severe	ADJ
dpc-5083	73	11	skin	skin	NOUN
dpc-5083	73	12	involvement	involvement	NOUN
dpc-5083	73	13	have	have	AUX
dpc-5083	73	14	also	also	ADV
dpc-5083	73	15	been	be	AUX
dpc-5083	73	16	published	publish	VERB
dpc-5083	73	17	[	[	X
dpc-5083	73	18	1,21	1,21	X
dpc-5083	73	19	]	]	PUNCT
dpc-5083	73	20	.	.	PUNCT
dpc-5083	74	1	general	general	ADJ
dpc-5083	74	2	symptoms	symptom	NOUN
dpc-5083	74	3	include	include	VERB
dpc-5083	74	4	malaise	malaise	NOUN
dpc-5083	74	5	,	,	PUNCT
dpc-5083	74	6	fever	fever	NOUN
dpc-5083	74	7	,	,	PUNCT
dpc-5083	74	8	and	and	CCONJ
dpc-5083	74	9	joint	joint	ADJ
dpc-5083	74	10	pain	pain	NOUN
dpc-5083	75	1	[	[	X
dpc-5083	75	2	29	29	NUM
dpc-5083	75	3	]	]	PUNCT
dpc-5083	75	4	,	,	PUNCT
dpc-5083	75	5	often	often	ADV
dpc-5083	75	6	presenting	present	VERB
dpc-5083	75	7	with	with	ADP
dpc-5083	75	8	feeding	feed	VERB
dpc-5083	75	9	difficulties	difficulty	NOUN
dpc-5083	75	10	.	.	PUNCT
dpc-5083	76	1	histopathology	histopathology	NOUN
dpc-5083	76	2	the	the	DET
dpc-5083	76	3	histopathological	histopathological	ADJ
dpc-5083	76	4	findings	finding	NOUN
dpc-5083	76	5	of	of	ADP
dpc-5083	76	6	rime	rime	NOUN
dpc-5083	76	7	are	be	AUX
dpc-5083	76	8	nonspecific	nonspecific	ADJ
dpc-5083	76	9	and	and	CCONJ
dpc-5083	76	10	can	can	AUX
dpc-5083	76	11	be	be	AUX
dpc-5083	76	12	indistinguishable	indistinguishable	ADJ
dpc-5083	76	13	from	from	ADP
dpc-5083	76	14	those	those	PRON
dpc-5083	76	15	of	of	ADP
dpc-5083	76	16	erythema	erythema	ADJ
dpc-5083	76	17	multiforme/	multiforme/	PROPN
dpc-5083	76	18	stevens	stevens	PROPN
dpc-5083	76	19	-	-	PUNCT
dpc-5083	76	20	johnson	johnson	PROPN
dpc-5083	76	21	syndrome	syndrome	PROPN
dpc-5083	76	22	(	(	PUNCT
dpc-5083	76	23	sjs	sjs	PROPN
dpc-5083	76	24	)	)	PUNCT
dpc-5083	76	25	or	or	CCONJ
dpc-5083	76	26	even	even	ADV
dpc-5083	76	27	toxic	toxic	ADJ
dpc-5083	76	28	epidermal	epidermal	ADJ
dpc-5083	76	29	necrolysis	necrolysis	NOUN
dpc-5083	76	30	(	(	PUNCT
dpc-5083	76	31	ten	ten	NUM
dpc-5083	76	32	)	)	PUNCT
dpc-5083	77	1	[	[	X
dpc-5083	77	2	21	21	NUM
dpc-5083	77	3	]	]	PUNCT
dpc-5083	77	4	.	.	PUNCT
dpc-5083	78	1	the	the	DET
dpc-5083	78	2	condition	condition	NOUN
dpc-5083	78	3	is	be	AUX
dpc-5083	78	4	characterized	characterize	VERB
dpc-5083	78	5	by	by	ADP
dpc-5083	78	6	subepidermal	subepidermal	NOUN
dpc-5083	78	7	separation	separation	NOUN
dpc-5083	78	8	and	and	CCONJ
dpc-5083	78	9	necrosis	necrosis	NOUN
dpc-5083	78	10	of	of	ADP
dpc-5083	78	11	keratinocytes	keratinocyte	NOUN
dpc-5083	78	12	within	within	ADP
dpc-5083	78	13	the	the	DET
dpc-5083	78	14	epidermis	epidermis	NOUN
dpc-5083	78	15	.	.	PUNCT
dpc-5083	79	1	a	a	DET
dpc-5083	79	2	perivascular	perivascular	ADJ
dpc-5083	79	3	lymphocytic	lymphocytic	ADJ
dpc-5083	79	4	infiltrate	infiltrate	NOUN
dpc-5083	79	5	is	be	AUX
dpc-5083	79	6	usually	usually	ADV
dpc-5083	79	7	present	present	ADJ
dpc-5083	79	8	,	,	PUNCT
dpc-5083	79	9	accompanied	accompany	VERB
dpc-5083	79	10	by	by	ADP
dpc-5083	79	11	vacuolar	vacuolar	ADJ
dpc-5083	79	12	or	or	CCONJ
dpc-5083	79	13	lichenoid	lichenoid	PROPN
dpc-5083	79	14	interface	interface	NOUN
dpc-5083	79	15	dermatitis	dermatitis	NOUN
dpc-5083	79	16	,	,	PUNCT
dpc-5083	79	17	affecting	affect	VERB
dpc-5083	79	18	both	both	CCONJ
dpc-5083	79	19	the	the	DET
dpc-5083	79	20	epidermis	epidermis	NOUN
dpc-5083	79	21	and	and	CCONJ
dpc-5083	79	22	the	the	DET
dpc-5083	79	23	follicular	follicular	ADJ
dpc-5083	79	24	epithelium	epithelium	NOUN
dpc-5083	80	1	[	[	X
dpc-5083	80	2	20	20	NUM
dpc-5083	80	3	]	]	PUNCT
dpc-5083	80	4	.	.	PUNCT
dpc-5083	81	1	additionally	additionally	ADV
dpc-5083	81	2	,	,	PUNCT
dpc-5083	81	3	neutrophils	neutrophil	NOUN
dpc-5083	81	4	and	and	CCONJ
dpc-5083	81	5	cells	cell	NOUN
dpc-5083	81	6	with	with	ADP
dpc-5083	81	7	a	a	DET
dpc-5083	81	8	myeloid	myeloid	NOUN
dpc-5083	81	9	and	and	CCONJ
dpc-5083	81	10	histiocytoid	histiocytoid	ADJ
dpc-5083	81	11	appearance	appearance	NOUN
dpc-5083	81	12	(	(	PUNCT
dpc-5083	81	13	cd68	cd68	PROPN
dpc-5083	81	14	+	+	PROPN
dpc-5083	81	15	,	,	PUNCT
dpc-5083	81	16	cd163	cd163	PROPN
dpc-5083	81	17	+	+	NOUN
dpc-5083	81	18	)	)	PUNCT
dpc-5083	81	19	can	can	AUX
dpc-5083	81	20	be	be	AUX
dpc-5083	81	21	present	present	ADJ
dpc-5083	81	22	within	within	ADP
dpc-5083	81	23	the	the	DET
dpc-5083	81	24	infiltrate	infiltrate	NOUN
dpc-5083	82	1	[	[	X
dpc-5083	82	2	17	17	NUM
dpc-5083	82	3	]	]	PUNCT
dpc-5083	82	4	.	.	PUNCT
dpc-5083	83	1	importantly	importantly	ADV
dpc-5083	83	2	,	,	PUNCT
dpc-5083	83	3	the	the	DET
dpc-5083	83	4	presence	presence	NOUN
dpc-5083	83	5	of	of	ADP
dpc-5083	83	6	these	these	DET
dpc-5083	83	7	cells	cell	NOUN
dpc-5083	83	8	has	have	AUX
dpc-5083	83	9	not	not	PART
dpc-5083	83	10	been	be	AUX
dpc-5083	83	11	proven	prove	VERB
dpc-5083	83	12	to	to	PART
dpc-5083	83	13	imply	imply	VERB
dpc-5083	83	14	an	an	DET
dpc-5083	83	15	underlying	underlying	ADJ
dpc-5083	83	16	malignant	malignant	ADJ
dpc-5083	83	17	hematopathology	hematopathology	NOUN
dpc-5083	83	18	.	.	PUNCT
dpc-5083	84	1	diagnosis	diagnosis	NOUN
dpc-5083	84	2	diagnosis	diagnosis	NOUN
dpc-5083	84	3	of	of	ADP
dpc-5083	84	4	rime	rime	NOUN
dpc-5083	84	5	is	be	AUX
dpc-5083	84	6	clinical	clinical	ADJ
dpc-5083	84	7	.	.	PUNCT
dpc-5083	85	1	in	in	ADP
dpc-5083	85	2	2015	2015	NUM
dpc-5083	85	3	,	,	PUNCT
dpc-5083	85	4	canavan	canavan	NOUN
dpc-5083	85	5	et	et	PROPN
dpc-5083	85	6	al	al	PROPN
dpc-5083	85	7	.	.	PROPN
dpc-5083	85	8	proposed	propose	VERB
dpc-5083	85	9	a	a	DET
dpc-5083	85	10	comprehensive	comprehensive	ADJ
dpc-5083	85	11	set	set	NOUN
dpc-5083	85	12	of	of	ADP
dpc-5083	85	13	diagnostic	diagnostic	ADJ
dpc-5083	85	14	criteria	criterion	NOUN
dpc-5083	85	15	for	for	ADP
dpc-5083	85	16	classic	classic	ADJ
dpc-5083	85	17	rime	rime	NOUN
dpc-5083	85	18	based	base	VERB
dpc-5083	85	19	on	on	ADP
dpc-5083	85	20	a	a	DET
dpc-5083	85	21	systematic	systematic	ADJ
dpc-5083	85	22	review	review	NOUN
dpc-5083	85	23	of	of	ADP
dpc-5083	85	24	202	202	NUM
dpc-5083	85	25	published	publish	VERB
dpc-5083	85	26	reports	report	NOUN
dpc-5083	85	27	[	[	X
dpc-5083	85	28	1	1	NUM
dpc-5083	85	29	]	]	PUNCT
dpc-5083	85	30	.	.	PUNCT
dpc-5083	86	1	these	these	DET
dpc-5083	86	2	criteria	criterion	NOUN
dpc-5083	86	3	include	include	VERB
dpc-5083	86	4	(	(	PUNCT
dpc-5083	86	5	i	i	NOUN
dpc-5083	86	6	)	)	PUNCT
dpc-5083	86	7	skin	skin	NOUN
dpc-5083	86	8	detachment	detachment	NOUN
dpc-5083	86	9	involving	involve	VERB
dpc-5083	86	10	less	less	ADJ
dpc-5083	86	11	than	than	ADP
dpc-5083	86	12	10	10	NUM
dpc-5083	86	13	%	%	NOUN
dpc-5083	86	14	of	of	ADP
dpc-5083	86	15	the	the	DET
dpc-5083	86	16	bsa	bsa	PROPN
dpc-5083	86	17	,	,	PUNCT
dpc-5083	86	18	(	(	PUNCT
dpc-5083	86	19	ii	ii	NOUN
dpc-5083	86	20	)	)	PUNCT
dpc-5083	86	21	involvement	involvement	NOUN
dpc-5083	86	22	of	of	ADP
dpc-5083	86	23	two	two	NUM
dpc-5083	86	24	or	or	CCONJ
dpc-5083	86	25	more	more	ADJ
dpc-5083	86	26	mucosal	mucosal	ADJ
dpc-5083	86	27	surfaces	surface	NOUN
dpc-5083	86	28	,	,	PUNCT
dpc-5083	86	29	(	(	PUNCT
dpc-5083	86	30	iii	iii	X
dpc-5083	86	31	)	)	PUNCT
dpc-5083	86	32	few	few	ADJ
dpc-5083	86	33	vesiculobullous	vesiculobullous	ADJ
dpc-5083	86	34	or	or	CCONJ
dpc-5083	86	35	targetoid	targetoid	NOUN
dpc-5083	86	36	lesions	lesion	NOUN
dpc-5083	86	37	,	,	PUNCT
dpc-5083	86	38	the	the	DET
dpc-5083	86	39	latter	latter	ADJ
dpc-5083	86	40	most	most	ADV
dpc-5083	86	41	frequently	frequently	ADV
dpc-5083	86	42	presenting	present	VERB
dpc-5083	86	43	as	as	ADP
dpc-5083	86	44	atypical	atypical	ADJ
dpc-5083	86	45	targets	target	NOUN
dpc-5083	86	46	,	,	PUNCT
dpc-5083	86	47	and	and	CCONJ
dpc-5083	86	48	(	(	PUNCT
dpc-5083	86	49	iv	iv	X
dpc-5083	86	50	)	)	PUNCT
dpc-5083	86	51	clinical	clinical	ADJ
dpc-5083	86	52	or	or	CCONJ
dpc-5083	86	53	laboratory	laboratory	NOUN
dpc-5083	86	54	evidence	evidence	NOUN
dpc-5083	86	55	of	of	ADP
dpc-5083	86	56	respiratory	respiratory	ADJ
dpc-5083	86	57	infection	infection	NOUN
dpc-5083	86	58	,	,	PUNCT
dpc-5083	86	59	such	such	ADJ
dpc-5083	86	60	as	as	ADP
dpc-5083	86	61	atypical	atypical	ADJ
dpc-5083	86	62	pneumonia	pneumonia	NOUN
dpc-5083	86	63	,	,	PUNCT
dpc-5083	86	64	elevated	elevated	ADJ
dpc-5083	86	65	igm	igm	PROPN
dpc-5083	86	66	antibodies	antibody	NOUN
dpc-5083	86	67	against	against	ADP
dpc-5083	86	68	mp	mp	PROPN
dpc-5083	86	69	,	,	PUNCT
dpc-5083	86	70	positive	positive	ADJ
dpc-5083	86	71	polymerase	polymerase	NOUN
dpc-5083	86	72	chain	chain	NOUN
dpc-5083	86	73	reaction	reaction	NOUN
dpc-5083	86	74	(	(	PUNCT
dpc-5083	86	75	pcr	pcr	NOUN
dpc-5083	86	76	)	)	PUNCT
dpc-5083	86	77	,	,	PUNCT
dpc-5083	86	78	and/or	and/or	CCONJ
dpc-5083	86	79	serial	serial	ADJ
dpc-5083	86	80	cold	cold	ADJ
dpc-5083	86	81	agglutinins	agglutinin	NOUN
dpc-5083	86	82	for	for	ADP
dpc-5083	86	83	mp	mp	PROPN
dpc-5083	86	84	in	in	ADP
dpc-5083	86	85	oropharyngeal	oropharyngeal	ADJ
dpc-5083	86	86	swabs	swab	NOUN
dpc-5083	86	87	or	or	CCONJ
dpc-5083	86	88	blister	blister	NOUN
dpc-5083	86	89	fluid	fluid	NOUN
dpc-5083	86	90	.	.	PUNCT
dpc-5083	87	1	it	it	PRON
dpc-5083	87	2	is	be	AUX
dpc-5083	87	3	crucial	crucial	ADJ
dpc-5083	87	4	to	to	AUX
dpc-5083	87	5	closely	closely	ADV
dpc-5083	87	6	monitor	monitor	VERB
dpc-5083	87	7	cases	case	NOUN
dpc-5083	87	8	where	where	SCONJ
dpc-5083	87	9	only	only	ADV
dpc-5083	87	10	one	one	NUM
dpc-5083	87	11	mucosal	mucosal	NOUN
dpc-5083	87	12	surface	surface	NOUN
dpc-5083	87	13	is	be	AUX
dpc-5083	87	14	affected	affect	VERB
dpc-5083	87	15	as	as	ADV
dpc-5083	87	16	well	well	ADV
dpc-5083	87	17	as	as	ADP
dpc-5083	87	18	cases	case	NOUN
dpc-5083	87	19	of	of	ADP
dpc-5083	87	20	rime	rime	NOUN
dpc-5083	87	21	sine	sine	ADJ
dpc-5083	87	22	rash	rash	NOUN
dpc-5083	87	23	.	.	PUNCT
dpc-5083	88	1	notably	notably	ADV
dpc-5083	88	2	,	,	PUNCT
dpc-5083	88	3	these	these	DET
dpc-5083	88	4	criteria	criterion	NOUN
dpc-5083	88	5	do	do	AUX
dpc-5083	88	6	not	not	PART
dpc-5083	88	7	include	include	VERB
dpc-5083	88	8	the	the	DET
dpc-5083	88	9	involvement	involvement	NOUN
dpc-5083	88	10	of	of	ADP
dpc-5083	88	11	nasal	nasal	NOUN
dpc-5083	88	12	(	(	PUNCT
dpc-5083	88	13	as	as	ADP
dpc-5083	88	14	in	in	ADP
dpc-5083	88	15	our	our	PRON
dpc-5083	88	16	case	case	NOUN
dpc-5083	88	17	)	)	PUNCT
dpc-5083	88	18	and	and	CCONJ
dpc-5083	88	19	anal	anal	ADJ
dpc-5083	88	20	mucosa	mucosa	NOUN
dpc-5083	88	21	or	or	CCONJ
dpc-5083	88	22	microbiological	microbiological	ADJ
dpc-5083	88	23	evidence	evidence	NOUN
dpc-5083	88	24	of	of	ADP
dpc-5083	88	25	other	other	ADJ
dpc-5083	88	26	etiological	etiological	ADJ
dpc-5083	88	27	agents	agent	NOUN
dpc-5083	88	28	,	,	PUNCT
dpc-5083	88	29	which	which	PRON
dpc-5083	88	30	have	have	AUX
dpc-5083	88	31	been	be	AUX
dpc-5083	88	32	identified	identify	VERB
dpc-5083	88	33	in	in	ADP
dpc-5083	88	34	subsequent	subsequent	ADJ
dpc-5083	88	35	reports	report	NOUN
dpc-5083	88	36	.	.	PUNCT
dpc-5083	89	1	differential	differential	ADJ
dpc-5083	89	2	diagnosis	diagnosis	NOUN
dpc-5083	89	3	differential	differential	NOUN
dpc-5083	89	4	diagnoses	diagnosis	NOUN
dpc-5083	89	5	include	include	VERB
dpc-5083	89	6	conditions	condition	NOUN
dpc-5083	89	7	with	with	ADP
dpc-5083	89	8	mucocutaneous	mucocutaneous	ADJ
dpc-5083	89	9	involvement	involvement	NOUN
dpc-5083	89	10	and	and	CCONJ
dpc-5083	89	11	epidermal	epidermal	ADJ
dpc-5083	89	12	detachment	detachment	NOUN
dpc-5083	89	13	.	.	PUNCT
dpc-5083	90	1	the	the	DET
dpc-5083	90	2	most	most	ADV
dpc-5083	90	3	important	important	ADJ
dpc-5083	90	4	and	and	CCONJ
dpc-5083	90	5	time	time	NOUN
dpc-5083	90	6	-	-	PUNCT
dpc-5083	90	7	dependent	dependent	ADJ
dpc-5083	90	8	differential	differential	ADJ
dpc-5083	90	9	diagnosis	diagnosis	NOUN
dpc-5083	90	10	is	be	AUX
dpc-5083	90	11	the	the	DET
dpc-5083	90	12	sjs	sjs	PROPN
dpc-5083	90	13	-	-	PUNCT
dpc-5083	90	14	ten	ten	NUM
dpc-5083	90	15	spectrum	spectrum	NOUN
dpc-5083	90	16	,	,	PUNCT
dpc-5083	90	17	usually	usually	ADV
dpc-5083	90	18	induced	induce	VERB
dpc-5083	90	19	by	by	ADP
dpc-5083	90	20	drugs	drug	NOUN
dpc-5083	90	21	or	or	CCONJ
dpc-5083	90	22	infections	infection	NOUN
dpc-5083	90	23	.	.	PUNCT
dpc-5083	91	1	sjs	sjs	PROPN
dpc-5083	91	2	-	-	PUNCT
dpc-5083	91	3	ten	ten	PROPN
dpc-5083	91	4	(	(	PUNCT
dpc-5083	91	5	or	or	CCONJ
dpc-5083	91	6	the	the	DET
dpc-5083	91	7	overarching	overarching	ADJ
dpc-5083	91	8	term	term	NOUN
dpc-5083	91	9	drug	drug	NOUN
dpc-5083	91	10	-	-	PUNCT
dpc-5083	91	11	induced	induce	VERB
dpc-5083	91	12	epidermal	epidermal	ADJ
dpc-5083	91	13	necrosis	necrosis	NOUN
dpc-5083	91	14	–	–	PUNCT
dpc-5083	91	15	den	den	NOUN
dpc-5083	91	16	)	)	PUNCT
dpc-5083	91	17	presents	present	VERB
dpc-5083	91	18	a	a	DET
dpc-5083	91	19	greater	great	ADJ
dpc-5083	91	20	extent	extent	NOUN
dpc-5083	91	21	of	of	ADP
dpc-5083	91	22	detachment	detachment	NOUN
dpc-5083	91	23	and	and	CCONJ
dpc-5083	91	24	worse	bad	ADJ
dpc-5083	91	25	prognosis	prognosis	NOUN
dpc-5083	91	26	.	.	PUNCT
dpc-5083	92	1	viral	viral	ADJ
dpc-5083	92	2	exanthems	exanthem	NOUN
dpc-5083	92	3	,	,	PUNCT
dpc-5083	92	4	like	like	ADP
dpc-5083	92	5	those	those	PRON
dpc-5083	92	6	caused	cause	VERB
dpc-5083	92	7	by	by	ADP
dpc-5083	92	8	ebv	ebv	NOUN
dpc-5083	92	9	,	,	PUNCT
dpc-5083	92	10	enterovirus	enterovirus	NOUN
dpc-5083	92	11	(	(	PUNCT
dpc-5083	92	12	like	like	INTJ
dpc-5083	92	13	hand	hand	NOUN
dpc-5083	92	14	,	,	PUNCT
dpc-5083	92	15	foot	foot	NOUN
dpc-5083	92	16	,	,	PUNCT
dpc-5083	92	17	and	and	CCONJ
dpc-5083	92	18	mouth	mouth	NOUN
dpc-5083	92	19	disease	disease	NOUN
dpc-5083	92	20	)	)	PUNCT
dpc-5083	92	21	,	,	PUNCT
dpc-5083	92	22	and	and	CCONJ
dpc-5083	92	23	cytomegalovirus	cytomegalovirus	NOUN
dpc-5083	92	24	(	(	PUNCT
dpc-5083	92	25	cmv	cmv	NOUN
dpc-5083	92	26	)	)	PUNCT
dpc-5083	92	27	can	can	AUX
dpc-5083	92	28	present	present	VERB
dpc-5083	92	29	with	with	ADP
dpc-5083	92	30	mucosal	mucosal	ADJ
dpc-5083	92	31	involvement	involvement	NOUN
dpc-5083	92	32	.	.	PUNCT
dpc-5083	93	1	notably	notably	ADV
dpc-5083	93	2	,	,	PUNCT
dpc-5083	93	3	primary	primary	ADJ
dpc-5083	93	4	infection	infection	NOUN
dpc-5083	93	5	by	by	ADP
dpc-5083	93	6	herpes	herpe	NOUN
dpc-5083	93	7	simplex	simplex	NOUN
dpc-5083	93	8	virus	virus	NOUN
dpc-5083	93	9	(	(	PUNCT
dpc-5083	93	10	hsv	hsv	PROPN
dpc-5083	93	11	)	)	PUNCT
dpc-5083	93	12	can	can	AUX
dpc-5083	93	13	be	be	AUX
dpc-5083	93	14	very	very	ADV
dpc-5083	93	15	difficult	difficult	ADJ
dpc-5083	93	16	to	to	PART
dpc-5083	93	17	distinguish	distinguish	VERB
dpc-5083	93	18	from	from	ADP
dpc-5083	93	19	rime	rime	NOUN
dpc-5083	93	20	,	,	PUNCT
dpc-5083	93	21	especially	especially	ADV
dpc-5083	93	22	in	in	ADP
dpc-5083	93	23	pediatric	pediatric	ADJ
dpc-5083	93	24	patients	patient	NOUN
dpc-5083	93	25	.	.	PUNCT
dpc-5083	94	1	it	it	PRON
dpc-5083	94	2	manifests	manifest	VERB
dpc-5083	94	3	with	with	ADP
dpc-5083	94	4	gingivostomatitis	gingivostomatitis	NOUN
dpc-5083	94	5	,	,	PUNCT
dpc-5083	94	6	pharyngitis	pharyngitis	NOUN
dpc-5083	94	7	,	,	PUNCT
dpc-5083	94	8	and	and	CCONJ
dpc-5083	94	9	feeding	feed	VERB
dpc-5083	94	10	difficulties	difficulty	NOUN
dpc-5083	94	11	,	,	PUNCT
dpc-5083	94	12	usually	usually	ADV
dpc-5083	94	13	accompanied	accompany	VERB
dpc-5083	94	14	by	by	ADP
dpc-5083	94	15	fever	fever	NOUN
dpc-5083	94	16	and	and	CCONJ
dpc-5083	94	17	lymphadenopathy	lymphadenopathy	ADJ
dpc-5083	94	18	.	.	PUNCT
dpc-5083	95	1	autoimmune	autoimmune	ADJ
dpc-5083	95	2	blistering	blister	VERB
dpc-5083	95	3	diseases	disease	NOUN
dpc-5083	95	4	should	should	AUX
dpc-5083	95	5	also	also	ADV
dpc-5083	95	6	be	be	AUX
dpc-5083	95	7	ruled	rule	VERB
dpc-5083	95	8	out	out	ADP
dpc-5083	95	9	.	.	PUNCT
dpc-5083	96	1	these	these	PRON
dpc-5083	96	2	include	include	VERB
dpc-5083	96	3	pemphigus	pemphigus	NOUN
dpc-5083	96	4	vulgaris	vulgaris	NOUN
dpc-5083	96	5	,	,	PUNCT
dpc-5083	96	6	paraneoplastic	paraneoplastic	ADJ
dpc-5083	96	7	pemphigus	pemphigus	NOUN
dpc-5083	96	8	,	,	PUNCT
dpc-5083	96	9	and	and	CCONJ
dpc-5083	96	10	bullous	bullous	ADJ
dpc-5083	96	11	lupus	lupus	PROPN
dpc-5083	96	12	erythematosus	erythematosus	PROPN
dpc-5083	96	13	.	.	PUNCT
dpc-5083	97	1	laboratory	laboratory	NOUN
dpc-5083	97	2	testing	testing	NOUN
dpc-5083	97	3	,	,	PUNCT
dpc-5083	97	4	histopathology	histopathology	NOUN
dpc-5083	97	5	,	,	PUNCT
dpc-5083	97	6	and	and	CCONJ
dpc-5083	97	7	immunofluorescence	immunofluorescence	NOUN
dpc-5083	97	8	are	be	AUX
dpc-5083	97	9	cornerstone	cornerstone	NOUN
dpc-5083	97	10	methods	method	NOUN
dpc-5083	97	11	in	in	ADP
dpc-5083	97	12	this	this	DET
dpc-5083	97	13	diagnostic	diagnostic	ADJ
dpc-5083	97	14	process	process	NOUN
dpc-5083	97	15	.	.	PUNCT
dpc-5083	98	1	kawasaki	kawasaki	PROPN
dpc-5083	98	2	disease	disease	PROPN
dpc-5083	98	3	usually	usually	ADV
dpc-5083	98	4	presents	present	VERB
dpc-5083	98	5	in	in	ADP
dpc-5083	98	6	patients	patient	NOUN
dpc-5083	98	7	younger	young	ADJ
dpc-5083	98	8	than	than	ADP
dpc-5083	98	9	5	5	NUM
dpc-5083	98	10	years	year	NOUN
dpc-5083	98	11	of	of	ADP
dpc-5083	98	12	age	age	NOUN
dpc-5083	98	13	and	and	CCONJ
dpc-5083	98	14	can	can	AUX
dpc-5083	98	15	manifest	manifest	VERB
dpc-5083	98	16	with	with	ADP
dpc-5083	98	17	targetoid	targetoid	ADJ
dpc-5083	98	18	lesions	lesion	NOUN
dpc-5083	98	19	and	and	CCONJ
dpc-5083	98	20	pulmonary	pulmonary	ADJ
dpc-5083	98	21	involvement	involvement	NOUN
dpc-5083	98	22	.	.	PUNCT
dpc-5083	99	1	however	however	ADV
dpc-5083	99	2	,	,	PUNCT
dpc-5083	99	3	lymphadenopathy	lymphadenopathy	ADJ
dpc-5083	99	4	is	be	AUX
dpc-5083	99	5	usually	usually	ADV
dpc-5083	99	6	present	present	ADJ
dpc-5083	99	7	,	,	PUNCT
dpc-5083	99	8	mucosal	mucosal	NOUN
dpc-5083	99	9	involvement	involvement	NOUN
dpc-5083	99	10	most	most	ADV
dpc-5083	99	11	frequently	frequently	ADV
dpc-5083	99	12	presents	present	VERB
dpc-5083	99	13	with	with	ADP
dpc-5083	99	14	strawberry	strawberry	NOUN
dpc-5083	99	15	tongue	tongue	NOUN
dpc-5083	99	16	and	and	CCONJ
dpc-5083	99	17	cracked	crack	VERB
dpc-5083	99	18	lips	lip	NOUN
dpc-5083	99	19	(	(	PUNCT
dpc-5083	99	20	non	non	ADJ
dpc-5083	99	21	-	-	ADJ
dpc-5083	99	22	painful	painful	ADJ
dpc-5083	99	23	hemorrhagic	hemorrhagic	ADJ
dpc-5083	99	24	erosions	erosion	NOUN
dpc-5083	99	25	or	or	CCONJ
dpc-5083	99	26	ulceration	ulceration	NOUN
dpc-5083	99	27	)	)	PUNCT
dpc-5083	99	28	,	,	PUNCT
dpc-5083	99	29	and	and	CCONJ
dpc-5083	99	30	other	other	ADJ
dpc-5083	99	31	signs	sign	NOUN
dpc-5083	99	32	such	such	ADJ
dpc-5083	99	33	as	as	ADP
dpc-5083	99	34	acral	acral	ADJ
dpc-5083	99	35	edema	edema	NOUN
dpc-5083	99	36	and	and	CCONJ
dpc-5083	99	37	coronary	coronary	ADJ
dpc-5083	99	38	aneurysms	aneurysm	NOUN
dpc-5083	99	39	may	may	AUX
dpc-5083	99	40	be	be	AUX
dpc-5083	99	41	present	present	ADJ
dpc-5083	99	42	[	[	X
dpc-5083	99	43	23	23	NUM
dpc-5083	99	44	]	]	PUNCT
dpc-5083	99	45	.	.	PUNCT
dpc-5083	100	1	management	management	NOUN
dpc-5083	100	2	no	no	DET
dpc-5083	100	3	standardized	standardized	ADJ
dpc-5083	100	4	protocol	protocol	NOUN
dpc-5083	100	5	exists	exist	VERB
dpc-5083	100	6	to	to	PART
dpc-5083	100	7	address	address	VERB
dpc-5083	100	8	the	the	DET
dpc-5083	100	9	diagnosis	diagnosis	NOUN
dpc-5083	100	10	of	of	ADP
dpc-5083	100	11	rime	rime	NOUN
dpc-5083	100	12	nor	nor	CCONJ
dpc-5083	100	13	its	its	PRON
dpc-5083	100	14	therapeutic	therapeutic	ADJ
dpc-5083	100	15	management	management	NOUN
dpc-5083	100	16	.	.	PUNCT
dpc-5083	101	1	this	this	DET
dpc-5083	101	2	work	work	NOUN
dpc-5083	101	3	intends	intend	VERB
dpc-5083	101	4	to	to	PART
dpc-5083	101	5	propose	propose	VERB
dpc-5083	101	6	a	a	DET
dpc-5083	101	7	diagnostic	diagnostic	ADJ
dpc-5083	101	8	and	and	CCONJ
dpc-5083	101	9	therapeutic	therapeutic	ADJ
dpc-5083	101	10	algorithm	algorithm	NOUN
dpc-5083	101	11	(	(	PUNCT
dpc-5083	101	12	figures	figure	NOUN
dpc-5083	101	13	  	  	SPACE
dpc-5083	101	14	1	1	NUM
dpc-5083	101	15	and	and	CCONJ
dpc-5083	101	16	2	2	NUM
dpc-5083	101	17	,	,	PUNCT
dpc-5083	101	18	respectively	respectively	ADV
dpc-5083	101	19	)	)	PUNCT
dpc-5083	101	20	,	,	PUNCT
dpc-5083	101	21	based	base	VERB
dpc-5083	101	22	on	on	ADP
dpc-5083	101	23	the	the	DET
dpc-5083	101	24	information	information	NOUN
dpc-5083	101	25	available	available	ADJ
dpc-5083	101	26	in	in	ADP
dpc-5083	101	27	the	the	DET
dpc-5083	101	28	recent	recent	ADJ
dpc-5083	101	29	literature	literature	NOUN
dpc-5083	101	30	,	,	PUNCT
dpc-5083	101	31	with	with	ADP
dpc-5083	101	32	the	the	DET
dpc-5083	101	33	aim	aim	NOUN
dpc-5083	101	34	of	of	ADP
dpc-5083	101	35	facilitating	facilitate	VERB
dpc-5083	101	36	the	the	DET
dpc-5083	101	37	management	management	NOUN
dpc-5083	101	38	of	of	ADP
dpc-5083	101	39	this	this	DET
dpc-5083	101	40	entity	entity	NOUN
dpc-5083	101	41	.	.	PUNCT
dpc-5083	102	1	laboratory	laboratory	NOUN
dpc-5083	102	2	evaluation	evaluation	NOUN
dpc-5083	102	3	should	should	AUX
dpc-5083	102	4	include	include	VERB
dpc-5083	102	5	a	a	DET
dpc-5083	102	6	complete	complete	ADJ
dpc-5083	102	7	blood	blood	NOUN
dpc-5083	102	8	count	count	NOUN
dpc-5083	102	9	with	with	ADP
dpc-5083	102	10	differential	differential	NOUN
dpc-5083	102	11	,	,	PUNCT
dpc-5083	102	12	as	as	SCONJ
dpc-5083	102	13	commonly	commonly	ADV
dpc-5083	102	14	reported	report	VERB
dpc-5083	102	15	hematologic	hematologic	NOUN
dpc-5083	102	16	abnormalities	abnormality	NOUN
dpc-5083	102	17	include	include	VERB
dpc-5083	102	18	anemia	anemia	NOUN
dpc-5083	102	19	,	,	PUNCT
dpc-5083	102	20	leukocytosis	leukocytosis	NOUN
dpc-5083	102	21	or	or	CCONJ
dpc-5083	102	22	leukopenia	leukopenia	PROPN
dpc-5083	102	23	,	,	PUNCT
dpc-5083	102	24	neutrophilia	neutrophilia	PROPN
dpc-5083	102	25	,	,	PUNCT
dpc-5083	102	26	monocytosis	monocytosis	NOUN
dpc-5083	102	27	,	,	PUNCT
dpc-5083	102	28	and	and	CCONJ
dpc-5083	102	29	reactive	reactive	ADJ
dpc-5083	102	30	thrombocytosis	thrombocytosis	NOUN
dpc-5083	102	31	.	.	PUNCT
dpc-5083	103	1	notably	notably	ADV
dpc-5083	103	2	,	,	PUNCT
dpc-5083	103	3	the	the	DET
dpc-5083	103	4	presence	presence	NOUN
dpc-5083	103	5	of	of	ADP
dpc-5083	103	6	anemia	anemia	NOUN
dpc-5083	103	7	should	should	AUX
dpc-5083	103	8	prompt	prompt	VERB
dpc-5083	103	9	screening	screening	NOUN
dpc-5083	103	10	of	of	ADP
dpc-5083	103	11	autoimmune	autoimmune	ADJ
dpc-5083	103	12	hemolysis	hemolysis	NOUN
dpc-5083	103	13	mediated	mediate	VERB
dpc-5083	103	14	by	by	ADP
dpc-5083	103	15	cold	cold	ADJ
dpc-5083	103	16	-	-	PUNCT
dpc-5083	103	17	agglutinin	agglutinin	ADJ
dpc-5083	103	18	antibodies	antibody	NOUN
dpc-5083	103	19	related	relate	VERB
dpc-5083	103	20	to	to	ADP
dpc-5083	103	21	mp	mp	PROPN
dpc-5083	103	22	(	(	PUNCT
dpc-5083	103	23	cold	cold	ADJ
dpc-5083	103	24	agglutinin	agglutinin	NOUN
dpc-5083	103	25	syndrome	syndrome	NOUN
dpc-5083	103	26	)	)	PUNCT
dpc-5083	104	1	[	[	X
dpc-5083	104	2	30	30	NUM
dpc-5083	104	3	]	]	PUNCT
dpc-5083	104	4	,	,	PUNCT
dpc-5083	104	5	which	which	PRON
dpc-5083	104	6	tends	tend	VERB
dpc-5083	104	7	to	to	PART
dpc-5083	104	8	be	be	AUX
dpc-5083	104	9	mild	mild	ADJ
dpc-5083	104	10	.	.	PUNCT
dpc-5083	105	1	liver	liver	NOUN
dpc-5083	105	2	and	and	CCONJ
dpc-5083	105	3	renal	renal	ADJ
dpc-5083	105	4	biochemistry	biochemistry	NOUN
dpc-5083	105	5	and	and	CCONJ
dpc-5083	105	6	acute	acute	ADJ
dpc-5083	105	7	phase	phase	NOUN
dpc-5083	105	8	reactants	reactant	NOUN
dpc-5083	105	9	,	,	PUNCT
dpc-5083	105	10	such	such	ADJ
dpc-5083	105	11	as	as	ADP
dpc-5083	105	12	crp	crp	PROPN
dpc-5083	105	13	and	and	CCONJ
dpc-5083	105	14	erythrocyte	erythrocyte	PROPN
dpc-5083	105	15	sedimentation	sedimentation	NOUN
dpc-5083	105	16	rate	rate	NOUN
dpc-5083	105	17	(	(	PUNCT
dpc-5083	105	18	esr	esr	PROPN
dpc-5083	105	19	)	)	PUNCT
dpc-5083	105	20	,	,	PUNCT
dpc-5083	105	21	should	should	AUX
dpc-5083	105	22	also	also	ADV
dpc-5083	105	23	be	be	AUX
dpc-5083	105	24	included	include	VERB
dpc-5083	105	25	in	in	ADP
dpc-5083	105	26	the	the	DET
dpc-5083	105	27	study	study	NOUN
dpc-5083	105	28	.	.	PUNCT
dpc-5083	106	1	serological	serological	ADJ
dpc-5083	106	2	testing	testing	NOUN
dpc-5083	106	3	for	for	ADP
dpc-5083	106	4	mp	mp	PROPN
dpc-5083	106	5	is	be	AUX
dpc-5083	106	6	crucial	crucial	ADJ
dpc-5083	106	7	at	at	ADP
dpc-5083	106	8	admission	admission	NOUN
dpc-5083	106	9	,	,	PUNCT
dpc-5083	106	10	after	after	ADP
dpc-5083	106	11	seven	seven	NUM
dpc-5083	106	12	days	day	NOUN
dpc-5083	106	13	,	,	PUNCT
dpc-5083	106	14	and	and	CCONJ
dpc-5083	106	15	at	at	ADP
dpc-5083	106	16	two	two	NUM
dpc-5083	106	17	months	month	NOUN
dpc-5083	106	18	.	.	PUNCT
dpc-5083	107	1	it	it	PRON
dpc-5083	107	2	is	be	AUX
dpc-5083	107	3	important	important	ADJ
dpc-5083	107	4	to	to	PART
dpc-5083	107	5	note	note	VERB
dpc-5083	107	6	that	that	SCONJ
dpc-5083	107	7	only	only	ADV
dpc-5083	107	8	igg	igg	PROPN
dpc-5083	107	9	may	may	AUX
dpc-5083	107	10	be	be	AUX
dpc-5083	107	11	detected	detect	VERB
dpc-5083	107	12	as	as	SCONJ
dpc-5083	107	13	igm	igm	PROPN
dpc-5083	107	14	responses	response	NOUN
dpc-5083	107	15	are	be	AUX
dpc-5083	107	16	not	not	PART
dpc-5083	107	17	always	always	ADV
dpc-5083	107	18	present	present	ADJ
dpc-5083	107	19	during	during	ADP
dpc-5083	107	20	primary	primary	ADJ
dpc-5083	107	21	infection	infection	NOUN
dpc-5083	107	22	.	.	PUNCT
dpc-5083	108	1	iga	iga	PROPN
dpc-5083	108	2	anti	anti	PROPN
dpc-5083	108	3	-	-	PROPN
dpc-5083	108	4	mp	mp	PROPN
dpc-5083	108	5	has	have	AUX
dpc-5083	108	6	proven	prove	VERB
dpc-5083	108	7	to	to	PART
dpc-5083	108	8	be	be	AUX
dpc-5083	108	9	a	a	DET
dpc-5083	108	10	more	more	ADV
dpc-5083	108	11	reliable	reliable	ADJ
dpc-5083	108	12	marker	marker	NOUN
dpc-5083	108	13	due	due	ADP
dpc-5083	108	14	to	to	ADP
dpc-5083	108	15	its	its	PRON
dpc-5083	108	16	early	early	ADJ
dpc-5083	108	17	rise	rise	NOUN
dpc-5083	108	18	,	,	PUNCT
dpc-5083	108	19	rapid	rapid	ADJ
dpc-5083	108	20	peak	peak	NOUN
dpc-5083	108	21	,	,	PUNCT
dpc-5083	108	22	and	and	CCONJ
dpc-5083	108	23	decline	decline	VERB
dpc-5083	108	24	before	before	ADP
dpc-5083	108	25	igm	igm	PROPN
dpc-5083	108	26	and	and	CCONJ
dpc-5083	108	27	igg	igg	PROPN
dpc-5083	108	28	,	,	PUNCT
dpc-5083	108	29	though	though	SCONJ
dpc-5083	108	30	its	its	PRON
dpc-5083	108	31	availability	availability	NOUN
dpc-5083	108	32	is	be	AUX
dpc-5083	108	33	limited	limit	VERB
dpc-5083	108	34	[	[	PUNCT
dpc-5083	108	35	31	31	NUM
dpc-5083	108	36	]	]	PUNCT
dpc-5083	108	37	.	.	PUNCT
dpc-5083	109	1	furthermore	furthermore	ADV
dpc-5083	109	2	,	,	PUNCT
dpc-5083	109	3	igg	igg	PROPN
dpc-5083	109	4	levels	level	NOUN
dpc-5083	109	5	have	have	VERB
dpc-5083	109	6	significant	significant	ADJ
dpc-5083	109	7	fluctuations	fluctuation	NOUN
dpc-5083	109	8	,	,	PUNCT
dpc-5083	109	9	and	and	CCONJ
dpc-5083	109	10	igm	igm	NOUN
dpc-5083	109	11	may	may	AUX
dpc-5083	109	12	remain	remain	VERB
dpc-5083	109	13	elevated	elevated	ADJ
dpc-5083	109	14	for	for	ADP
dpc-5083	109	15	months	month	NOUN
dpc-5083	109	16	if	if	SCONJ
dpc-5083	109	17	reinfections	reinfection	NOUN
dpc-5083	109	18	occur	occur	VERB
dpc-5083	109	19	,	,	PUNCT
dpc-5083	109	20	making	make	VERB
dpc-5083	109	21	it	it	PRON
dpc-5083	109	22	difficult	difficult	ADJ
dpc-5083	109	23	to	to	PART
dpc-5083	109	24	discriminate	discriminate	VERB
dpc-5083	109	25	between	between	ADP
dpc-5083	109	26	recent	recent	ADJ
dpc-5083	109	27	and	and	CCONJ
dpc-5083	109	28	remote	remote	ADJ
dpc-5083	109	29	infections	infection	NOUN
dpc-5083	109	30	.	.	PUNCT
dpc-5083	110	1	for	for	ADP
dpc-5083	110	2	cp	cp	PROPN
dpc-5083	110	3	,	,	PUNCT
dpc-5083	110	4	igm	igm	PROPN
dpc-5083	110	5	levels	level	NOUN
dpc-5083	110	6	exceeding	exceed	VERB
dpc-5083	110	7	the	the	DET
dpc-5083	110	8	positivity	positivity	NOUN
dpc-5083	110	9	laboratory	laboratory	NOUN
dpc-5083	110	10	threshold	threshold	NOUN
dpc-5083	110	11	or	or	CCONJ
dpc-5083	110	12	a	a	DET
dpc-5083	110	13	fourfold	fourfold	ADJ
dpc-5083	110	14	increase	increase	NOUN
dpc-5083	110	15	in	in	ADP
dpc-5083	110	16	igg	igg	PROPN
dpc-5083	110	17	of	of	ADP
dpc-5083	110	18	paired	pair	VERB
dpc-5083	110	19	sera	sera	NOUN
dpc-5083	110	20	is	be	AUX
dpc-5083	110	21	necessary	necessary	ADJ
dpc-5083	110	22	for	for	ADP
dpc-5083	110	23	diagnosis	diagnosis	NOUN
dpc-5083	110	24	[	[	X
dpc-5083	110	25	3	3	NUM
dpc-5083	110	26	]	]	PUNCT
dpc-5083	110	27	.	.	PUNCT
dpc-5083	111	1	serological	serological	ADJ
dpc-5083	111	2	tests	test	NOUN
dpc-5083	111	3	should	should	AUX
dpc-5083	111	4	also	also	ADV
dpc-5083	111	5	include	include	VERB
dpc-5083	111	6	hsv-1	hsv-1	NOUN
dpc-5083	111	7	,	,	PUNCT
dpc-5083	111	8	hsv-2	hsv-2	NOUN
dpc-5083	111	9	,	,	PUNCT
dpc-5083	111	10	varicella	varicella	NOUN
dpc-5083	111	11	-	-	PUNCT
dpc-5083	111	12	zoster	zoster	NOUN
dpc-5083	111	13	virus	virus	NOUN
dpc-5083	111	14	(	(	PUNCT
dpc-5083	111	15	vzv	vzv	PROPN
dpc-5083	111	16	)	)	PUNCT
dpc-5083	111	17	,	,	PUNCT
dpc-5083	111	18	and	and	CCONJ
dpc-5083	111	19	cmv	cmv	NOUN
dpc-5083	111	20	antibodies	antibodie	VERB
dpc-5083	111	21	.	.	PUNCT
dpc-5083	112	1	serological	serological	ADJ
dpc-5083	112	2	status	status	NOUN
dpc-5083	112	3	of	of	ADP
dpc-5083	112	4	hepatitis	hepatitis	PROPN
dpc-5083	112	5	b	b	PROPN
dpc-5083	112	6	virus	virus	NOUN
dpc-5083	112	7	(	(	PUNCT
dpc-5083	112	8	hbv	hbv	NOUN
dpc-5083	112	9	)	)	PUNCT
dpc-5083	112	10	,	,	PUNCT
dpc-5083	112	11	hepatitis	hepatitis	PROPN
dpc-5083	112	12	c	c	PROPN
dpc-5083	112	13	virus	virus	NOUN
dpc-5083	112	14	(	(	PUNCT
dpc-5083	112	15	hcv	hcv	PROPN
dpc-5083	112	16	)	)	PUNCT
dpc-5083	112	17	,	,	PUNCT
dpc-5083	112	18	and	and	CCONJ
dpc-5083	112	19	human	human	ADJ
dpc-5083	112	20	immunodeficiency	immunodeficiency	NOUN
dpc-5083	112	21	virus	virus	NOUN
dpc-5083	112	22	(	(	PUNCT
dpc-5083	112	23	hiv	hiv	PROPN
dpc-5083	112	24	)	)	PUNCT
dpc-5083	112	25	should	should	AUX
dpc-5083	112	26	be	be	AUX
dpc-5083	112	27	investigated	investigate	VERB
dpc-5083	112	28	,	,	PUNCT
dpc-5083	112	29	especially	especially	ADV
dpc-5083	112	30	if	if	SCONJ
dpc-5083	112	31	immunosuppressive	immunosuppressive	ADJ
dpc-5083	112	32	drugs	drug	NOUN
dpc-5083	112	33	are	be	AUX
dpc-5083	112	34	used	use	VERB
dpc-5083	112	35	.	.	PUNCT
dpc-5083	113	1	anti	anti	ADJ
dpc-5083	113	2	-	-	ADJ
dpc-5083	113	3	desmoglein	desmoglein	ADJ
dpc-5083	113	4	1	1	NUM
dpc-5083	113	5	and	and	CCONJ
dpc-5083	113	6	3	3	NUM
dpc-5083	113	7	and	and	CCONJ
dpc-5083	113	8	anti	anti	ADJ
dpc-5083	113	9	-	-	ADJ
dpc-5083	113	10	bullous	bullous	ADJ
dpc-5083	113	11	pemphigoid	pemphigoid	NOUN
dpc-5083	113	12	(	(	PUNCT
dpc-5083	113	13	bp	bp	PROPN
dpc-5083	113	14	)	)	PUNCT
dpc-5083	113	15	180	180	NUM
dpc-5083	113	16	and	and	CCONJ
dpc-5083	113	17	anti	anti	ADJ
dpc-5083	113	18	-	-	ADJ
dpc-5083	113	19	bp230	bp230	ADJ
dpc-5083	113	20	antibodies	antibody	NOUN
dpc-5083	113	21	are	be	AUX
dpc-5083	113	22	useful	useful	ADJ
dpc-5083	113	23	to	to	PART
dpc-5083	113	24	discern	discern	VERB
dpc-5083	113	25	autoimmune	autoimmune	ADJ
dpc-5083	113	26	blistering	blister	VERB
dpc-5083	113	27	diseases	disease	NOUN
dpc-5083	113	28	.	.	PUNCT
dpc-5083	114	1	4	4	NUM
dpc-5083	114	2	review	review	NOUN
dpc-5083	114	3	|	|	ADV
dpc-5083	114	4	dermatol	dermatol	ADJ
dpc-5083	114	5	pract	pract	NOUN
dpc-5083	114	6	concept	concept	NOUN
dpc-5083	114	7	.	.	PUNCT
dpc-5083	115	1	2025;15(3):5083	2025;15(3):5083	NUM
dpc-5083	115	2	figure	figure	NOUN
dpc-5083	115	3	1	1	NUM
dpc-5083	115	4	.	.	PUNCT
dpc-5083	115	5	proposed	propose	VERB
dpc-5083	115	6	diagnostic	diagnostic	ADJ
dpc-5083	115	7	algorithm	algorithm	NOUN
dpc-5083	115	8	.	.	PUNCT
dpc-5083	116	1	(	(	PUNCT
dpc-5083	116	2	ana	ana	NOUN
dpc-5083	116	3	=	=	SYM
dpc-5083	116	4	anti	anti	ADJ
dpc-5083	116	5	-	-	ADJ
dpc-5083	116	6	nuclear	nuclear	ADJ
dpc-5083	116	7	antibodies	antibody	NOUN
dpc-5083	116	8	;	;	PUNCT
dpc-5083	116	9	cbc	cbc	NOUN
dpc-5083	116	10	=	=	SYM
dpc-5083	116	11	complete	complete	ADJ
dpc-5083	116	12	blood	blood	NOUN
dpc-5083	116	13	count	count	NOUN
dpc-5083	116	14	;	;	PUNCT
dpc-5083	116	15	crp	crp	X
dpc-5083	116	16	=	=	SYM
dpc-5083	117	1	c	c	X
dpc-5083	117	2	-	-	PUNCT
dpc-5083	117	3	reactive	reactive	ADJ
dpc-5083	117	4	protein	protein	NOUN
dpc-5083	117	5	;	;	PUNCT
dpc-5083	117	6	dif	dif	X
dpc-5083	117	7	=	=	PUNCT
dpc-5083	117	8	direct	direct	ADJ
dpc-5083	117	9	immunofluorescence	immunofluorescence	NOUN
dpc-5083	117	10	;	;	PUNCT
dpc-5083	117	11	esr	esr	PROPN
dpc-5083	117	12	=	=	PROPN
dpc-5083	117	13	erythrocyte	erythrocyte	PROPN
dpc-5083	117	14	sedimentation	sedimentation	NOUN
dpc-5083	117	15	rate	rate	NOUN
dpc-5083	117	16	;	;	PUNCT
dpc-5083	117	17	hsv	hsv	PROPN
dpc-5083	117	18	=	=	PUNCT
dpc-5083	117	19	herpes	herpe	NOUN
dpc-5083	117	20	simplex	simplex	NOUN
dpc-5083	117	21	virus	virus	NOUN
dpc-5083	117	22	;	;	PUNCT
dpc-5083	117	23	pcr	pcr	ADJ
dpc-5083	117	24	=	=	SYM
dpc-5083	117	25	polymerase	polymerase	NOUN
dpc-5083	117	26	chain	chain	NOUN
dpc-5083	117	27	reaction	reaction	NOUN
dpc-5083	117	28	;	;	PUNCT
dpc-5083	117	29	rime	rime	NOUN
dpc-5083	117	30	=	=	SYM
dpc-5083	117	31	reactive	reactive	ADJ
dpc-5083	117	32	infectious	infectious	ADJ
dpc-5083	117	33	mucocutaneous	mucocutaneous	ADJ
dpc-5083	117	34	eruption	eruption	NOUN
dpc-5083	117	35	;	;	PUNCT
dpc-5083	118	1	sars	sar	NOUN
dpc-5083	118	2	-	-	PUNCT
dpc-5083	118	3	cov-2	cov-2	NOUN
dpc-5083	118	4	=	=	VERB
dpc-5083	118	5	severe	severe	ADJ
dpc-5083	118	6	acute	acute	ADJ
dpc-5083	118	7	respiratory	respiratory	ADJ
dpc-5083	118	8	syndrome	syndrome	NOUN
dpc-5083	118	9	coronavirus	coronavirus	NOUN
dpc-5083	118	10	2	2	NUM
dpc-5083	118	11	;	;	PUNCT
dpc-5083	118	12	vzv	vzv	PROPN
dpc-5083	118	13	=	=	PUNCT
dpc-5083	118	14	varicella	varicella	NOUN
dpc-5083	118	15	-	-	PUNCT
dpc-5083	118	16	zoster	zoster	NOUN
dpc-5083	118	17	virus	virus	NOUN
dpc-5083	118	18	.	.	PUNCT
dpc-5083	118	19	)	)	PUNCT
dpc-5083	118	20	figure	figure	NOUN
dpc-5083	118	21	2	2	NUM
dpc-5083	118	22	.	.	PUNCT
dpc-5083	118	23	proposed	propose	VERB
dpc-5083	118	24	therapeutic	therapeutic	ADJ
dpc-5083	118	25	algorithm	algorithm	NOUN
dpc-5083	118	26	.	.	PUNCT
dpc-5083	119	1	(	(	PUNCT
dpc-5083	119	2	ivig	ivig	NOUN
dpc-5083	119	3	=	=	SYM
dpc-5083	119	4	intravenous	intravenous	ADJ
dpc-5083	119	5	immunoglobulin	immunoglobulin	NOUN
dpc-5083	119	6	therapy	therapy	NOUN
dpc-5083	119	7	;	;	PUNCT
dpc-5083	119	8	pcr	pcr	PROPN
dpc-5083	119	9	=	=	SYM
dpc-5083	119	10	polymerase	polymerase	NOUN
dpc-5083	119	11	chain	chain	NOUN
dpc-5083	119	12	reaction	reaction	NOUN
dpc-5083	119	13	.	.	PUNCT
dpc-5083	119	14	)	)	PUNCT
dpc-5083	120	1	review	review	VERB
dpc-5083	120	2	|	|	ADV
dpc-5083	120	3	dermatol	dermatol	ADJ
dpc-5083	120	4	pract	pract	NOUN
dpc-5083	120	5	concept	concept	NOUN
dpc-5083	120	6	.	.	PUNCT
dpc-5083	121	1	2025;15(3):5083	2025;15(3):5083	NUM
dpc-5083	121	2	5	5	NUM
dpc-5083	121	3	local	local	ADJ
dpc-5083	121	4	treatment	treatment	NOUN
dpc-5083	121	5	includes	include	VERB
dpc-5083	121	6	the	the	DET
dpc-5083	121	7	use	use	NOUN
dpc-5083	121	8	of	of	ADP
dpc-5083	121	9	non	non	ADJ
dpc-5083	121	10	-	-	ADJ
dpc-5083	121	11	adhesive	adhesive	ADJ
dpc-5083	121	12	dressings	dressing	NOUN
dpc-5083	121	13	for	for	ADP
dpc-5083	121	14	cutaneous	cutaneous	ADJ
dpc-5083	121	15	lesions	lesion	NOUN
dpc-5083	121	16	,	,	PUNCT
dpc-5083	121	17	prioritizing	prioritize	VERB
dpc-5083	121	18	hydrogel	hydrogel	NOUN
dpc-5083	121	19	or	or	CCONJ
dpc-5083	121	20	hydrocolloid	hydrocolloid	NOUN
dpc-5083	121	21	dressings	dressing	NOUN
dpc-5083	121	22	.	.	PUNCT
dpc-5083	122	1	for	for	ADP
dpc-5083	122	2	pain	pain	NOUN
dpc-5083	122	3	relief	relief	NOUN
dpc-5083	122	4	in	in	ADP
dpc-5083	122	5	mucositis	mucositis	PROPN
dpc-5083	122	6	,	,	PUNCT
dpc-5083	122	7	specific	specific	ADJ
dpc-5083	122	8	compounds	compound	NOUN
dpc-5083	122	9	can	can	AUX
dpc-5083	122	10	be	be	AUX
dpc-5083	122	11	used	use	VERB
dpc-5083	122	12	.	.	PUNCT
dpc-5083	123	1	the	the	DET
dpc-5083	123	2	authors	author	NOUN
dpc-5083	123	3	prescribe	prescribe	VERB
dpc-5083	123	4	an	an	DET
dpc-5083	123	5	oral	oral	ADJ
dpc-5083	123	6	solution	solution	NOUN
dpc-5083	123	7	which	which	PRON
dpc-5083	123	8	contains	contain	VERB
dpc-5083	123	9	20	20	NUM
dpc-5083	123	10	mg	mg	NUM
dpc-5083	123	11	/	/	SYM
dpc-5083	123	12	ml	ml	NOUN
dpc-5083	123	13	methylprednisolone	methylprednisolone	NOUN
dpc-5083	123	14	,	,	PUNCT
dpc-5083	123	15	2	2	NUM
dpc-5083	123	16	%	%	NOUN
dpc-5083	123	17	mepivacaine	mepivacaine	NOUN
dpc-5083	123	18	,	,	PUNCT
dpc-5083	123	19	40	40	NUM
dpc-5083	123	20	mg	mg	NUM
dpc-5083	123	21	/	/	SYM
dpc-5083	123	22	ml	ml	X
dpc-5083	123	23	gentamicin	gentamicin	VERB
dpc-5083	123	24	,	,	PUNCT
dpc-5083	123	25	100	100	NUM
dpc-5083	123	26	000	000	NUM
dpc-5083	123	27	ui	ui	PROPN
dpc-5083	123	28	/	/	SYM
dpc-5083	123	29	ml	ml	NOUN
dpc-5083	123	30	nystatin	nystatin	NOUN
dpc-5083	123	31	,	,	PUNCT
dpc-5083	123	32	and	and	CCONJ
dpc-5083	123	33	1/6	1/6	DET
dpc-5083	123	34	molar	molar	ADJ
dpc-5083	123	35	bicarbonate	bicarbonate	NOUN
dpc-5083	123	36	.	.	PUNCT
dpc-5083	124	1	furthermore	furthermore	ADV
dpc-5083	124	2	,	,	PUNCT
dpc-5083	124	3	in	in	ADP
dpc-5083	124	4	our	our	PRON
dpc-5083	124	5	experience	experience	NOUN
dpc-5083	124	6	,	,	PUNCT
dpc-5083	124	7	adding	add	VERB
dpc-5083	124	8	viscous	viscous	ADJ
dpc-5083	124	9	lidocaine	lidocaine	NOUN
dpc-5083	124	10	2%–4	2%–4	NUM
dpc-5083	124	11	%	%	NOUN
dpc-5083	124	12	30	30	NUM
dpc-5083	124	13	minutes	minute	NOUN
dpc-5083	124	14	before	before	SCONJ
dpc-5083	124	15	meals	meal	NOUN
dpc-5083	124	16	decreases	decrease	VERB
dpc-5083	124	17	pain	pain	NOUN
dpc-5083	124	18	and	and	CCONJ
dpc-5083	124	19	feeding	feed	VERB
dpc-5083	124	20	difficulties	difficulty	NOUN
dpc-5083	124	21	.	.	PUNCT
dpc-5083	125	1	cutaneous	cutaneous	ADJ
dpc-5083	125	2	lesions	lesion	NOUN
dpc-5083	125	3	can	can	AUX
dpc-5083	125	4	be	be	AUX
dpc-5083	125	5	managed	manage	VERB
dpc-5083	125	6	with	with	ADP
dpc-5083	125	7	high	high	ADJ
dpc-5083	125	8	-	-	PUNCT
dpc-5083	125	9	potency	potency	NOUN
dpc-5083	125	10	topical	topical	ADJ
dpc-5083	125	11	corticosteroids	corticosteroid	NOUN
dpc-5083	125	12	such	such	ADJ
dpc-5083	125	13	as	as	ADP
dpc-5083	125	14	clobetasol	clobetasol	NOUN
dpc-5083	125	15	0.05	0.05	NUM
dpc-5083	125	16	%	%	NOUN
dpc-5083	125	17	ointment	ointment	NOUN
dpc-5083	125	18	.	.	PUNCT
dpc-5083	126	1	if	if	SCONJ
dpc-5083	126	2	there	there	PRON
dpc-5083	126	3	is	be	VERB
dpc-5083	126	4	ocular	ocular	ADJ
dpc-5083	126	5	involvement	involvement	NOUN
dpc-5083	126	6	,	,	PUNCT
dpc-5083	126	7	it	it	PRON
dpc-5083	126	8	is	be	AUX
dpc-5083	126	9	imperative	imperative	ADJ
dpc-5083	126	10	to	to	PART
dpc-5083	126	11	request	request	VERB
dpc-5083	126	12	evaluation	evaluation	NOUN
dpc-5083	126	13	by	by	ADP
dpc-5083	126	14	an	an	DET
dpc-5083	126	15	ophthalmologist	ophthalmologist	NOUN
dpc-5083	126	16	.	.	PUNCT
dpc-5083	127	1	fluorescein	fluorescein	NOUN
dpc-5083	127	2	staining	stain	VERB
dpc-5083	127	3	may	may	AUX
dpc-5083	127	4	help	help	VERB
dpc-5083	127	5	assess	assess	VERB
dpc-5083	127	6	the	the	DET
dpc-5083	127	7	severity	severity	NOUN
dpc-5083	127	8	of	of	ADP
dpc-5083	127	9	the	the	DET
dpc-5083	127	10	disease	disease	NOUN
dpc-5083	127	11	.	.	PUNCT
dpc-5083	128	1	prescribed	prescribe	VERB
dpc-5083	128	2	treatments	treatment	NOUN
dpc-5083	128	3	will	will	AUX
dpc-5083	128	4	often	often	ADV
dpc-5083	128	5	include	include	VERB
dpc-5083	128	6	lubricants	lubricant	NOUN
dpc-5083	128	7	in	in	ADP
dpc-5083	128	8	mild	mild	ADJ
dpc-5083	128	9	cases	case	NOUN
dpc-5083	128	10	and	and	CCONJ
dpc-5083	128	11	a	a	DET
dpc-5083	128	12	combination	combination	NOUN
dpc-5083	128	13	of	of	ADP
dpc-5083	128	14	antibiotic/	antibiotic/	NUM
dpc-5083	128	15	corticosteroid	corticosteroid	ADJ
dpc-5083	128	16	eye	eye	NOUN
dpc-5083	128	17	drops	drop	NOUN
dpc-5083	128	18	such	such	ADJ
dpc-5083	128	19	as	as	ADP
dpc-5083	128	20	tobramycin	tobramycin	NOUN
dpc-5083	128	21	0.3	0.3	NUM
dpc-5083	128	22	%	%	NOUN
dpc-5083	128	23	and	and	CCONJ
dpc-5083	128	24	dexamethasone	dexamethasone	NOUN
dpc-5083	128	25	0.1	0.1	NUM
dpc-5083	128	26	%	%	NOUN
dpc-5083	128	27	if	if	SCONJ
dpc-5083	128	28	the	the	DET
dpc-5083	128	29	ocular	ocular	ADJ
dpc-5083	128	30	involvement	involvement	NOUN
dpc-5083	128	31	is	be	AUX
dpc-5083	128	32	moderate	moderate	ADJ
dpc-5083	128	33	[	[	X
dpc-5083	128	34	35	35	NUM
dpc-5083	128	35	]	]	PUNCT
dpc-5083	128	36	.	.	PUNCT
dpc-5083	129	1	topical	topical	ADJ
dpc-5083	129	2	cyclosporine	cyclosporine	NOUN
dpc-5083	129	3	a	a	DET
dpc-5083	129	4	(	(	PUNCT
dpc-5083	129	5	csa	csa	PROPN
dpc-5083	129	6	)	)	PUNCT
dpc-5083	129	7	eye	eye	NOUN
dpc-5083	129	8	drops	drop	NOUN
dpc-5083	129	9	have	have	AUX
dpc-5083	129	10	also	also	ADV
dpc-5083	129	11	been	be	AUX
dpc-5083	129	12	used	use	VERB
dpc-5083	129	13	in	in	ADP
dpc-5083	129	14	combination	combination	NOUN
dpc-5083	129	15	with	with	ADP
dpc-5083	129	16	systemic	systemic	ADJ
dpc-5083	129	17	therapy	therapy	NOUN
dpc-5083	129	18	[	[	X
dpc-5083	129	19	21	21	NUM
dpc-5083	129	20	]	]	PUNCT
dpc-5083	129	21	.	.	PUNCT
dpc-5083	130	1	if	if	SCONJ
dpc-5083	130	2	there	there	PRON
dpc-5083	130	3	is	be	VERB
dpc-5083	130	4	progression	progression	NOUN
dpc-5083	130	5	despite	despite	SCONJ
dpc-5083	130	6	the	the	DET
dpc-5083	130	7	aforementioned	aforementioned	ADJ
dpc-5083	130	8	therapies	therapy	NOUN
dpc-5083	130	9	,	,	PUNCT
dpc-5083	130	10	amniotic	amniotic	ADJ
dpc-5083	130	11	membrane	membrane	NOUN
dpc-5083	130	12	transplantation	transplantation	NOUN
dpc-5083	130	13	and	and	CCONJ
dpc-5083	130	14	other	other	ADJ
dpc-5083	130	15	advanced	advanced	ADJ
dpc-5083	130	16	therapies	therapy	NOUN
dpc-5083	130	17	might	might	AUX
dpc-5083	130	18	be	be	AUX
dpc-5083	130	19	necessary	necessary	ADJ
dpc-5083	130	20	in	in	ADP
dpc-5083	130	21	a	a	DET
dpc-5083	130	22	subset	subset	NOUN
dpc-5083	130	23	of	of	ADP
dpc-5083	130	24	patients	patient	NOUN
dpc-5083	130	25	[	[	X
dpc-5083	130	26	15,21,35	15,21,35	NUM
dpc-5083	130	27	]	]	PUNCT
dpc-5083	130	28	.	.	PUNCT
dpc-5083	131	1	according	accord	VERB
dpc-5083	131	2	to	to	ADP
dpc-5083	131	3	the	the	DET
dpc-5083	131	4	literature	literature	NOUN
dpc-5083	131	5	and	and	CCONJ
dpc-5083	131	6	based	base	VERB
dpc-5083	131	7	on	on	ADP
dpc-5083	131	8	the	the	DET
dpc-5083	131	9	authors	author	NOUN
dpc-5083	131	10	’	’	PART
dpc-5083	131	11	experience	experience	NOUN
dpc-5083	131	12	,	,	PUNCT
dpc-5083	131	13	all	all	DET
dpc-5083	131	14	patients	patient	NOUN
dpc-5083	131	15	will	will	AUX
dpc-5083	131	16	need	need	VERB
dpc-5083	131	17	systemic	systemic	ADJ
dpc-5083	131	18	treatment	treatment	NOUN
dpc-5083	131	19	.	.	PUNCT
dpc-5083	132	1	if	if	SCONJ
dpc-5083	132	2	mp	mp	PROPN
dpc-5083	132	3	or	or	CCONJ
dpc-5083	132	4	cp	cp	NUM
dpc-5083	132	5	infection	infection	NOUN
dpc-5083	132	6	is	be	AUX
dpc-5083	132	7	demonstrated	demonstrate	VERB
dpc-5083	132	8	,	,	PUNCT
dpc-5083	132	9	azithromycin	azithromycin	PROPN
dpc-5083	132	10	,	,	PUNCT
dpc-5083	132	11	tetracyclines	tetracycline	NOUN
dpc-5083	132	12	,	,	PUNCT
dpc-5083	132	13	or	or	CCONJ
dpc-5083	132	14	quinolones	quinolone	NOUN
dpc-5083	132	15	can	can	AUX
dpc-5083	132	16	be	be	AUX
dpc-5083	132	17	prescribed	prescribe	VERB
dpc-5083	132	18	.	.	PUNCT
dpc-5083	133	1	however	however	ADV
dpc-5083	133	2	,	,	PUNCT
dpc-5083	133	3	their	their	PRON
dpc-5083	133	4	impact	impact	NOUN
dpc-5083	133	5	on	on	ADP
dpc-5083	133	6	rime	rime	NOUN
dpc-5083	133	7	disease	disease	NOUN
dpc-5083	133	8	progression	progression	NOUN
dpc-5083	133	9	is	be	AUX
dpc-5083	133	10	uncertain	uncertain	ADJ
dpc-5083	133	11	[	[	X
dpc-5083	133	12	6	6	NUM
dpc-5083	133	13	]	]	PUNCT
dpc-5083	133	14	.	.	PUNCT
dpc-5083	134	1	azithromycin	azithromycin	PROPN
dpc-5083	134	2	can	can	AUX
dpc-5083	134	3	be	be	AUX
dpc-5083	134	4	administered	administer	VERB
dpc-5083	134	5	at	at	ADP
dpc-5083	134	6	a	a	DET
dpc-5083	134	7	dose	dose	NOUN
dpc-5083	134	8	of	of	ADP
dpc-5083	134	9	500	500	NUM
dpc-5083	134	10	mg	mg	NOUN
dpc-5083	134	11	daily	daily	ADV
dpc-5083	134	12	for	for	ADP
dpc-5083	134	13	three	three	NUM
dpc-5083	134	14	days	day	NOUN
dpc-5083	134	15	,	,	PUNCT
dpc-5083	134	16	either	either	CCONJ
dpc-5083	134	17	orally	orally	ADV
dpc-5083	134	18	or	or	CCONJ
dpc-5083	134	19	intravenously	intravenously	ADV
dpc-5083	134	20	.	.	PUNCT
dpc-5083	135	1	doxycycline	doxycycline	NOUN
dpc-5083	135	2	is	be	AUX
dpc-5083	135	3	a	a	DET
dpc-5083	135	4	valid	valid	ADJ
dpc-5083	135	5	alternative	alternative	NOUN
dpc-5083	135	6	if	if	SCONJ
dpc-5083	135	7	suspicion	suspicion	NOUN
dpc-5083	135	8	of	of	ADP
dpc-5083	135	9	resistant	resistant	ADJ
dpc-5083	135	10	mp	mp	NOUN
dpc-5083	135	11	(	(	PUNCT
dpc-5083	135	12	more	more	ADV
dpc-5083	135	13	prevalent	prevalent	ADJ
dpc-5083	135	14	in	in	ADP
dpc-5083	135	15	asia	asia	PROPN
dpc-5083	135	16	)	)	PUNCT
dpc-5083	135	17	in	in	ADP
dpc-5083	135	18	patients	patient	NOUN
dpc-5083	135	19	over	over	ADP
dpc-5083	135	20	8	8	NUM
dpc-5083	135	21	years	year	NOUN
dpc-5083	135	22	of	of	ADP
dpc-5083	135	23	age	age	NOUN
dpc-5083	135	24	.	.	PUNCT
dpc-5083	136	1	additionally	additionally	ADV
dpc-5083	136	2	,	,	PUNCT
dpc-5083	136	3	if	if	SCONJ
dpc-5083	136	4	herpetic	herpetic	ADJ
dpc-5083	136	5	infection	infection	NOUN
dpc-5083	136	6	can	can	AUX
dpc-5083	136	7	not	not	PART
dpc-5083	136	8	be	be	AUX
dpc-5083	136	9	ruled	rule	VERB
dpc-5083	136	10	out	out	ADP
dpc-5083	136	11	,	,	PUNCT
dpc-5083	136	12	prescription	prescription	NOUN
dpc-5083	136	13	of	of	ADP
dpc-5083	136	14	acyclovir	acyclovir	PROPN
dpc-5083	136	15	until	until	SCONJ
dpc-5083	136	16	confirmed	confirm	VERB
dpc-5083	136	17	negativity	negativity	NOUN
dpc-5083	136	18	in	in	ADP
dpc-5083	136	19	serology	serology	NOUN
dpc-5083	136	20	or	or	CCONJ
dpc-5083	136	21	pcr	pcr	NOUN
dpc-5083	136	22	might	might	AUX
dpc-5083	136	23	be	be	AUX
dpc-5083	136	24	a	a	DET
dpc-5083	136	25	prudent	prudent	ADJ
dpc-5083	136	26	conditional	conditional	ADJ
dpc-5083	136	27	recommendation	recommendation	NOUN
dpc-5083	136	28	.	.	PUNCT
dpc-5083	137	1	anti	anti	ADJ
dpc-5083	137	2	-	-	ADJ
dpc-5083	137	3	inflammatory	inflammatory	ADJ
dpc-5083	137	4	and	and	CCONJ
dpc-5083	137	5	immunosuppressive	immunosuppressive	ADJ
dpc-5083	137	6	agents	agent	NOUN
dpc-5083	137	7	are	be	AUX
dpc-5083	137	8	the	the	DET
dpc-5083	137	9	keystone	keystone	NOUN
dpc-5083	137	10	of	of	ADP
dpc-5083	137	11	systemic	systemic	ADJ
dpc-5083	137	12	treatment	treatment	NOUN
dpc-5083	137	13	.	.	PUNCT
dpc-5083	138	1	if	if	SCONJ
dpc-5083	138	2	strongyloides	strongyloide	NOUN
dpc-5083	138	3	stercolaris	stercolaris	VERB
dpc-5083	138	4	serology	serology	NOUN
dpc-5083	138	5	is	be	AUX
dpc-5083	138	6	pending	pende	VERB
dpc-5083	138	7	,	,	PUNCT
dpc-5083	138	8	unavailable	unavailable	ADJ
dpc-5083	138	9	,	,	PUNCT
dpc-5083	138	10	or	or	CCONJ
dpc-5083	138	11	the	the	DET
dpc-5083	138	12	patient	patient	NOUN
dpc-5083	138	13	comes	come	VERB
dpc-5083	138	14	from	from	ADP
dpc-5083	138	15	or	or	CCONJ
dpc-5083	138	16	travels	travel	VERB
dpc-5083	138	17	to	to	ADP
dpc-5083	138	18	endemic	endemic	ADJ
dpc-5083	138	19	areas	area	NOUN
dpc-5083	138	20	,	,	PUNCT
dpc-5083	138	21	empirical	empirical	ADJ
dpc-5083	138	22	prophylaxis	prophylaxis	NOUN
dpc-5083	138	23	with	with	ADP
dpc-5083	138	24	ivermectin	ivermectin	NOUN
dpc-5083	138	25	can	can	AUX
dpc-5083	138	26	be	be	AUX
dpc-5083	138	27	considered	consider	VERB
dpc-5083	138	28	.	.	PUNCT
dpc-5083	139	1	most	most	ADJ
dpc-5083	139	2	published	publish	VERB
dpc-5083	139	3	cases	case	NOUN
dpc-5083	139	4	have	have	AUX
dpc-5083	139	5	been	be	AUX
dpc-5083	139	6	treated	treat	VERB
dpc-5083	139	7	with	with	ADP
dpc-5083	139	8	systemic	systemic	ADJ
dpc-5083	139	9	corticosteroids	corticosteroid	NOUN
dpc-5083	139	10	,	,	PUNCT
dpc-5083	139	11	which	which	PRON
dpc-5083	139	12	are	be	AUX
dpc-5083	139	13	thus	thus	ADV
dpc-5083	139	14	considered	consider	VERB
dpc-5083	139	15	the	the	DET
dpc-5083	139	16	first	first	ADJ
dpc-5083	139	17	line	line	NOUN
dpc-5083	139	18	of	of	ADP
dpc-5083	139	19	treatment	treatment	NOUN
dpc-5083	139	20	[	[	X
dpc-5083	139	21	36	36	NUM
dpc-5083	139	22	]	]	PUNCT
dpc-5083	139	23	.	.	PUNCT
dpc-5083	140	1	prednisone	prednisone	PROPN
dpc-5083	140	2	or	or	CCONJ
dpc-5083	140	3	methylprednisolone	methylprednisolone	NOUN
dpc-5083	140	4	0.5–1	0.5–1	NOUN
dpc-5083	140	5	mg	mg	PROPN
dpc-5083	140	6	/	/	SYM
dpc-5083	140	7	kg	kg	PROPN
dpc-5083	140	8	/	/	SYM
dpc-5083	140	9	day	day	NOUN
dpc-5083	140	10	for	for	ADP
dpc-5083	140	11	5–7	5–7	NUM
dpc-5083	140	12	days	day	NOUN
dpc-5083	140	13	[	[	X
dpc-5083	140	14	20	20	NUM
dpc-5083	140	15	]	]	PUNCT
dpc-5083	140	16	or	or	CCONJ
dpc-5083	140	17	hydrocortisone	hydrocortisone	NOUN
dpc-5083	140	18	at	at	ADP
dpc-5083	140	19	100	100	NUM
dpc-5083	140	20	mg	mg	NOUN
dpc-5083	140	21	every	every	DET
dpc-5083	140	22	8	8	NUM
dpc-5083	140	23	hours	hour	NOUN
dpc-5083	140	24	for	for	ADP
dpc-5083	140	25	three	three	NUM
dpc-5083	140	26	days	day	NOUN
dpc-5083	140	27	have	have	AUX
dpc-5083	140	28	been	be	AUX
dpc-5083	140	29	described	describe	VERB
dpc-5083	140	30	with	with	ADP
dpc-5083	140	31	successful	successful	ADJ
dpc-5083	140	32	outcomes	outcome	NOUN
dpc-5083	140	33	[	[	X
dpc-5083	140	34	12	12	NUM
dpc-5083	140	35	]	]	PUNCT
dpc-5083	140	36	.	.	PUNCT
dpc-5083	141	1	pulse	pulse	NOUN
dpc-5083	141	2	therapy	therapy	NOUN
dpc-5083	141	3	with	with	ADP
dpc-5083	141	4	methylprednisolone	methylprednisolone	NOUN
dpc-5083	141	5	,	,	PUNCT
dpc-5083	141	6	up	up	ADP
dpc-5083	141	7	to	to	PART
dpc-5083	141	8	1000	1000	NUM
dpc-5083	141	9	mg	mg	NOUN
dpc-5083	141	10	distributed	distribute	VERB
dpc-5083	141	11	over	over	ADP
dpc-5083	141	12	3–4	3–4	NUM
dpc-5083	141	13	days	day	NOUN
dpc-5083	141	14	,	,	PUNCT
dpc-5083	141	15	may	may	AUX
dpc-5083	141	16	also	also	ADV
dpc-5083	141	17	be	be	AUX
dpc-5083	141	18	used	use	VERB
dpc-5083	141	19	.	.	PUNCT
dpc-5083	142	1	csa	csa	PROPN
dpc-5083	142	2	at	at	ADP
dpc-5083	142	3	a	a	DET
dpc-5083	142	4	dose	dose	NOUN
dpc-5083	142	5	of	of	ADP
dpc-5083	142	6	3–5	3–5	NUM
dpc-5083	142	7	mg	mg	PROPN
dpc-5083	142	8	/	/	SYM
dpc-5083	142	9	kg	kg	PROPN
dpc-5083	142	10	/	/	SYM
dpc-5083	142	11	day	day	NOUN
dpc-5083	142	12	for	for	ADP
dpc-5083	142	13	5–8	5–8	NOUN
dpc-5083	142	14	days	day	NOUN
dpc-5083	142	15	can	can	AUX
dpc-5083	142	16	be	be	AUX
dpc-5083	142	17	used	use	VERB
dpc-5083	142	18	as	as	ADP
dpc-5083	142	19	either	either	CCONJ
dpc-5083	142	20	a	a	DET
dpc-5083	142	21	firstor	firstor	NOUN
dpc-5083	142	22	second	second	ADJ
dpc-5083	142	23	-	-	PUNCT
dpc-5083	142	24	line	line	NOUN
dpc-5083	142	25	treatment	treatment	NOUN
dpc-5083	142	26	,	,	PUNCT
dpc-5083	142	27	in	in	ADP
dpc-5083	142	28	monotherapy	monotherapy	NOUN
dpc-5083	142	29	or	or	CCONJ
dpc-5083	142	30	in	in	ADP
dpc-5083	142	31	association	association	NOUN
dpc-5083	142	32	with	with	ADP
dpc-5083	142	33	systemic	systemic	ADJ
dpc-5083	142	34	steroids	steroid	NOUN
dpc-5083	143	1	[	[	X
dpc-5083	143	2	21	21	NUM
dpc-5083	143	3	]	]	PUNCT
dpc-5083	143	4	.	.	PUNCT
dpc-5083	144	1	the	the	DET
dpc-5083	144	2	dose	dose	NOUN
dpc-5083	144	3	can	can	AUX
dpc-5083	144	4	be	be	AUX
dpc-5083	144	5	continued	continue	VERB
dpc-5083	144	6	at	at	ADP
dpc-5083	144	7	3	3	NUM
dpc-5083	144	8	mg	mg	PROPN
dpc-5083	144	9	/	/	SYM
dpc-5083	144	10	kg	kg	PROPN
dpc-5083	144	11	/	/	SYM
dpc-5083	144	12	day	day	NOUN
dpc-5083	144	13	for	for	ADP
dpc-5083	144	14	1–2	1–2	NUM
dpc-5083	144	15	weeks	week	NOUN
dpc-5083	144	16	,	,	PUNCT
dpc-5083	144	17	followed	follow	VERB
dpc-5083	144	18	by	by	ADP
dpc-5083	144	19	abrupt	abrupt	ADJ
dpc-5083	144	20	discontinuation	discontinuation	NOUN
dpc-5083	144	21	.	.	PUNCT
dpc-5083	145	1	csa	csa	PROPN
dpc-5083	145	2	serves	serve	VERB
dpc-5083	145	3	as	as	ADP
dpc-5083	145	4	a	a	DET
dpc-5083	145	5	steroid	steroid	NOUN
dpc-5083	145	6	-	-	PUNCT
dpc-5083	145	7	sparing	spare	VERB
dpc-5083	145	8	agent	agent	NOUN
dpc-5083	145	9	,	,	PUNCT
dpc-5083	145	10	and	and	CCONJ
dpc-5083	145	11	as	as	SCONJ
dpc-5083	145	12	it	it	PRON
dpc-5083	145	13	can	can	AUX
dpc-5083	145	14	shorten	shorten	VERB
dpc-5083	145	15	hospitalization	hospitalization	NOUN
dpc-5083	145	16	by	by	ADP
dpc-5083	145	17	6–7	6–7	NUM
dpc-5083	145	18	days	day	NOUN
dpc-5083	145	19	compared	compare	VERB
dpc-5083	145	20	to	to	ADP
dpc-5083	145	21	autoimmunity	autoimmunity	NOUN
dpc-5083	145	22	panels	panel	NOUN
dpc-5083	145	23	,	,	PUNCT
dpc-5083	145	24	including	include	VERB
dpc-5083	145	25	antinuclear	antinuclear	ADJ
dpc-5083	145	26	antibodies	antibody	NOUN
dpc-5083	145	27	,	,	PUNCT
dpc-5083	145	28	anti	anti	ADJ
dpc-5083	145	29	-	-	ADJ
dpc-5083	145	30	double	double	ADJ
dpc-5083	145	31	stranded	strand	VERB
dpc-5083	145	32	dna	dna	NOUN
dpc-5083	145	33	,	,	PUNCT
dpc-5083	145	34	antineutrophil	antineutrophil	PROPN
dpc-5083	145	35	cytoplasmic	cytoplasmic	ADJ
dpc-5083	145	36	antibodies	antibody	NOUN
dpc-5083	145	37	,	,	PUNCT
dpc-5083	145	38	complement	complement	NOUN
dpc-5083	145	39	levels	level	NOUN
dpc-5083	145	40	,	,	PUNCT
dpc-5083	145	41	immunoglobulins	immunoglobulin	NOUN
dpc-5083	145	42	,	,	PUNCT
dpc-5083	145	43	and	and	CCONJ
dpc-5083	145	44	rheumatoid	rheumatoid	NOUN
dpc-5083	145	45	factor	factor	NOUN
dpc-5083	145	46	,	,	PUNCT
dpc-5083	145	47	are	be	AUX
dpc-5083	145	48	also	also	ADV
dpc-5083	145	49	useful	useful	ADJ
dpc-5083	145	50	in	in	ADP
dpc-5083	145	51	the	the	DET
dpc-5083	145	52	diagnostic	diagnostic	ADJ
dpc-5083	145	53	process	process	NOUN
dpc-5083	145	54	.	.	PUNCT
dpc-5083	146	1	venous	venous	ADJ
dpc-5083	146	2	blood	blood	NOUN
dpc-5083	146	3	gas	gas	NOUN
dpc-5083	146	4	analysis	analysis	NOUN
dpc-5083	146	5	may	may	AUX
dpc-5083	146	6	be	be	AUX
dpc-5083	146	7	of	of	ADP
dpc-5083	146	8	value	value	NOUN
dpc-5083	146	9	in	in	ADP
dpc-5083	146	10	the	the	DET
dpc-5083	146	11	emergency	emergency	NOUN
dpc-5083	146	12	room	room	NOUN
dpc-5083	146	13	to	to	PART
dpc-5083	146	14	detect	detect	VERB
dpc-5083	146	15	acidosis	acidosis	NOUN
dpc-5083	146	16	or	or	CCONJ
dpc-5083	146	17	alkalosis	alkalosis	NOUN
dpc-5083	146	18	,	,	PUNCT
dpc-5083	146	19	given	give	VERB
dpc-5083	146	20	that	that	SCONJ
dpc-5083	146	21	patients	patient	NOUN
dpc-5083	146	22	with	with	ADP
dpc-5083	146	23	rime	rime	NOUN
dpc-5083	146	24	usually	usually	ADV
dpc-5083	146	25	have	have	AUX
dpc-5083	146	26	difficulty	difficulty	NOUN
dpc-5083	146	27	in	in	ADP
dpc-5083	146	28	solid	solid	ADJ
dpc-5083	146	29	and	and	CCONJ
dpc-5083	146	30	liquid	liquid	ADJ
dpc-5083	146	31	intake	intake	NOUN
dpc-5083	146	32	prior	prior	ADV
dpc-5083	146	33	to	to	ADP
dpc-5083	146	34	consultation	consultation	NOUN
dpc-5083	146	35	.	.	PUNCT
dpc-5083	147	1	a	a	DET
dpc-5083	147	2	urinalysis	urinalysis	NOUN
dpc-5083	147	3	can	can	AUX
dpc-5083	147	4	also	also	ADV
dpc-5083	147	5	be	be	AUX
dpc-5083	147	6	informative	informative	ADJ
dpc-5083	147	7	,	,	PUNCT
dpc-5083	147	8	since	since	SCONJ
dpc-5083	147	9	the	the	DET
dpc-5083	147	10	presence	presence	NOUN
dpc-5083	147	11	of	of	ADP
dpc-5083	147	12	hematuria	hematuria	NOUN
dpc-5083	147	13	and/or	and/or	CCONJ
dpc-5083	147	14	abundant	abundant	ADJ
dpc-5083	147	15	epithelial	epithelial	ADJ
dpc-5083	147	16	cells	cell	NOUN
dpc-5083	147	17	in	in	ADP
dpc-5083	147	18	the	the	DET
dpc-5083	147	19	sediment	sediment	NOUN
dpc-5083	147	20	can	can	AUX
dpc-5083	147	21	be	be	AUX
dpc-5083	147	22	an	an	DET
dpc-5083	147	23	indirect	indirect	ADJ
dpc-5083	147	24	sign	sign	NOUN
dpc-5083	147	25	of	of	ADP
dpc-5083	147	26	inflammation	inflammation	NOUN
dpc-5083	147	27	of	of	ADP
dpc-5083	147	28	the	the	DET
dpc-5083	147	29	urethral	urethral	ADJ
dpc-5083	147	30	mucosa	mucosa	NOUN
dpc-5083	148	1	[	[	X
dpc-5083	148	2	26	26	NUM
dpc-5083	148	3	]	]	PUNCT
dpc-5083	148	4	.	.	PUNCT
dpc-5083	148	5	nasopharyngeal	nasopharyngeal	ADJ
dpc-5083	148	6	and	and	CCONJ
dpc-5083	148	7	oropharyngeal	oropharyngeal	ADJ
dpc-5083	148	8	swabs	swab	NOUN
dpc-5083	148	9	for	for	ADP
dpc-5083	148	10	mp	mp	PROPN
dpc-5083	148	11	,	,	PUNCT
dpc-5083	148	12	cp	cp	PROPN
dpc-5083	148	13	,	,	PUNCT
dpc-5083	148	14	sars	sar	NOUN
dpc-5083	148	15	-	-	PUNCT
dpc-5083	148	16	cov-2	cov-2	NOUN
dpc-5083	148	17	,	,	PUNCT
dpc-5083	148	18	influenza	influenza	NOUN
dpc-5083	148	19	,	,	PUNCT
dpc-5083	148	20	and	and	CCONJ
dpc-5083	148	21	other	other	ADJ
dpc-5083	148	22	agents	agent	NOUN
dpc-5083	148	23	are	be	AUX
dpc-5083	148	24	also	also	ADV
dpc-5083	148	25	recommended	recommend	VERB
dpc-5083	148	26	.	.	PUNCT
dpc-5083	149	1	multiplex	multiplex	PROPN
dpc-5083	149	2	pcr	pcr	PROPN
dpc-5083	149	3	,	,	PUNCT
dpc-5083	149	4	if	if	SCONJ
dpc-5083	149	5	available	available	ADJ
dpc-5083	149	6	,	,	PUNCT
dpc-5083	149	7	is	be	AUX
dpc-5083	149	8	a	a	DET
dpc-5083	149	9	rapid	rapid	ADJ
dpc-5083	149	10	and	and	CCONJ
dpc-5083	149	11	efficient	efficient	ADJ
dpc-5083	149	12	diagnostic	diagnostic	ADJ
dpc-5083	149	13	tool	tool	NOUN
dpc-5083	149	14	.	.	PUNCT
dpc-5083	150	1	if	if	SCONJ
dpc-5083	150	2	tonsillitis	tonsillitis	NOUN
dpc-5083	150	3	is	be	AUX
dpc-5083	150	4	present	present	ADJ
dpc-5083	150	5	,	,	PUNCT
dpc-5083	150	6	rapid	rapid	ADJ
dpc-5083	150	7	test	test	NOUN
dpc-5083	150	8	for	for	ADP
dpc-5083	150	9	group	group	NOUN
dpc-5083	150	10	a	a	DET
dpc-5083	150	11	streptococcus	streptococcus	NOUN
dpc-5083	150	12	is	be	AUX
dpc-5083	150	13	indicated	indicate	VERB
dpc-5083	150	14	.	.	PUNCT
dpc-5083	151	1	the	the	DET
dpc-5083	151	2	performance	performance	NOUN
dpc-5083	151	3	of	of	ADP
dpc-5083	151	4	the	the	DET
dpc-5083	151	5	tzanck	tzanck	ADJ
dpc-5083	151	6	smear	smear	NOUN
dpc-5083	151	7	for	for	ADP
dpc-5083	151	8	cytological	cytological	ADJ
dpc-5083	151	9	evaluation	evaluation	NOUN
dpc-5083	151	10	can	can	AUX
dpc-5083	151	11	be	be	AUX
dpc-5083	151	12	helpful	helpful	ADJ
dpc-5083	151	13	to	to	PART
dpc-5083	151	14	detect	detect	VERB
dpc-5083	151	15	signs	sign	NOUN
dpc-5083	151	16	of	of	ADP
dpc-5083	151	17	herpetic	herpetic	ADJ
dpc-5083	151	18	infection	infection	NOUN
dpc-5083	151	19	or	or	CCONJ
dpc-5083	151	20	blistering	blister	VERB
dpc-5083	151	21	disease	disease	NOUN
dpc-5083	151	22	when	when	SCONJ
dpc-5083	151	23	used	use	VERB
dpc-5083	151	24	by	by	ADP
dpc-5083	151	25	trained	train	VERB
dpc-5083	151	26	personnel	personnel	NOUN
dpc-5083	151	27	.	.	PUNCT
dpc-5083	152	1	an	an	DET
dpc-5083	152	2	electrocardiogram	electrocardiogram	NOUN
dpc-5083	152	3	is	be	AUX
dpc-5083	152	4	a	a	DET
dpc-5083	152	5	cheap	cheap	ADJ
dpc-5083	152	6	and	and	CCONJ
dpc-5083	152	7	valuable	valuable	ADJ
dpc-5083	152	8	diagnostic	diagnostic	ADJ
dpc-5083	152	9	tool	tool	NOUN
dpc-5083	152	10	which	which	PRON
dpc-5083	152	11	should	should	AUX
dpc-5083	152	12	be	be	AUX
dpc-5083	152	13	performed	perform	VERB
dpc-5083	152	14	if	if	SCONJ
dpc-5083	152	15	there	there	PRON
dpc-5083	152	16	are	be	VERB
dpc-5083	152	17	signs	sign	NOUN
dpc-5083	152	18	or	or	CCONJ
dpc-5083	152	19	symptoms	symptom	NOUN
dpc-5083	152	20	of	of	ADP
dpc-5083	152	21	pericarditis	pericarditis	NOUN
dpc-5083	152	22	,	,	PUNCT
dpc-5083	152	23	since	since	SCONJ
dpc-5083	152	24	pericarditis	pericarditis	NOUN
dpc-5083	152	25	is	be	AUX
dpc-5083	152	26	a	a	DET
dpc-5083	152	27	recognized	recognize	VERB
dpc-5083	152	28	extrapulmonary	extrapulmonary	ADJ
dpc-5083	152	29	manifestation	manifestation	NOUN
dpc-5083	152	30	of	of	ADP
dpc-5083	152	31	mp	mp	PROPN
dpc-5083	153	1	[	[	X
dpc-5083	153	2	32	32	NUM
dpc-5083	153	3	]	]	PUNCT
dpc-5083	153	4	.	.	PUNCT
dpc-5083	154	1	diffuse	diffuse	PROPN
dpc-5083	154	2	concave	concave	VERB
dpc-5083	154	3	upward	upward	PROPN
dpc-5083	154	4	st	st	PROPN
dpc-5083	154	5	segment	segment	PROPN
dpc-5083	154	6	elevation	elevation	NOUN
dpc-5083	154	7	and/or	and/or	CCONJ
dpc-5083	154	8	pr	pr	NOUN
dpc-5083	154	9	segment	segment	NOUN
dpc-5083	154	10	depression	depression	NOUN
dpc-5083	154	11	are	be	AUX
dpc-5083	154	12	the	the	DET
dpc-5083	154	13	most	most	ADV
dpc-5083	154	14	prominent	prominent	ADJ
dpc-5083	154	15	electrocardiographic	electrocardiographic	ADJ
dpc-5083	154	16	findings	finding	NOUN
dpc-5083	154	17	in	in	ADP
dpc-5083	154	18	early	early	ADJ
dpc-5083	154	19	phases	phase	NOUN
dpc-5083	154	20	.	.	PUNCT
dpc-5083	155	1	chest	chest	NOUN
dpc-5083	155	2	x	x	X
dpc-5083	155	3	-	-	NOUN
dpc-5083	155	4	ray	ray	NOUN
dpc-5083	155	5	is	be	AUX
dpc-5083	155	6	recommended	recommend	VERB
dpc-5083	155	7	to	to	PART
dpc-5083	155	8	identify	identify	VERB
dpc-5083	155	9	signs	sign	NOUN
dpc-5083	155	10	of	of	ADP
dpc-5083	155	11	atypical	atypical	ADJ
dpc-5083	155	12	pneumonia	pneumonia	NOUN
dpc-5083	155	13	(	(	PUNCT
dpc-5083	155	14	patchy	patchy	ADJ
dpc-5083	155	15	infiltrates	infiltrate	NOUN
dpc-5083	155	16	or	or	CCONJ
dpc-5083	155	17	interstitial	interstitial	ADJ
dpc-5083	155	18	patterns	pattern	NOUN
dpc-5083	155	19	)	)	PUNCT
dpc-5083	155	20	,	,	PUNCT
dpc-5083	155	21	although	although	SCONJ
dpc-5083	155	22	it	it	PRON
dpc-5083	155	23	should	should	AUX
dpc-5083	155	24	be	be	AUX
dpc-5083	155	25	remembered	remember	VERB
dpc-5083	155	26	that	that	SCONJ
dpc-5083	155	27	den	den	NOUN
dpc-5083	155	28	might	might	AUX
dpc-5083	155	29	also	also	ADV
dpc-5083	155	30	present	present	VERB
dpc-5083	155	31	with	with	ADP
dpc-5083	155	32	interstitial	interstitial	ADJ
dpc-5083	155	33	pneumonitis	pneumonitis	NOUN
dpc-5083	156	1	[	[	X
dpc-5083	156	2	33	33	NUM
dpc-5083	156	3	]	]	PUNCT
dpc-5083	156	4	.	.	PUNCT
dpc-5083	157	1	sample	sample	NOUN
dpc-5083	157	2	collection	collection	NOUN
dpc-5083	157	3	is	be	AUX
dpc-5083	157	4	also	also	ADV
dpc-5083	157	5	fundamental	fundamental	ADJ
dpc-5083	157	6	.	.	PUNCT
dpc-5083	158	1	this	this	PRON
dpc-5083	158	2	should	should	AUX
dpc-5083	158	3	include	include	VERB
dpc-5083	158	4	bacterial	bacterial	ADJ
dpc-5083	158	5	cultures	culture	NOUN
dpc-5083	158	6	to	to	PART
dpc-5083	158	7	rule	rule	VERB
dpc-5083	158	8	out	out	ADP
dpc-5083	158	9	secondary	secondary	ADJ
dpc-5083	158	10	infection	infection	NOUN
dpc-5083	158	11	as	as	ADV
dpc-5083	158	12	well	well	ADV
dpc-5083	158	13	as	as	ADP
dpc-5083	158	14	swabs	swab	NOUN
dpc-5083	158	15	for	for	ADP
dpc-5083	158	16	pcr	pcr	ADJ
dpc-5083	158	17	test	test	NOUN
dpc-5083	158	18	for	for	ADP
dpc-5083	158	19	ulcerative	ulcerative	ADJ
dpc-5083	158	20	diseases	disease	NOUN
dpc-5083	158	21	(	(	PUNCT
dpc-5083	158	22	hsv-1	hsv-1	X
dpc-5083	158	23	,	,	PUNCT
dpc-5083	158	24	hsv-2	hsv-2	X
dpc-5083	158	25	,	,	PUNCT
dpc-5083	158	26	vzv	vzv	PROPN
dpc-5083	158	27	)	)	PUNCT
dpc-5083	158	28	.	.	PUNCT
dpc-5083	159	1	ideally	ideally	ADV
dpc-5083	159	2	,	,	PUNCT
dpc-5083	159	3	two	two	NUM
dpc-5083	159	4	skin	skin	NOUN
dpc-5083	159	5	biopsies	biopsy	NOUN
dpc-5083	159	6	for	for	ADP
dpc-5083	159	7	hematoxylin	hematoxylin	NOUN
dpc-5083	159	8	-	-	PUNCT
dpc-5083	159	9	eosin	eosin	NOUN
dpc-5083	159	10	study	study	NOUN
dpc-5083	159	11	and	and	CCONJ
dpc-5083	159	12	direct	direct	ADJ
dpc-5083	159	13	immunofluorescence	immunofluorescence	NOUN
dpc-5083	159	14	should	should	AUX
dpc-5083	159	15	be	be	AUX
dpc-5083	159	16	performed	perform	VERB
dpc-5083	159	17	.	.	PUNCT
dpc-5083	160	1	since	since	SCONJ
dpc-5083	160	2	many	many	ADJ
dpc-5083	160	3	patients	patient	NOUN
dpc-5083	160	4	may	may	AUX
dpc-5083	160	5	have	have	AUX
dpc-5083	160	6	used	use	VERB
dpc-5083	160	7	analgesics	analgesic	NOUN
dpc-5083	160	8	or	or	CCONJ
dpc-5083	160	9	non	non	ADJ
dpc-5083	160	10	steroidal	steroidal	NOUN
dpc-5083	160	11	anti	anti	ADJ
dpc-5083	160	12	-	-	ADJ
dpc-5083	160	13	inflammatory	inflammatory	ADJ
dpc-5083	160	14	drugs	drug	NOUN
dpc-5083	160	15	,	,	PUNCT
dpc-5083	160	16	among	among	ADP
dpc-5083	160	17	other	other	ADJ
dpc-5083	160	18	medications	medication	NOUN
dpc-5083	160	19	,	,	PUNCT
dpc-5083	160	20	prior	prior	ADV
dpc-5083	160	21	to	to	ADP
dpc-5083	160	22	consultation	consultation	NOUN
dpc-5083	160	23	,	,	PUNCT
dpc-5083	160	24	further	further	ADJ
dpc-5083	160	25	testing	testing	NOUN
dpc-5083	160	26	to	to	PART
dpc-5083	160	27	identify	identify	VERB
dpc-5083	160	28	any	any	DET
dpc-5083	160	29	potential	potential	ADJ
dpc-5083	160	30	drug	drug	NOUN
dpc-5083	160	31	hypersensitivity	hypersensitivity	NOUN
dpc-5083	160	32	reaction	reaction	NOUN
dpc-5083	160	33	(	(	PUNCT
dpc-5083	160	34	immunofluorescence	immunofluorescence	NOUN
dpc-5083	160	35	,	,	PUNCT
dpc-5083	160	36	lymphocyte	lymphocyte	ADJ
dpc-5083	160	37	activation	activation	NOUN
dpc-5083	160	38	assay	assay	VERB
dpc-5083	160	39	,	,	PUNCT
dpc-5083	160	40	patch	patch	ADJ
dpc-5083	160	41	test	test	NOUN
dpc-5083	160	42	,	,	PUNCT
dpc-5083	160	43	intradermal	intradermal	ADJ
dpc-5083	160	44	test	test	NOUN
dpc-5083	160	45	,	,	PUNCT
dpc-5083	160	46	or	or	CCONJ
dpc-5083	160	47	drug	drug	NOUN
dpc-5083	160	48	provocation	provocation	NOUN
dpc-5083	160	49	testing	testing	NOUN
dpc-5083	160	50	)	)	PUNCT
dpc-5083	160	51	could	could	AUX
dpc-5083	160	52	be	be	AUX
dpc-5083	160	53	performed	perform	VERB
dpc-5083	160	54	if	if	SCONJ
dpc-5083	160	55	in	in	ADP
dpc-5083	160	56	doubt	doubt	NOUN
dpc-5083	160	57	or	or	CCONJ
dpc-5083	160	58	if	if	SCONJ
dpc-5083	160	59	overlapping	overlap	VERB
dpc-5083	160	60	features	feature	NOUN
dpc-5083	160	61	exist	exist	VERB
dpc-5083	160	62	[	[	X
dpc-5083	160	63	34	34	NUM
dpc-5083	160	64	]	]	PUNCT
dpc-5083	160	65	.	.	PUNCT
dpc-5083	161	1	however	however	ADV
dpc-5083	161	2	,	,	PUNCT
dpc-5083	161	3	it	it	PRON
dpc-5083	161	4	should	should	AUX
dpc-5083	161	5	be	be	AUX
dpc-5083	161	6	noted	note	VERB
dpc-5083	161	7	that	that	SCONJ
dpc-5083	161	8	the	the	DET
dpc-5083	161	9	sensitivity	sensitivity	NOUN
dpc-5083	161	10	of	of	ADP
dpc-5083	161	11	these	these	DET
dpc-5083	161	12	tests	test	NOUN
dpc-5083	161	13	can	can	AUX
dpc-5083	161	14	vary	vary	VERB
dpc-5083	161	15	significantly	significantly	ADV
dpc-5083	161	16	.	.	PUNCT
dpc-5083	162	1	the	the	DET
dpc-5083	162	2	available	available	ADJ
dpc-5083	162	3	evidence	evidence	NOUN
dpc-5083	162	4	on	on	ADP
dpc-5083	162	5	the	the	DET
dpc-5083	162	6	therapeutic	therapeutic	ADJ
dpc-5083	162	7	management	management	NOUN
dpc-5083	162	8	of	of	ADP
dpc-5083	162	9	rime	rime	NOUN
dpc-5083	162	10	,	,	PUNCT
dpc-5083	162	11	sparse	sparse	ADJ
dpc-5083	162	12	and	and	CCONJ
dpc-5083	162	13	limited	limit	VERB
dpc-5083	162	14	in	in	ADP
dpc-5083	162	15	quality	quality	NOUN
dpc-5083	162	16	,	,	PUNCT
dpc-5083	162	17	is	be	AUX
dpc-5083	162	18	based	base	VERB
dpc-5083	162	19	on	on	ADP
dpc-5083	162	20	case	case	NOUN
dpc-5083	162	21	reports	report	NOUN
dpc-5083	162	22	,	,	PUNCT
dpc-5083	162	23	case	case	NOUN
dpc-5083	162	24	series	series	NOUN
dpc-5083	162	25	,	,	PUNCT
dpc-5083	162	26	and	and	CCONJ
dpc-5083	162	27	a	a	DET
dpc-5083	162	28	systematic	systematic	ADJ
dpc-5083	162	29	review	review	NOUN
dpc-5083	162	30	published	publish	VERB
dpc-5083	162	31	by	by	ADP
dpc-5083	162	32	vujic	vujic	PROPN
dpc-5083	162	33	et	et	PROPN
dpc-5083	162	34	al	al	PROPN
dpc-5083	162	35	.	.	PUNCT
dpc-5083	162	36	addressing	address	VERB
dpc-5083	162	37	solely	solely	ADV
dpc-5083	162	38	mirm	mirm	ADJ
dpc-5083	162	39	[	[	X
dpc-5083	162	40	31	31	NUM
dpc-5083	162	41	]	]	PUNCT
dpc-5083	162	42	.	.	PUNCT
dpc-5083	163	1	the	the	DET
dpc-5083	163	2	approach	approach	NOUN
dpc-5083	163	3	to	to	ADP
dpc-5083	163	4	rime	rime	NOUN
dpc-5083	163	5	includes	include	VERB
dpc-5083	163	6	supportive	supportive	ADJ
dpc-5083	163	7	care	care	NOUN
dpc-5083	163	8	,	,	PUNCT
dpc-5083	163	9	which	which	PRON
dpc-5083	163	10	usually	usually	ADV
dpc-5083	163	11	requires	require	VERB
dpc-5083	163	12	hospitalization	hospitalization	NOUN
dpc-5083	163	13	.	.	PUNCT
dpc-5083	164	1	dietary	dietary	ADJ
dpc-5083	164	2	adjustments	adjustment	NOUN
dpc-5083	164	3	are	be	AUX
dpc-5083	164	4	essential	essential	ADJ
dpc-5083	164	5	,	,	PUNCT
dpc-5083	164	6	including	include	VERB
dpc-5083	164	7	the	the	DET
dpc-5083	164	8	implementation	implementation	NOUN
dpc-5083	164	9	of	of	ADP
dpc-5083	164	10	a	a	DET
dpc-5083	164	11	liquid	liquid	ADJ
dpc-5083	164	12	diet	diet	NOUN
dpc-5083	164	13	or	or	CCONJ
dpc-5083	164	14	fluid	fluid	NOUN
dpc-5083	164	15	therapy	therapy	NOUN
dpc-5083	164	16	as	as	SCONJ
dpc-5083	164	17	needed	need	VERB
dpc-5083	164	18	and	and	CCONJ
dpc-5083	164	19	avoiding	avoid	VERB
dpc-5083	164	20	nasogastric	nasogastric	ADJ
dpc-5083	164	21	tube	tube	NOUN
dpc-5083	164	22	insertion	insertion	NOUN
dpc-5083	164	23	.	.	PUNCT
dpc-5083	165	1	adequate	adequate	ADJ
dpc-5083	165	2	analgesia	analgesia	PROPN
dpc-5083	165	3	is	be	AUX
dpc-5083	165	4	also	also	ADV
dpc-5083	165	5	key	key	ADJ
dpc-5083	165	6	in	in	ADP
dpc-5083	165	7	supportive	supportive	ADJ
dpc-5083	165	8	care	care	NOUN
dpc-5083	165	9	.	.	PUNCT
dpc-5083	166	1	6	6	NUM
dpc-5083	166	2	review	review	NOUN
dpc-5083	166	3	|	|	ADV
dpc-5083	166	4	dermatol	dermatol	ADJ
dpc-5083	166	5	pract	pract	NOUN
dpc-5083	166	6	concept	concept	NOUN
dpc-5083	166	7	.	.	PUNCT
dpc-5083	167	1	2025;15(3):5083	2025;15(3):5083	NUM
dpc-5083	167	2	usually	usually	ADV
dpc-5083	167	3	necessary	necessary	ADJ
dpc-5083	167	4	for	for	ADP
dpc-5083	167	5	supportive	supportive	ADJ
dpc-5083	167	6	care	care	NOUN
dpc-5083	167	7	.	.	PUNCT
dpc-5083	168	1	systemic	systemic	ADJ
dpc-5083	168	2	steroids	steroid	NOUN
dpc-5083	168	3	and/	and/	PROPN
dpc-5083	168	4	or	or	CCONJ
dpc-5083	168	5	csa	csa	PROPN
dpc-5083	168	6	are	be	AUX
dpc-5083	168	7	the	the	DET
dpc-5083	168	8	most	most	ADV
dpc-5083	168	9	reported	report	VERB
dpc-5083	168	10	effective	effective	ADJ
dpc-5083	168	11	treatments	treatment	NOUN
dpc-5083	168	12	.	.	PUNCT
dpc-5083	169	1	the	the	DET
dpc-5083	169	2	role	role	NOUN
dpc-5083	169	3	of	of	ADP
dpc-5083	169	4	antibiotics	antibiotic	NOUN
dpc-5083	169	5	is	be	AUX
dpc-5083	169	6	unclear	unclear	ADJ
dpc-5083	169	7	,	,	PUNCT
dpc-5083	169	8	but	but	CCONJ
dpc-5083	169	9	macrolides	macrolide	NOUN
dpc-5083	169	10	or	or	CCONJ
dpc-5083	169	11	tetracyclines	tetracycline	NOUN
dpc-5083	169	12	are	be	AUX
dpc-5083	169	13	often	often	ADV
dpc-5083	169	14	used	use	VERB
dpc-5083	169	15	if	if	SCONJ
dpc-5083	169	16	there	there	PRON
dpc-5083	169	17	are	be	VERB
dpc-5083	169	18	signs	sign	NOUN
dpc-5083	169	19	of	of	ADP
dpc-5083	169	20	pneumonia	pneumonia	NOUN
dpc-5083	169	21	or	or	CCONJ
dpc-5083	169	22	demonstration	demonstration	NOUN
dpc-5083	169	23	of	of	ADP
dpc-5083	169	24	mp	mp	PROPN
dpc-5083	169	25	or	or	CCONJ
dpc-5083	169	26	cp	cp	NUM
dpc-5083	169	27	infection	infection	NOUN
dpc-5083	169	28	.	.	PUNCT
dpc-5083	170	1	other	other	ADJ
dpc-5083	170	2	therapies	therapy	NOUN
dpc-5083	170	3	include	include	VERB
dpc-5083	170	4	anti	anti	ADJ
dpc-5083	170	5	-	-	ADJ
dpc-5083	170	6	tnfα	tnfα	ADJ
dpc-5083	170	7	agents	agent	NOUN
dpc-5083	170	8	(	(	PUNCT
dpc-5083	170	9	infliximab	infliximab	NOUN
dpc-5083	170	10	or	or	CCONJ
dpc-5083	170	11	etanercept	etanercept	NOUN
dpc-5083	170	12	)	)	PUNCT
dpc-5083	170	13	,	,	PUNCT
dpc-5083	170	14	ivig	ivig	NOUN
dpc-5083	170	15	,	,	PUNCT
dpc-5083	170	16	or	or	CCONJ
dpc-5083	170	17	plasmapheresis	plasmapheresis	NOUN
dpc-5083	170	18	.	.	PUNCT
dpc-5083	171	1	prognosis	prognosis	NOUN
dpc-5083	171	2	is	be	AUX
dpc-5083	171	3	generally	generally	ADV
dpc-5083	171	4	favorable	favorable	ADJ
dpc-5083	171	5	,	,	PUNCT
dpc-5083	171	6	but	but	CCONJ
dpc-5083	171	7	complications	complication	NOUN
dpc-5083	171	8	can	can	AUX
dpc-5083	171	9	occur	occur	VERB
dpc-5083	171	10	.	.	PUNCT
dpc-5083	172	1	these	these	PRON
dpc-5083	172	2	include	include	VERB
dpc-5083	172	3	secondary	secondary	ADJ
dpc-5083	172	4	bacterial	bacterial	ADJ
dpc-5083	172	5	superinfection	superinfection	NOUN
dpc-5083	172	6	,	,	PUNCT
dpc-5083	172	7	disseminated	disseminate	VERB
dpc-5083	172	8	hsv	hsv	NOUN
dpc-5083	172	9	infection	infection	NOUN
dpc-5083	172	10	,	,	PUNCT
dpc-5083	172	11	and	and	CCONJ
dpc-5083	172	12	ocular	ocular	ADJ
dpc-5083	172	13	sequelae	sequelae	NOUN
dpc-5083	172	14	.	.	PUNCT
dpc-5083	173	1	recurrences	recurrence	NOUN
dpc-5083	173	2	,	,	PUNCT
dpc-5083	173	3	though	though	SCONJ
dpc-5083	173	4	uncommon	uncommon	ADJ
dpc-5083	173	5	,	,	PUNCT
dpc-5083	173	6	seem	seem	VERB
dpc-5083	173	7	more	more	ADV
dpc-5083	173	8	frequent	frequent	ADJ
dpc-5083	173	9	in	in	ADP
dpc-5083	173	10	hla	hla	NOUN
dpc-5083	173	11	-	-	PUNCT
dpc-5083	173	12	b51	b51	ADJ
dpc-5083	173	13	and	and	CCONJ
dpc-5083	173	14	b27	b27	NOUN
dpc-5083	173	15	carriers	carrier	NOUN
dpc-5083	173	16	.	.	PUNCT
dpc-5083	174	1	they	they	PRON
dpc-5083	174	2	can	can	AUX
dpc-5083	174	3	be	be	AUX
dpc-5083	174	4	caused	cause	VERB
dpc-5083	174	5	by	by	ADP
dpc-5083	174	6	different	different	ADJ
dpc-5083	174	7	agents	agent	NOUN
dpc-5083	174	8	,	,	PUNCT
dpc-5083	174	9	but	but	CCONJ
dpc-5083	174	10	the	the	DET
dpc-5083	174	11	first	first	ADJ
dpc-5083	174	12	episode	episode	NOUN
dpc-5083	174	13	is	be	AUX
dpc-5083	174	14	generally	generally	ADV
dpc-5083	174	15	related	relate	VERB
dpc-5083	174	16	to	to	ADP
dpc-5083	174	17	mp	mp	PROPN
dpc-5083	174	18	.	.	PUNCT
dpc-5083	175	1	further	further	ADJ
dpc-5083	175	2	research	research	NOUN
dpc-5083	175	3	is	be	AUX
dpc-5083	175	4	needed	need	VERB
dpc-5083	175	5	to	to	PART
dpc-5083	175	6	establish	establish	VERB
dpc-5083	175	7	diagnostic	diagnostic	ADJ
dpc-5083	175	8	and	and	CCONJ
dpc-5083	175	9	therapeutic	therapeutic	ADJ
dpc-5083	175	10	protocols	protocol	NOUN
dpc-5083	175	11	to	to	PART
dpc-5083	175	12	enhance	enhance	VERB
dpc-5083	175	13	patient	patient	ADJ
dpc-5083	175	14	care	care	NOUN
dpc-5083	175	15	in	in	ADP
dpc-5083	175	16	rime	rime	NOUN
dpc-5083	175	17	cases	case	NOUN
dpc-5083	175	18	.	.	PUNCT
dpc-5083	176	1	ethics	ethic	NOUN
dpc-5083	176	2	statement	statement	NOUN
dpc-5083	176	3	:	:	PUNCT
dpc-5083	176	4	the	the	DET
dpc-5083	176	5	clinical	clinical	ADJ
dpc-5083	176	6	images	image	NOUN
dpc-5083	176	7	included	include	VERB
dpc-5083	176	8	have	have	AUX
dpc-5083	176	9	been	be	AUX
dpc-5083	176	10	provided	provide	VERB
dpc-5083	176	11	by	by	ADP
dpc-5083	176	12	the	the	DET
dpc-5083	176	13	authors	author	NOUN
dpc-5083	176	14	.	.	PUNCT
dpc-5083	177	1	informed	informed	ADJ
dpc-5083	177	2	consent	consent	NOUN
dpc-5083	177	3	was	be	AUX
dpc-5083	177	4	retrieved	retrieve	VERB
dpc-5083	177	5	.	.	PUNCT
dpc-5083	178	1	references	reference	NOUN
dpc-5083	178	2	1	1	NUM
dpc-5083	178	3	.	.	PUNCT
dpc-5083	178	4	canavan	canavan	PROPN
dpc-5083	178	5	tn	tn	PROPN
dpc-5083	178	6	,	,	PUNCT
dpc-5083	178	7	mathes	mathes	PROPN
dpc-5083	178	8	ef	ef	PROPN
dpc-5083	178	9	,	,	PUNCT
dpc-5083	178	10	frieden	frieden	PROPN
dpc-5083	179	1	i	i	PROPN
dpc-5083	179	2	,	,	PUNCT
dpc-5083	179	3	shinkai	shinkai	PROPN
dpc-5083	179	4	k.	k.	PROPN
dpc-5083	179	5	mycoplasma	mycoplasma	PROPN
dpc-5083	179	6	pneumoniae	pneumoniae	ADV
dpc-5083	179	7	–	–	PUNCT
dpc-5083	179	8	induced	induced	ADJ
dpc-5083	179	9	rash	rash	NOUN
dpc-5083	179	10	and	and	CCONJ
dpc-5083	179	11	mucositis	mucositis	NOUN
dpc-5083	179	12	as	as	ADP
dpc-5083	179	13	a	a	DET
dpc-5083	179	14	syndrome	syndrome	NOUN
dpc-5083	179	15	distinct	distinct	ADJ
dpc-5083	179	16	from	from	ADP
dpc-5083	179	17	stevens	stevens	PROPN
dpc-5083	179	18	-	-	PUNCT
dpc-5083	179	19	johnson	johnson	PROPN
dpc-5083	179	20	syndrome	syndrome	NOUN
dpc-5083	179	21	and	and	CCONJ
dpc-5083	179	22	erythema	erythema	ADJ
dpc-5083	179	23	multiforme	multiforme	NOUN
dpc-5083	179	24	:	:	PUNCT
dpc-5083	179	25	a	a	DET
dpc-5083	179	26	systematic	systematic	ADJ
dpc-5083	179	27	review	review	NOUN
dpc-5083	179	28	.	.	PUNCT
dpc-5083	180	1	j	j	PROPN
dpc-5083	180	2	am	be	AUX
dpc-5083	180	3	acad	acad	ADJ
dpc-5083	180	4	dermatol	dermatol	NOUN
dpc-5083	180	5	.	.	PUNCT
dpc-5083	181	1	2015;72:239	2015;72:239	NUM
dpc-5083	181	2	-	-	PUNCT
dpc-5083	181	3	245.e4	245.e4	NUM
dpc-5083	181	4	.	.	PUNCT
dpc-5083	182	1	doi	doi	NOUN
dpc-5083	182	2	:	:	PUNCT
dpc-5083	182	3	10.1016	10.1016	NUM
dpc-5083	182	4	/	/	SYM
dpc-5083	182	5	j.jaad.2014.06.026	j.jaad.2014.06.026	PROPN
dpc-5083	182	6	.	.	PUNCT
dpc-5083	183	1	pmid	pmid	NOUN
dpc-5083	183	2	:	:	PUNCT
dpc-5083	183	3	25592340	25592340	NUM
dpc-5083	183	4	.	.	PUNCT
dpc-5083	184	1	2	2	X
dpc-5083	184	2	.	.	X
dpc-5083	184	3	farhan	farhan	PROPN
dpc-5083	184	4	r	r	PROPN
dpc-5083	184	5	,	,	PUNCT
dpc-5083	184	6	salim	salim	NOUN
dpc-5083	184	7	s	s	PROPN
dpc-5083	184	8	,	,	PUNCT
dpc-5083	184	9	surani	surani	ADJ
dpc-5083	184	10	a.	a.	NOUN
dpc-5083	184	11	reactive	reactive	ADJ
dpc-5083	184	12	infectious	infectious	ADJ
dpc-5083	184	13	mucocutaneous	mucocutaneous	ADJ
dpc-5083	184	14	eruptions	eruption	NOUN
dpc-5083	184	15	(	(	PUNCT
dpc-5083	184	16	rime	rime	NOUN
dpc-5083	184	17	)	)	PUNCT
dpc-5083	184	18	in	in	ADP
dpc-5083	184	19	covid-19	covid-19	PROPN
dpc-5083	184	20	.	.	PUNCT
dpc-5083	184	21	wmj	wmj	PROPN
dpc-5083	184	22	.	.	PUNCT
dpc-5083	185	1	2023;122:368–71	2023;122:368–71	PROPN
dpc-5083	185	2	.	.	PUNCT
dpc-5083	186	1	pmid	pmid	NOUN
dpc-5083	186	2	:	:	PUNCT
dpc-5083	186	3	38180926	38180926	NUM
dpc-5083	186	4	.	.	PUNCT
dpc-5083	187	1	3	3	X
dpc-5083	187	2	.	.	X
dpc-5083	187	3	carballido	carballido	ADJ
dpc-5083	187	4	-	-	PUNCT
dpc-5083	187	5	vázquez	vázquez	NOUN
dpc-5083	187	6	am	am	NOUN
dpc-5083	187	7	,	,	PUNCT
dpc-5083	187	8	volo	volo	NOUN
dpc-5083	187	9	v	v	NOUN
dpc-5083	187	10	,	,	PUNCT
dpc-5083	187	11	vega	vega	PROPN
dpc-5083	187	12	-	-	PUNCT
dpc-5083	187	13	lópez	lópez	PROPN
dpc-5083	187	14	tl	tl	PROPN
dpc-5083	187	15	,	,	PUNCT
dpc-5083	187	16	et	et	PROPN
dpc-5083	187	17	al	al	PROPN
dpc-5083	187	18	.	.	PROPN
dpc-5083	187	19	recurrent	recurrent	ADJ
dpc-5083	187	20	reactive	reactive	ADJ
dpc-5083	187	21	infectious	infectious	ADJ
dpc-5083	187	22	mucocutaneous	mucocutaneous	ADJ
dpc-5083	187	23	eruption	eruption	NOUN
dpc-5083	187	24	(	(	PUNCT
dpc-5083	187	25	rime	rime	NOUN
dpc-5083	187	26	)	)	PUNCT
dpc-5083	187	27	secondary	secondary	ADJ
dpc-5083	187	28	to	to	AUX
dpc-5083	187	29	chlamydophila	chlamydophila	VERB
dpc-5083	187	30	pneumoniae	pneumoniae	ADJ
dpc-5083	187	31	infection	infection	NOUN
dpc-5083	187	32	in	in	ADP
dpc-5083	187	33	an	an	DET
dpc-5083	187	34	adult	adult	NOUN
dpc-5083	187	35	.	.	PUNCT
dpc-5083	188	1	australas	australas	PROPN
dpc-5083	188	2	j	j	PROPN
dpc-5083	188	3	dermatol	dermatol	NOUN
dpc-5083	188	4	.	.	PUNCT
dpc-5083	189	1	2023;64:537–43	2023;64:537–43	X
dpc-5083	189	2	.	.	PUNCT
dpc-5083	189	3	doi	doi	PROPN
dpc-5083	189	4	:	:	PUNCT
dpc-5083	189	5	  	  	SPACE
dpc-5083	189	6	10.1111	10.1111	NUM
dpc-5083	189	7	/	/	SYM
dpc-5083	189	8	ajd	ajd	PROPN
dpc-5083	189	9	.14173	.14173	PROPN
dpc-5083	189	10	.	.	PUNCT
dpc-5083	190	1	pmid	pmid	NOUN
dpc-5083	190	2	:	:	PUNCT
dpc-5083	190	3	 	 	SPACE
dpc-5083	190	4	37823565	37823565	NUM
dpc-5083	190	5	.	.	PUNCT
dpc-5083	191	1	4	4	X
dpc-5083	191	2	.	.	X
dpc-5083	191	3	liakos	liakos	PROPN
dpc-5083	191	4	w	w	PROPN
dpc-5083	191	5	,	,	PUNCT
dpc-5083	191	6	xu	xu	PROPN
dpc-5083	191	7	a	a	X
dpc-5083	191	8	,	,	PUNCT
dpc-5083	191	9	finelt	finelt	PROPN
dpc-5083	191	10	n.	n.	PROPN
dpc-5083	191	11	clinical	clinical	ADJ
dpc-5083	191	12	features	feature	NOUN
dpc-5083	191	13	of	of	ADP
dpc-5083	191	14	recurrent	recurrent	ADJ
dpc-5083	191	15	mycoplasma	mycoplasma	NOUN
dpc-5083	191	16	pneumoniae	pneumoniae	ADV
dpc-5083	191	17	-	-	PUNCT
dpc-5083	191	18	induced	induce	VERB
dpc-5083	191	19	rash	rash	NOUN
dpc-5083	191	20	and	and	CCONJ
dpc-5083	191	21	mucositis	mucositis	NOUN
dpc-5083	191	22	.	.	PUNCT
dpc-5083	192	1	pediatr	pediatr	ADJ
dpc-5083	192	2	dermatol	dermatol	NOUN
dpc-5083	192	3	.	.	PUNCT
dpc-5083	193	1	2021;38:154–8	2021;38:154–8	NUM
dpc-5083	193	2	.	.	PUNCT
dpc-5083	194	1	doi	doi	NOUN
dpc-5083	194	2	:	:	PUNCT
dpc-5083	194	3	 	 	SPACE
dpc-5083	194	4	10.1111	10.1111	NUM
dpc-5083	194	5	/	/	SYM
dpc-5083	194	6	pde.14472	pde.14472	PROPN
dpc-5083	194	7	.	.	PUNCT
dpc-5083	195	1	pmid	pmid	NOUN
dpc-5083	195	2	:	:	PUNCT
dpc-5083	195	3	  	  	SPACE
dpc-5083	195	4	33247484	33247484	NUM
dpc-5083	195	5	.	.	PUNCT
dpc-5083	196	1	5	5	X
dpc-5083	196	2	.	.	X
dpc-5083	196	3	ramasamy	ramasamy	NOUN
dpc-5083	196	4	a	a	PRON
dpc-5083	196	5	,	,	PUNCT
dpc-5083	196	6	patel	patel	PROPN
dpc-5083	196	7	c	c	NOUN
dpc-5083	196	8	,	,	PUNCT
dpc-5083	196	9	conlon	conlon	PROPN
dpc-5083	196	10	c.	c.	PROPN
dpc-5083	196	11	incomplete	incomplete	PROPN
dpc-5083	196	12	stevensjohnson	stevensjohnson	PROPN
dpc-5083	196	13	syndrome	syndrome	VERB
dpc-5083	196	14	secondary	secondary	ADJ
dpc-5083	196	15	to	to	ADP
dpc-5083	196	16	atypical	atypical	ADJ
dpc-5083	196	17	pneumonia	pneumonia	NOUN
dpc-5083	196	18	.	.	PUNCT
dpc-5083	197	1	case	case	NOUN
dpc-5083	197	2	reports	report	VERB
dpc-5083	197	3	.	.	PUNCT
dpc-5083	198	1	2011;2011	2011;2011	NUM
dpc-5083	198	2	:	:	PUNCT
dpc-5083	198	3	bcr0820114568	bcr0820114568	NOUN
dpc-5083	198	4	–	–	PUNCT
dpc-5083	198	5	bcr0820114568	bcr0820114568	NOUN
dpc-5083	198	6	.	.	PUNCT
dpc-5083	199	1	doi	doi	NOUN
dpc-5083	199	2	:	:	PUNCT
dpc-5083	199	3	10.1136	10.1136	NUM
dpc-5083	199	4	/	/	SYM
dpc-5083	199	5	bc	bc	PROPN
dpc-5083	199	6	r.08.2011.4568	r.08.2011.4568	PROPN
dpc-5083	199	7	.	.	PUNCT
dpc-5083	199	8	 	 	SPACE
dpc-5083	200	1	pmid	pmid	PROPN
dpc-5083	200	2	:	:	PUNCT
dpc-5083	200	3	 	 	SPACE
dpc-5083	200	4	22679161	22679161	NUM
dpc-5083	200	5	6	6	NUM
dpc-5083	200	6	.	.	PUNCT
dpc-5083	201	1	olson	olson	PROPN
dpc-5083	201	2	d	d	PROPN
dpc-5083	201	3	,	,	PUNCT
dpc-5083	201	4	abbott	abbott	PROPN
dpc-5083	201	5	j	j	PROPN
dpc-5083	201	6	,	,	PUNCT
dpc-5083	201	7	lin	lin	PROPN
dpc-5083	201	8	c	c	AUX
dpc-5083	201	9	,	,	PUNCT
dpc-5083	201	10	prok	prok	PROPN
dpc-5083	201	11	l	l	PROPN
dpc-5083	201	12	,	,	PUNCT
dpc-5083	201	13	dominguez	dominguez	PROPN
dpc-5083	201	14	sr	sr	PROPN
dpc-5083	201	15	.	.	PUNCT
dpc-5083	202	1	characterization	characterization	NOUN
dpc-5083	202	2	of	of	ADP
dpc-5083	202	3	children	child	NOUN
dpc-5083	202	4	with	with	ADP
dpc-5083	202	5	recurrent	recurrent	ADJ
dpc-5083	202	6	episodes	episode	NOUN
dpc-5083	202	7	of	of	ADP
dpc-5083	202	8	stevens	stevens	PROPN
dpc-5083	202	9	johnson	johnson	PROPN
dpc-5083	202	10	syndrome	syndrome	PROPN
dpc-5083	202	11	.	.	PUNCT
dpc-5083	203	1	journal	journal	NOUN
dpc-5083	203	2	of	of	ADP
dpc-5083	203	3	the	the	DET
dpc-5083	203	4	pediatric	pediatric	ADJ
dpc-5083	203	5	infectious	infectious	ADJ
dpc-5083	203	6	diseases	disease	NOUN
dpc-5083	203	7	society	society	NOUN
dpc-5083	203	8	.	.	PUNCT
dpc-5083	204	1	2017;6	2017;6	NUM
dpc-5083	204	2	:	:	PUNCT
dpc-5083	204	3	e140–3	e140–3	ADJ
dpc-5083	204	4	.	.	PUNCT
dpc-5083	205	1	doi	doi	NOUN
dpc-5083	205	2	:	:	PUNCT
dpc-5083	205	3	10.1093	10.1093	NUM
dpc-5083	205	4	/	/	SYM
dpc-5083	205	5	jpids	jpids	PROPN
dpc-5083	205	6	/	/	SYM
dpc-5083	205	7	piw085	piw085	NOUN
dpc-5083	205	8	.	.	PUNCT
dpc-5083	206	1	pmid	pmid	NOUN
dpc-5083	206	2	:	:	PUNCT
dpc-5083	206	3	 	 	SPACE
dpc-5083	206	4	28339562	28339562	NUM
dpc-5083	206	5	.	.	PUNCT
dpc-5083	207	1	7	7	X
dpc-5083	207	2	.	.	X
dpc-5083	207	3	mayor	mayor	NOUN
dpc-5083	207	4	-	-	PUNCT
dpc-5083	207	5	ibarguren	ibarguren	PROPN
dpc-5083	207	6	a	a	PRON
dpc-5083	207	7	,	,	PUNCT
dpc-5083	207	8	feito	feito	PROPN
dpc-5083	207	9	-	-	PROPN
dpc-5083	207	10	rodriguez	rodriguez	PROPN
dpc-5083	207	11	m	m	PROPN
dpc-5083	207	12	,	,	PUNCT
dpc-5083	207	13	gonzález	gonzález	PROPN
dpc-5083	207	14	-	-	PUNCT
dpc-5083	207	15	ramos	ramos	PROPN
dpc-5083	207	16	j	j	PROPN
dpc-5083	207	17	,	,	PUNCT
dpc-5083	207	18	et	et	PROPN
dpc-5083	207	19	al	al	PROPN
dpc-5083	207	20	.	.	PUNCT
dpc-5083	208	1	mucositis	mucositis	PROPN
dpc-5083	208	2	secondary	secondary	ADJ
dpc-5083	208	3	to	to	ADP
dpc-5083	208	4	chlamydia	chlamydia	NOUN
dpc-5083	208	5	pneumoniae	pneumoniae	ADJ
dpc-5083	208	6	infection	infection	NOUN
dpc-5083	208	7	:	:	PUNCT
dpc-5083	208	8	expanding	expand	VERB
dpc-5083	208	9	the	the	DET
dpc-5083	208	10	mycoplasma	mycoplasma	NOUN
dpc-5083	208	11	pneumoniae	pneumoniae	ADV
dpc-5083	208	12	-	-	PUNCT
dpc-5083	208	13	induced	induce	VERB
dpc-5083	208	14	rash	rash	NOUN
dpc-5083	208	15	and	and	CCONJ
dpc-5083	208	16	mucositis	mucositis	NOUN
dpc-5083	208	17	concept	concept	NOUN
dpc-5083	208	18	.	.	PUNCT
dpc-5083	209	1	pediatr	pediatr	ADJ
dpc-5083	209	2	dermatol	dermatol	NOUN
dpc-5083	209	3	.	.	PUNCT
dpc-5083	210	1	2017;34:465–72	2017;34:465–72	X
dpc-5083	210	2	.	.	PUNCT
dpc-5083	210	3	doi	doi	PROPN
dpc-5083	210	4	:	:	PUNCT
dpc-5083	210	5	 	 	SPACE
dpc-5083	210	6	10.1111	10.1111	NUM
dpc-5083	210	7	/	/	SYM
dpc-5083	210	8	pde.13140	pde.13140	NOUN
dpc-5083	210	9	.	.	PUNCT
dpc-5083	211	1	pmid	pmid	NOUN
dpc-5083	211	2	:	:	PUNCT
dpc-5083	211	3	28568680	28568680	NUM
dpc-5083	211	4	.	.	PUNCT
dpc-5083	212	1	8	8	X
dpc-5083	212	2	.	.	X
dpc-5083	212	3	mazori	mazori	PROPN
dpc-5083	212	4	dr	dr	PROPN
dpc-5083	212	5	,	,	PUNCT
dpc-5083	212	6	nagarajan	nagarajan	NOUN
dpc-5083	212	7	s	s	PROPN
dpc-5083	212	8	,	,	PUNCT
dpc-5083	212	9	glick	glick	PROPN
dpc-5083	212	10	sa	sa	PROPN
dpc-5083	212	11	.	.	PUNCT
dpc-5083	212	12	recurrent	recurrent	ADJ
dpc-5083	212	13	reactive	reactive	ADJ
dpc-5083	212	14	infectious	infectious	ADJ
dpc-5083	212	15	mucocutaneous	mucocutaneous	ADJ
dpc-5083	212	16	eruption	eruption	NOUN
dpc-5083	212	17	(	(	PUNCT
dpc-5083	212	18	rime	rime	NOUN
dpc-5083	212	19	):	):	PUNCT
dpc-5083	212	20	insights	insight	NOUN
dpc-5083	212	21	from	from	ADP
dpc-5083	212	22	a	a	DET
dpc-5083	212	23	child	child	NOUN
dpc-5083	212	24	with	with	ADP
dpc-5083	212	25	three	three	NUM
dpc-5083	212	26	episodes	episode	NOUN
dpc-5083	212	27	.	.	PUNCT
dpc-5083	213	1	pediatr	pediatr	ADJ
dpc-5083	213	2	dermatol	dermatol	NOUN
dpc-5083	213	3	.	.	PUNCT
dpc-5083	214	1	2020;37:545–7	2020;37:545–7	NUM
dpc-5083	214	2	.	.	PUNCT
dpc-5083	215	1	doi	doi	NOUN
dpc-5083	215	2	:	:	PUNCT
dpc-5083	215	3	10.1111	10.1111	NUM
dpc-5083	215	4	/	/	SYM
dpc-5083	215	5	pde.14142	pde.14142	X
dpc-5083	215	6	.	.	PUNCT
dpc-5083	216	1	pmid	pmid	NOUN
dpc-5083	216	2	:	:	PUNCT
dpc-5083	216	3	32172537	32172537	NUM
dpc-5083	216	4	.	.	PUNCT
dpc-5083	217	1	9	9	X
dpc-5083	217	2	.	.	X
dpc-5083	217	3	gholap	gholap	NOUN
dpc-5083	217	4	rs	rs	NOUN
dpc-5083	217	5	,	,	PUNCT
dpc-5083	217	6	engelmann	engelmann	PROPN
dpc-5083	217	7	ar	ar	PROPN
dpc-5083	217	8	,	,	PUNCT
dpc-5083	217	9	munir	munir	PROPN
dpc-5083	217	10	wm	wm	PROPN
dpc-5083	217	11	.	.	PROPN
dpc-5083	217	12	chlamydia	chlamydia	PROPN
dpc-5083	217	13	psittaci	psittaci	NOUN
dpc-5083	217	14	–	–	PUNCT
dpc-5083	217	15	induced	induce	VERB
dpc-5083	217	16	reactive	reactive	ADJ
dpc-5083	217	17	infectious	infectious	ADJ
dpc-5083	217	18	mucocutaneous	mucocutaneous	ADJ
dpc-5083	217	19	eruption	eruption	NOUN
dpc-5083	217	20	with	with	ADP
dpc-5083	217	21	ocular	ocular	ADJ
dpc-5083	217	22	involvement	involvement	NOUN
dpc-5083	217	23	.	.	PUNCT
dpc-5083	218	1	eye	eye	NOUN
dpc-5083	218	2	&	&	CCONJ
dpc-5083	218	3	contact	contact	PROPN
dpc-5083	218	4	lens	len	NOUN
dpc-5083	218	5	:	:	PUNCT
dpc-5083	218	6	science	science	NOUN
dpc-5083	218	7	&	&	CCONJ
dpc-5083	218	8	clinical	clinical	ADJ
dpc-5083	218	9	practice	practice	NOUN
dpc-5083	218	10	.	.	PUNCT
dpc-5083	219	1	corticosteroids	corticosteroid	NOUN
dpc-5083	219	2	,	,	PUNCT
dpc-5083	219	3	it	it	PRON
dpc-5083	219	4	is	be	AUX
dpc-5083	219	5	therefore	therefore	ADV
dpc-5083	219	6	considered	consider	VERB
dpc-5083	219	7	as	as	ADP
dpc-5083	219	8	first	first	ADJ
dpc-5083	219	9	-	-	PUNCT
dpc-5083	219	10	line	line	NOUN
dpc-5083	219	11	treatment	treatment	NOUN
dpc-5083	219	12	by	by	ADP
dpc-5083	219	13	some	some	DET
dpc-5083	219	14	authors	author	NOUN
dpc-5083	219	15	[	[	X
dpc-5083	219	16	13,25	13,25	X
dpc-5083	219	17	]	]	X
dpc-5083	219	18	.	.	PUNCT
dpc-5083	220	1	other	other	ADJ
dpc-5083	220	2	alternative	alternative	ADJ
dpc-5083	220	3	treatments	treatment	NOUN
dpc-5083	220	4	include	include	VERB
dpc-5083	220	5	anti	anti	ADJ
dpc-5083	220	6	-	-	ADJ
dpc-5083	220	7	tumor	tumor	ADJ
dpc-5083	220	8	necrosis	necrosis	NOUN
dpc-5083	220	9	factor	factor	NOUN
dpc-5083	220	10	alpha	alpha	NOUN
dpc-5083	220	11	(	(	PUNCT
dpc-5083	220	12	tnfα	tnfα	NOUN
dpc-5083	220	13	)	)	PUNCT
dpc-5083	220	14	such	such	ADJ
dpc-5083	220	15	as	as	ADP
dpc-5083	220	16	infliximab	infliximab	NOUN
dpc-5083	220	17	and	and	CCONJ
dpc-5083	220	18	etanercept	etanercept	NOUN
dpc-5083	220	19	.	.	PUNCT
dpc-5083	221	1	these	these	PRON
dpc-5083	221	2	have	have	AUX
dpc-5083	221	3	been	be	AUX
dpc-5083	221	4	used	use	VERB
dpc-5083	221	5	with	with	ADP
dpc-5083	221	6	limited	limited	ADJ
dpc-5083	221	7	evidence	evidence	NOUN
dpc-5083	221	8	,	,	PUNCT
dpc-5083	221	9	extrapolated	extrapolate	VERB
dpc-5083	221	10	from	from	ADP
dpc-5083	221	11	data	datum	NOUN
dpc-5083	221	12	on	on	ADP
dpc-5083	221	13	den	den	PROPN
dpc-5083	221	14	.	.	PUNCT
dpc-5083	222	1	infliximab	infliximab	PROPN
dpc-5083	222	2	may	may	AUX
dpc-5083	222	3	be	be	AUX
dpc-5083	222	4	considered	consider	VERB
dpc-5083	222	5	,	,	PUNCT
dpc-5083	222	6	administered	administer	VERB
dpc-5083	222	7	at	at	ADP
dpc-5083	222	8	a	a	DET
dpc-5083	222	9	single	single	ADJ
dpc-5083	222	10	5	5	NUM
dpc-5083	222	11	mg	mg	PROPN
dpc-5083	222	12	/	/	SYM
dpc-5083	222	13	kg	kg	PROPN
dpc-5083	222	14	dose	dose	PROPN
dpc-5083	222	15	.	.	PUNCT
dpc-5083	223	1	etanercept	etanercept	VERB
dpc-5083	223	2	at	at	ADP
dpc-5083	223	3	0.6–0.8	0.6–0.8	PRON
dpc-5083	223	4	mg	mg	PROPN
dpc-5083	223	5	/	/	SYM
dpc-5083	223	6	kg	kg	PROPN
dpc-5083	223	7	(	(	PUNCT
dpc-5083	223	8	children	child	NOUN
dpc-5083	223	9	)	)	PUNCT
dpc-5083	223	10	or	or	CCONJ
dpc-5083	223	11	50	50	NUM
dpc-5083	223	12	mg	mg	NOUN
dpc-5083	223	13	(	(	PUNCT
dpc-5083	223	14	adults	adult	NOUN
dpc-5083	223	15	)	)	PUNCT
dpc-5083	223	16	,	,	PUNCT
dpc-5083	223	17	with	with	ADP
dpc-5083	223	18	a	a	DET
dpc-5083	223	19	second	second	ADJ
dpc-5083	223	20	possible	possible	ADJ
dpc-5083	223	21	dose	dose	NOUN
dpc-5083	223	22	if	if	SCONJ
dpc-5083	223	23	no	no	DET
dpc-5083	223	24	improvement	improvement	NOUN
dpc-5083	223	25	is	be	AUX
dpc-5083	223	26	seen	see	VERB
dpc-5083	223	27	after	after	ADP
dpc-5083	223	28	48	48	NUM
dpc-5083	223	29	hours	hour	NOUN
dpc-5083	223	30	,	,	PUNCT
dpc-5083	223	31	has	have	AUX
dpc-5083	223	32	also	also	ADV
dpc-5083	223	33	been	be	AUX
dpc-5083	223	34	described	describe	VERB
dpc-5083	223	35	[	[	PRON
dpc-5083	223	36	21,29	21,29	NUM
dpc-5083	223	37	]	]	PUNCT
dpc-5083	223	38	.	.	PUNCT
dpc-5083	224	1	intravenous	intravenous	ADJ
dpc-5083	224	2	immunoglobulins	immunoglobulin	NOUN
dpc-5083	224	3	(	(	PUNCT
dpc-5083	224	4	ivig	ivig	NOUN
dpc-5083	224	5	)	)	PUNCT
dpc-5083	224	6	at	at	ADP
dpc-5083	224	7	0.5–2	0.5–2	PROPN
dpc-5083	224	8	g	g	PROPN
dpc-5083	224	9	/	/	SYM
dpc-5083	224	10	kg	kg	PROPN
dpc-5083	224	11	/	/	SYM
dpc-5083	224	12	day	day	NOUN
dpc-5083	224	13	for	for	ADP
dpc-5083	224	14	4–5	4–5	PROPN
dpc-5083	224	15	days	day	NOUN
dpc-5083	224	16	may	may	AUX
dpc-5083	224	17	also	also	ADV
dpc-5083	224	18	be	be	AUX
dpc-5083	224	19	administered	administer	VERB
dpc-5083	224	20	,	,	PUNCT
dpc-5083	224	21	ensuring	ensure	VERB
dpc-5083	224	22	there	there	PRON
dpc-5083	224	23	is	be	VERB
dpc-5083	224	24	no	no	DET
dpc-5083	224	25	iga	iga	PROPN
dpc-5083	224	26	deficiency	deficiency	NOUN
dpc-5083	224	27	prior	prior	ADV
dpc-5083	224	28	to	to	ADP
dpc-5083	224	29	the	the	DET
dpc-5083	224	30	administration	administration	NOUN
dpc-5083	225	1	[	[	X
dpc-5083	225	2	20,23,35	20,23,35	X
dpc-5083	225	3	]	]	X
dpc-5083	225	4	.	.	PUNCT
dpc-5083	226	1	lastly	lastly	ADV
dpc-5083	226	2	,	,	PUNCT
dpc-5083	226	3	plasmapheresis	plasmapheresis	NOUN
dpc-5083	226	4	has	have	AUX
dpc-5083	226	5	been	be	AUX
dpc-5083	226	6	described	describe	VERB
dpc-5083	226	7	in	in	ADP
dpc-5083	226	8	a	a	DET
dpc-5083	226	9	single	single	ADJ
dpc-5083	226	10	case	case	NOUN
dpc-5083	226	11	[	[	X
dpc-5083	226	12	37	37	NUM
dpc-5083	226	13	]	]	PUNCT
dpc-5083	226	14	.	.	PUNCT
dpc-5083	227	1	prognosis	prognosis	NOUN
dpc-5083	227	2	rime	rime	NOUN
dpc-5083	227	3	generally	generally	ADV
dpc-5083	227	4	portends	portend	VERB
dpc-5083	227	5	a	a	DET
dpc-5083	227	6	favorable	favorable	ADJ
dpc-5083	227	7	prognosis	prognosis	NOUN
dpc-5083	227	8	,	,	PUNCT
dpc-5083	227	9	with	with	ADP
dpc-5083	227	10	a	a	DET
dpc-5083	227	11	typically	typically	ADV
dpc-5083	227	12	benign	benign	ADJ
dpc-5083	227	13	course	course	NOUN
dpc-5083	227	14	leading	lead	VERB
dpc-5083	227	15	to	to	ADP
dpc-5083	227	16	complete	complete	ADJ
dpc-5083	227	17	recovery	recovery	NOUN
dpc-5083	227	18	within	within	ADP
dpc-5083	227	19	seven	seven	NUM
dpc-5083	227	20	to	to	PART
dpc-5083	227	21	21	21	NUM
dpc-5083	227	22	days	day	NOUN
dpc-5083	227	23	.	.	PUNCT
dpc-5083	228	1	however	however	ADV
dpc-5083	228	2	,	,	PUNCT
dpc-5083	228	3	certain	certain	ADJ
dpc-5083	228	4	complications	complication	NOUN
dpc-5083	228	5	can	can	AUX
dpc-5083	228	6	arise	arise	VERB
dpc-5083	228	7	,	,	PUNCT
dpc-5083	228	8	such	such	ADJ
dpc-5083	228	9	as	as	ADP
dpc-5083	228	10	secondary	secondary	ADJ
dpc-5083	228	11	bacterial	bacterial	ADJ
dpc-5083	228	12	superinfections	superinfection	NOUN
dpc-5083	228	13	by	by	ADP
dpc-5083	228	14	grampositive	grampositive	ADJ
dpc-5083	228	15	skin	skin	NOUN
dpc-5083	228	16	flora	flora	NOUN
dpc-5083	228	17	.	.	PUNCT
dpc-5083	229	1	there	there	PRON
dpc-5083	229	2	is	be	VERB
dpc-5083	229	3	a	a	DET
dpc-5083	229	4	report	report	NOUN
dpc-5083	229	5	of	of	ADP
dpc-5083	229	6	a	a	DET
dpc-5083	229	7	patient	patient	NOUN
dpc-5083	229	8	presenting	present	VERB
dpc-5083	229	9	both	both	CCONJ
dpc-5083	229	10	staphylococcus	staphylococcus	NOUN
dpc-5083	229	11	bacteremia	bacteremia	NOUN
dpc-5083	229	12	and	and	CCONJ
dpc-5083	229	13	disseminated	disseminate	VERB
dpc-5083	229	14	hsv	hsv	PROPN
dpc-5083	229	15	infection	infection	NOUN
dpc-5083	229	16	as	as	ADP
dpc-5083	229	17	complications	complication	NOUN
dpc-5083	229	18	of	of	ADP
dpc-5083	229	19	rime	rime	NOUN
dpc-5083	229	20	[	[	X
dpc-5083	229	21	38	38	NUM
dpc-5083	229	22	]	]	PUNCT
dpc-5083	229	23	.	.	PUNCT
dpc-5083	230	1	gram	gram	NOUN
dpc-5083	230	2	-	-	PUNCT
dpc-5083	230	3	negative	negative	ADJ
dpc-5083	230	4	superinfection	superinfection	NOUN
dpc-5083	230	5	can	can	AUX
dpc-5083	230	6	also	also	ADV
dpc-5083	230	7	arise	arise	VERB
dpc-5083	230	8	[	[	X
dpc-5083	230	9	22	22	NUM
dpc-5083	230	10	]	]	PUNCT
dpc-5083	230	11	.	.	PUNCT
dpc-5083	231	1	long	long	ADJ
dpc-5083	231	2	-	-	PUNCT
dpc-5083	231	3	term	term	NOUN
dpc-5083	231	4	sequelae	sequelae	NOUN
dpc-5083	231	5	,	,	PUNCT
dpc-5083	231	6	though	though	SCONJ
dpc-5083	231	7	relatively	relatively	ADV
dpc-5083	231	8	uncommon	uncommon	ADJ
dpc-5083	231	9	,	,	PUNCT
dpc-5083	231	10	may	may	AUX
dpc-5083	231	11	include	include	VERB
dpc-5083	231	12	ocular	ocular	ADJ
dpc-5083	231	13	and	and	CCONJ
dpc-5083	231	14	genital	genital	ADJ
dpc-5083	231	15	synechiae	synechiae	NOUN
dpc-5083	231	16	,	,	PUNCT
dpc-5083	231	17	post	post	ADJ
dpc-5083	231	18	-	-	ADJ
dpc-5083	231	19	inflammatory	inflammatory	ADJ
dpc-5083	231	20	hyperpigmentation	hyperpigmentation	NOUN
dpc-5083	231	21	,	,	PUNCT
dpc-5083	231	22	and	and	CCONJ
dpc-5083	231	23	lymphopenia	lymphopenia	NOUN
dpc-5083	231	24	.	.	PUNCT
dpc-5083	232	1	recurrences	recurrence	NOUN
dpc-5083	232	2	occur	occur	VERB
dpc-5083	232	3	in	in	ADP
dpc-5083	232	4	approximately	approximately	ADV
dpc-5083	232	5	8–38	8–38	ADJ
dpc-5083	232	6	%	%	NOUN
dpc-5083	232	7	of	of	ADP
dpc-5083	232	8	the	the	DET
dpc-5083	232	9	patients	patient	NOUN
dpc-5083	232	10	[	[	X
dpc-5083	232	11	4	4	NUM
dpc-5083	232	12	]	]	PUNCT
dpc-5083	232	13	,	,	PUNCT
dpc-5083	232	14	with	with	ADP
dpc-5083	232	15	presumable	presumable	ADJ
dpc-5083	232	16	higher	high	ADJ
dpc-5083	232	17	frequency	frequency	NOUN
dpc-5083	232	18	in	in	ADP
dpc-5083	232	19	hla	hla	PROPN
dpc-5083	232	20	-	-	PUNCT
dpc-5083	232	21	b51	b51	ADJ
dpc-5083	232	22	and	and	CCONJ
dpc-5083	232	23	b27	b27	NOUN
dpc-5083	232	24	carriers	carrier	NOUN
dpc-5083	232	25	[	[	X
dpc-5083	232	26	6,24	6,24	X
dpc-5083	232	27	]	]	PUNCT
dpc-5083	232	28	.	.	PUNCT
dpc-5083	233	1	recurrences	recurrence	NOUN
dpc-5083	233	2	have	have	AUX
dpc-5083	233	3	been	be	AUX
dpc-5083	233	4	reported	report	VERB
dpc-5083	233	5	following	follow	VERB
dpc-5083	233	6	infections	infection	NOUN
dpc-5083	233	7	with	with	ADP
dpc-5083	233	8	both	both	DET
dpc-5083	233	9	mp	mp	PROPN
dpc-5083	233	10	(	(	PUNCT
dpc-5083	233	11	more	more	ADV
dpc-5083	233	12	frequently	frequently	ADV
dpc-5083	233	13	)	)	PUNCT
dpc-5083	233	14	and	and	CCONJ
dpc-5083	233	15	cp	cp	INTJ
dpc-5083	233	16	,	,	PUNCT
dpc-5083	233	17	among	among	ADP
dpc-5083	233	18	many	many	ADJ
dpc-5083	233	19	.	.	PUNCT
dpc-5083	233	20	epstein	epstein	PROPN
dpc-5083	233	21	-	-	PUNCT
dpc-5083	233	22	barr	barr	PROPN
dpc-5083	233	23	virus	virus	PROPN
dpc-5083	233	24	reactivation	reactivation	NOUN
dpc-5083	233	25	has	have	AUX
dpc-5083	233	26	been	be	AUX
dpc-5083	233	27	described	describe	VERB
dpc-5083	233	28	in	in	ADP
dpc-5083	233	29	a	a	DET
dpc-5083	233	30	patient	patient	NOUN
dpc-5083	233	31	with	with	ADP
dpc-5083	233	32	recurrent	recurrent	ADJ
dpc-5083	233	33	rime	rime	NOUN
dpc-5083	233	34	,	,	PUNCT
dpc-5083	233	35	with	with	ADP
dpc-5083	233	36	uncertain	uncertain	ADJ
dpc-5083	233	37	clinical	clinical	ADJ
dpc-5083	233	38	significance	significance	NOUN
dpc-5083	234	1	[	[	X
dpc-5083	234	2	39	39	NUM
dpc-5083	234	3	]	]	PUNCT
dpc-5083	234	4	.	.	PUNCT
dpc-5083	235	1	interestingly	interestingly	ADV
dpc-5083	235	2	,	,	PUNCT
dpc-5083	235	3	recurrent	recurrent	ADJ
dpc-5083	235	4	episodes	episode	NOUN
dpc-5083	235	5	are	be	AUX
dpc-5083	235	6	often	often	ADV
dpc-5083	235	7	milder	mild	ADJ
dpc-5083	235	8	and	and	CCONJ
dpc-5083	235	9	may	may	AUX
dpc-5083	235	10	affect	affect	VERB
dpc-5083	235	11	only	only	ADV
dpc-5083	235	12	one	one	NUM
dpc-5083	235	13	mucosa	mucosa	NOUN
dpc-5083	235	14	[	[	X
dpc-5083	235	15	8	8	NUM
dpc-5083	235	16	]	]	PUNCT
dpc-5083	235	17	.	.	PUNCT
dpc-5083	236	1	however	however	ADV
dpc-5083	236	2	,	,	PUNCT
dpc-5083	236	3	more	more	ADV
dpc-5083	236	4	severe	severe	ADJ
dpc-5083	236	5	recurrences	recurrence	NOUN
dpc-5083	236	6	can	can	AUX
dpc-5083	236	7	occasionally	occasionally	ADV
dpc-5083	236	8	occur	occur	VERB
dpc-5083	236	9	.	.	PUNCT
dpc-5083	237	1	while	while	SCONJ
dpc-5083	237	2	different	different	ADJ
dpc-5083	237	3	agents	agent	NOUN
dpc-5083	237	4	may	may	AUX
dpc-5083	237	5	trigger	trigger	VERB
dpc-5083	237	6	recurrences	recurrence	NOUN
dpc-5083	237	7	,	,	PUNCT
dpc-5083	237	8	mp	mp	PROPN
dpc-5083	237	9	is	be	AUX
dpc-5083	237	10	usually	usually	ADV
dpc-5083	237	11	responsible	responsible	ADJ
dpc-5083	237	12	for	for	ADP
dpc-5083	237	13	the	the	DET
dpc-5083	237	14	first	first	ADJ
dpc-5083	237	15	episode	episode	NOUN
dpc-5083	238	1	[	[	X
dpc-5083	238	2	10,16	10,16	NUM
dpc-5083	238	3	]	]	PUNCT
dpc-5083	238	4	.	.	PUNCT
dpc-5083	239	1	conclusions	conclusion	NOUN
dpc-5083	239	2	rime	rime	NOUN
dpc-5083	239	3	is	be	AUX
dpc-5083	239	4	an	an	DET
dpc-5083	239	5	underreported	underreported	ADJ
dpc-5083	239	6	and	and	CCONJ
dpc-5083	239	7	probably	probably	ADV
dpc-5083	239	8	misdiagnosed	misdiagnose	VERB
dpc-5083	239	9	entity	entity	NOUN
dpc-5083	239	10	that	that	PRON
dpc-5083	239	11	presents	present	VERB
dpc-5083	239	12	predominantly	predominantly	ADV
dpc-5083	239	13	in	in	ADP
dpc-5083	239	14	pediatric	pediatric	ADJ
dpc-5083	239	15	and	and	CCONJ
dpc-5083	239	16	young	young	ADJ
dpc-5083	239	17	adult	adult	NOUN
dpc-5083	239	18	patients	patient	NOUN
dpc-5083	239	19	,	,	PUNCT
dpc-5083	239	20	although	although	SCONJ
dpc-5083	239	21	some	some	DET
dpc-5083	239	22	cases	case	NOUN
dpc-5083	239	23	in	in	ADP
dpc-5083	239	24	older	old	ADJ
dpc-5083	239	25	adults	adult	NOUN
dpc-5083	239	26	have	have	AUX
dpc-5083	239	27	been	be	AUX
dpc-5083	239	28	described	describe	VERB
dpc-5083	239	29	.	.	PUNCT
dpc-5083	240	1	its	its	PRON
dpc-5083	240	2	distinctive	distinctive	ADJ
dpc-5083	240	3	clinical	clinical	ADJ
dpc-5083	240	4	feature	feature	NOUN
dpc-5083	240	5	is	be	AUX
dpc-5083	240	6	extensive	extensive	ADJ
dpc-5083	240	7	mucosal	mucosal	NOUN
dpc-5083	240	8	involvement	involvement	NOUN
dpc-5083	240	9	accompanied	accompany	VERB
dpc-5083	240	10	by	by	ADP
dpc-5083	240	11	minimal	minimal	ADJ
dpc-5083	240	12	cutaneous	cutaneous	ADJ
dpc-5083	240	13	manifestations	manifestation	NOUN
dpc-5083	240	14	.	.	PUNCT
dpc-5083	241	1	initially	initially	ADV
dpc-5083	241	2	attributed	attribute	VERB
dpc-5083	241	3	solely	solely	ADV
dpc-5083	241	4	to	to	ADP
dpc-5083	241	5	mp	mp	PROPN
dpc-5083	241	6	,	,	PUNCT
dpc-5083	241	7	the	the	DET
dpc-5083	241	8	list	list	NOUN
dpc-5083	241	9	of	of	ADP
dpc-5083	241	10	etiological	etiological	ADJ
dpc-5083	241	11	agents	agent	NOUN
dpc-5083	241	12	is	be	AUX
dpc-5083	241	13	gradually	gradually	ADV
dpc-5083	241	14	becoming	become	VERB
dpc-5083	241	15	broader	broad	ADJ
dpc-5083	241	16	,	,	PUNCT
dpc-5083	241	17	including	include	VERB
dpc-5083	241	18	bacterial	bacterial	ADJ
dpc-5083	241	19	and	and	CCONJ
dpc-5083	241	20	viral	viral	ADJ
dpc-5083	241	21	infections	infection	NOUN
dpc-5083	241	22	.	.	PUNCT
dpc-5083	242	1	diagnosis	diagnosis	NOUN
dpc-5083	242	2	can	can	AUX
dpc-5083	242	3	be	be	AUX
dpc-5083	242	4	challenging	challenge	VERB
dpc-5083	242	5	due	due	ADJ
dpc-5083	242	6	to	to	ADP
dpc-5083	242	7	overlapping	overlap	VERB
dpc-5083	242	8	features	feature	NOUN
dpc-5083	242	9	with	with	ADP
dpc-5083	242	10	other	other	ADJ
dpc-5083	242	11	entities	entity	NOUN
dpc-5083	242	12	with	with	ADP
dpc-5083	242	13	prominent	prominent	ADJ
dpc-5083	242	14	mucositis	mucositis	NOUN
dpc-5083	242	15	,	,	PUNCT
dpc-5083	242	16	such	such	ADJ
dpc-5083	242	17	as	as	ADP
dpc-5083	242	18	den	den	NOUN
dpc-5083	242	19	,	,	PUNCT
dpc-5083	242	20	herpetic	herpetic	ADJ
dpc-5083	242	21	gingivostomatitis	gingivostomatitis	NOUN
dpc-5083	242	22	,	,	PUNCT
dpc-5083	242	23	and	and	CCONJ
dpc-5083	242	24	autoimmune	autoimmune	ADJ
dpc-5083	242	25	bullous	bullous	ADJ
dpc-5083	242	26	diseases	disease	NOUN
dpc-5083	242	27	.	.	PUNCT
dpc-5083	243	1	there	there	PRON
dpc-5083	243	2	is	be	VERB
dpc-5083	243	3	a	a	DET
dpc-5083	243	4	paucity	paucity	NOUN
dpc-5083	243	5	of	of	ADP
dpc-5083	243	6	knowledge	knowledge	NOUN
dpc-5083	243	7	on	on	ADP
dpc-5083	243	8	the	the	DET
dpc-5083	243	9	management	management	NOUN
dpc-5083	243	10	of	of	ADP
dpc-5083	243	11	rime	rime	NOUN
dpc-5083	243	12	,	,	PUNCT
dpc-5083	243	13	but	but	CCONJ
dpc-5083	243	14	hospitalization	hospitalization	NOUN
dpc-5083	243	15	is	be	AUX
dpc-5083	243	16	review	review	NOUN
dpc-5083	243	17	|	|	ADV
dpc-5083	243	18	dermatol	dermatol	ADJ
dpc-5083	243	19	pract	pract	NOUN
dpc-5083	243	20	concept	concept	NOUN
dpc-5083	243	21	.	.	PUNCT
dpc-5083	244	1	2025;15(3):5083	2025;15(3):5083	NUM
dpc-5083	244	2	7	7	NUM
dpc-5083	244	3	23	23	NUM
dpc-5083	244	4	.	.	PUNCT
dpc-5083	245	1	gámez	gámez	NOUN
dpc-5083	245	2	-	-	PUNCT
dpc-5083	245	3	gonzález	gonzález	PROPN
dpc-5083	245	4	lb	lb	NOUN
dpc-5083	245	5	,	,	PUNCT
dpc-5083	245	6	peña	peña	PROPN
dpc-5083	245	7	-	-	PUNCT
dpc-5083	245	8	varela	varela	PROPN
dpc-5083	245	9	c	c	PROPN
dpc-5083	245	10	,	,	PUNCT
dpc-5083	245	11	ramírez	ramírez	NOUN
dpc-5083	245	12	-	-	PUNCT
dpc-5083	245	13	lópez	lópez	NOUN
dpc-5083	245	14	jm	jm	PROPN
dpc-5083	245	15	,	,	PUNCT
dpc-5083	245	16	yamazaki	yamazaki	PROPN
dpc-5083	245	17	-	-	PUNCT
dpc-5083	245	18	nakashimada	nakashimada	PROPN
dpc-5083	245	19	ma	ma	PROPN
dpc-5083	245	20	.	.	PROPN
dpc-5083	245	21	adenoviral	adenoviral	PROPN
dpc-5083	245	22	-	-	PUNCT
dpc-5083	245	23	induced	induce	VERB
dpc-5083	245	24	rash	rash	NOUN
dpc-5083	245	25	and	and	CCONJ
dpc-5083	245	26	mucositis	mucositis	NOUN
dpc-5083	245	27	:	:	PUNCT
dpc-5083	245	28	expanding	expand	VERB
dpc-5083	245	29	the	the	DET
dpc-5083	245	30	spectrum	spectrum	NOUN
dpc-5083	245	31	of	of	ADP
dpc-5083	245	32	reactive	reactive	ADJ
dpc-5083	245	33	infectious	infectious	ADJ
dpc-5083	245	34	mucocutaneous	mucocutaneous	ADJ
dpc-5083	245	35	eruption	eruption	NOUN
dpc-5083	245	36	.	.	PUNCT
dpc-5083	246	1	pediatr	pediatr	ADJ
dpc-5083	246	2	dermatol	dermatol	NOUN
dpc-5083	246	3	.	.	PUNCT
dpc-5083	247	1	2021;38:306–8	2021;38:306–8	NUM
dpc-5083	247	2	.	.	PUNCT
dpc-5083	247	3	doi	doi	NOUN
dpc-5083	247	4	:	:	PUNCT
dpc-5083	247	5	 	 	SPACE
dpc-5083	247	6	10.1111	10.1111	NUM
dpc-5083	247	7	/pde.14419	/pde.14419	PROPN
dpc-5083	247	8	.	.	PUNCT
dpc-5083	248	1	pmid	pmid	NOUN
dpc-5083	248	2	:	:	PUNCT
dpc-5083	248	3	33063905	33063905	NUM
dpc-5083	248	4	.	.	PUNCT
dpc-5083	249	1	24	24	NUM
dpc-5083	249	2	.	.	PUNCT
dpc-5083	250	1	brazel	brazel	PROPN
dpc-5083	250	2	d	d	NOUN
dpc-5083	250	3	,	,	PUNCT
dpc-5083	250	4	kulp	kulp	NOUN
dpc-5083	250	5	b	b	NOUN
dpc-5083	250	6	,	,	PUNCT
dpc-5083	250	7	bautista	bautista	PROPN
dpc-5083	250	8	g	g	PROPN
dpc-5083	250	9	,	,	PUNCT
dpc-5083	250	10	bonwit	bonwit	ADJ
dpc-5083	250	11	a.	a.	NOUN
dpc-5083	250	12	rash	rash	NOUN
dpc-5083	250	13	and	and	CCONJ
dpc-5083	250	14	mucositis	mucositis	NOUN
dpc-5083	250	15	associated	associate	VERB
dpc-5083	250	16	with	with	ADP
dpc-5083	250	17	mycoplasma	mycoplasma	NOUN
dpc-5083	250	18	pneumoniae	pneumoniae	NOUN
dpc-5083	250	19	and	and	CCONJ
dpc-5083	250	20	chlamydophila	chlamydophila	NOUN
dpc-5083	250	21	pneumoniae	pneumoniae	VERB
dpc-5083	250	22	:	:	PUNCT
dpc-5083	250	23	a	a	DET
dpc-5083	250	24	recurrence	recurrence	NOUN
dpc-5083	250	25	of	of	ADP
dpc-5083	250	26	mirm	mirm	NOUN
dpc-5083	250	27	?	?	PUNCT
dpc-5083	251	1	j	j	PROPN
dpc-5083	251	2	pediatric	pediatric	ADJ
dpc-5083	251	3	infect	infect	PROPN
dpc-5083	251	4	dis	dis	PROPN
dpc-5083	251	5	soc	soc	NOUN
dpc-5083	251	6	.	.	PUNCT
dpc-5083	252	1	2021;10:220–4	2021;10:220–4	X
dpc-5083	252	2	.	.	PUNCT
dpc-5083	253	1	doi	doi	NOUN
dpc-5083	253	2	:	:	PUNCT
dpc-5083	253	3	 	 	SPACE
dpc-5083	253	4	10.1093	10.1093	NUM
dpc-5083	253	5	/	/	SYM
dpc-5083	253	6	jpids	jpid	NOUN
dpc-5083	253	7	/	/	SYM
dpc-5083	253	8	piaa028	piaa028	PROPN
dpc-5083	253	9	.	.	PUNCT
dpc-5083	254	1	pmid	pmid	NOUN
dpc-5083	254	2	:	:	PUNCT
dpc-5083	254	3	32275058	32275058	NUM
dpc-5083	254	4	.	.	PUNCT
dpc-5083	255	1	25	25	NUM
dpc-5083	255	2	.	.	PUNCT
dpc-5083	255	3	li	li	PROPN
dpc-5083	255	4	ho	ho	PROPN
dpc-5083	255	5	-	-	PUNCT
dpc-5083	255	6	y	y	PROPN
dpc-5083	255	7	,	,	PUNCT
dpc-5083	255	8	colantonio	colantonio	PROPN
dpc-5083	255	9	s	s	PART
dpc-5083	255	10	,	,	PUNCT
dpc-5083	255	11	ramien	ramien	PROPN
dpc-5083	255	12	ml	ml	NOUN
dpc-5083	255	13	.	.	PUNCT
dpc-5083	256	1	treatment	treatment	NOUN
dpc-5083	256	2	of	of	ADP
dpc-5083	256	3	mycoplasma	mycoplasma	NOUN
dpc-5083	256	4	pneumoniae	pneumoniae	ADV
dpc-5083	256	5	-	-	PUNCT
dpc-5083	256	6	induced	induce	VERB
dpc-5083	256	7	rash	rash	NOUN
dpc-5083	256	8	and	and	CCONJ
dpc-5083	256	9	mucositis	mucositis	NOUN
dpc-5083	256	10	with	with	ADP
dpc-5083	256	11	cyclosporine	cyclosporine	NOUN
dpc-5083	256	12	.	.	PUNCT
dpc-5083	257	1	j	j	PROPN
dpc-5083	257	2	cutan	cutan	PROPN
dpc-5083	257	3	med	med	ADJ
dpc-5083	257	4	surg	surg	NOUN
dpc-5083	257	5	.	.	PUNCT
dpc-5083	258	1	2019;23:608–12	2019;23:608–12	X
dpc-5083	258	2	.	.	PUNCT
dpc-5083	258	3	doi	doi	PROPN
dpc-5083	258	4	:	:	PUNCT
dpc-5083	258	5	  	  	SPACE
dpc-5083	258	6	10.1177/120347	10.1177/120347	NUM
dpc-5083	258	7	5419874444	5419874444	NUM
dpc-5083	258	8	.	.	PUNCT
dpc-5083	259	1	pmid	pmid	NOUN
dpc-5083	259	2	:	:	PUNCT
dpc-5083	259	3	31502864	31502864	NUM
dpc-5083	259	4	.	.	PUNCT
dpc-5083	260	1	26	26	NUM
dpc-5083	260	2	.	.	X
dpc-5083	260	3	norton	norton	PROPN
dpc-5083	260	4	sa	sa	PROPN
dpc-5083	260	5	.	.	PUNCT
dpc-5083	261	1	diagnosing	diagnosing	NOUN
dpc-5083	261	2	mycoplasma	mycoplasma	NOUN
dpc-5083	261	3	pneumoniae	pneumoniae	ADV
dpc-5083	261	4	-	-	PUNCT
dpc-5083	261	5	induced	induce	VERB
dpc-5083	261	6	rash	rash	NOUN
dpc-5083	261	7	and	and	CCONJ
dpc-5083	261	8	mucositis	mucositis	NOUN
dpc-5083	261	9	(	(	PUNCT
dpc-5083	261	10	mirm	mirm	NOUN
dpc-5083	261	11	)	)	PUNCT
dpc-5083	261	12	in	in	ADP
dpc-5083	261	13	the	the	DET
dpc-5083	261	14	emergency	emergency	NOUN
dpc-5083	261	15	room	room	NOUN
dpc-5083	261	16	.	.	PUNCT
dpc-5083	262	1	j	j	PROPN
dpc-5083	262	2	am	be	AUX
dpc-5083	262	3	acad	acad	ADJ
dpc-5083	262	4	dermatol	dermatol	NOUN
dpc-5083	262	5	.	.	PUNCT
dpc-5083	263	1	2015;73	2015;73	NUM
dpc-5083	263	2	:	:	PUNCT
dpc-5083	263	3	e67	e67	NOUN
dpc-5083	263	4	.	.	PUNCT
dpc-5083	264	1	doi	doi	PROPN
dpc-5083	264	2	:	:	PUNCT
dpc-5083	264	3	  	  	SPACE
dpc-5083	264	4	10.1016	10.1016	NUM
dpc-5083	264	5	/	/	SYM
dpc-5083	264	6	j.jaad.2015.03.060	j.jaad.2015.03.060	NOUN
dpc-5083	264	7	.	.	PUNCT
dpc-5083	265	1	pmid	pmid	NOUN
dpc-5083	265	2	:	:	PUNCT
dpc-5083	265	3	26184002	26184002	NUM
dpc-5083	265	4	.	.	PUNCT
dpc-5083	266	1	27	27	NUM
dpc-5083	266	2	.	.	PUNCT
dpc-5083	267	1	khalili	khalili	PROPN
dpc-5083	267	2	a	a	PROPN
dpc-5083	267	3	,	,	PUNCT
dpc-5083	267	4	ackerman	ackerman	PROPN
dpc-5083	267	5	i	i	PROPN
dpc-5083	267	6	m	m	PROPN
dpc-5083	267	7	,	,	PUNCT
dpc-5083	267	8	gorski	gorski	PROPN
dpc-5083	267	9	mg	mg	PROPN
dpc-5083	267	10	,	,	PUNCT
dpc-5083	267	11	et	et	PROPN
dpc-5083	267	12	al	al	PROPN
dpc-5083	267	13	.	.	PUNCT
dpc-5083	268	1	ophthalmic	ophthalmic	ADJ
dpc-5083	268	2	findings	finding	NOUN
dpc-5083	268	3	of	of	ADP
dpc-5083	268	4	mycoplasma	mycoplasma	NOUN
dpc-5083	268	5	-	-	PUNCT
dpc-5083	268	6	induced	induce	VERB
dpc-5083	268	7	rash	rash	NOUN
dpc-5083	268	8	and	and	CCONJ
dpc-5083	268	9	mucositis	mucositis	NOUN
dpc-5083	268	10	(	(	PUNCT
dpc-5083	268	11	mirm	mirm	NOUN
dpc-5083	268	12	)	)	PUNCT
dpc-5083	268	13	distinct	distinct	ADJ
dpc-5083	268	14	from	from	ADP
dpc-5083	268	15	stevens	stevens	PROPN
dpc-5083	268	16	-	-	PUNCT
dpc-5083	268	17	johnson	johnson	PROPN
dpc-5083	268	18	syndrome	syndrome	NOUN
dpc-5083	268	19	.	.	PUNCT
dpc-5083	269	1	j	j	PROPN
dpc-5083	269	2	aapos	aapos	PROPN
dpc-5083	269	3	.	.	PUNCT
dpc-5083	270	1	2021;25:348.e1348.e6	2021;25:348.e1348.e6	ADJ
dpc-5083	270	2	.	.	PUNCT
dpc-5083	271	1	doi	doi	NOUN
dpc-5083	271	2	:	:	PUNCT
dpc-5083	271	3	 	 	SPACE
dpc-5083	271	4	10.1016	10.1016	NUM
dpc-5083	271	5	/	/	SYM
dpc-5083	271	6	j.jaapos.2021.06.003	j.jaapos.2021.06.003	PROPN
dpc-5083	271	7	.	.	PUNCT
dpc-5083	272	1	pmid	pmid	NOUN
dpc-5083	272	2	:	:	PUNCT
dpc-5083	272	3	34687875	34687875	NUM
dpc-5083	272	4	.	.	PUNCT
dpc-5083	273	1	28	28	NUM
dpc-5083	273	2	.	.	PUNCT
dpc-5083	274	1	wang	wang	PROPN
dpc-5083	274	2	w	w	PROPN
dpc-5083	274	3	-	-	PROPN
dpc-5083	274	4	y	y	PROPN
dpc-5083	274	5	,	,	PUNCT
dpc-5083	274	6	hu	hu	PROPN
dpc-5083	274	7	sc	sc	PROPN
dpc-5083	274	8	-	-	PUNCT
dpc-5083	274	9	s.	s.	PROPN
dpc-5083	274	10	mycoplasma	mycoplasma	VERB
dpc-5083	274	11	pneumoniae	pneumoniae	ADV
dpc-5083	274	12	-	-	PUNCT
dpc-5083	274	13	associated	associated	ADJ
dpc-5083	274	14	reactive	reactive	ADJ
dpc-5083	274	15	infectious	infectious	ADJ
dpc-5083	274	16	mucocutaneous	mucocutaneous	ADJ
dpc-5083	274	17	eruption	eruption	NOUN
dpc-5083	274	18	sine	sine	NOUN
dpc-5083	274	19	rash	rash	NOUN
dpc-5083	274	20	.	.	PUNCT
dpc-5083	275	1	the	the	DET
dpc-5083	275	2	american	american	PROPN
dpc-5083	275	3	journal	journal	PROPN
dpc-5083	275	4	of	of	ADP
dpc-5083	275	5	medicine	medicine	NOUN
dpc-5083	275	6	.	.	PUNCT
dpc-5083	276	1	2024;137	2024;137	NUM
dpc-5083	276	2	:	:	PUNCT
dpc-5083	276	3	e111–2	e111–2	PROPN
dpc-5083	276	4	.	.	PUNCT
dpc-5083	277	1	doi	doi	NOUN
dpc-5083	277	2	:	:	PUNCT
dpc-5083	277	3	10.1016	10.1016	NUM
dpc-5083	277	4	/j.amjmed.2024.02.008	/j.amjmed.2024.02.008	NOUN
dpc-5083	277	5	.	.	PUNCT
dpc-5083	278	1	pmid	pmid	NOUN
dpc-5083	278	2	:	:	PUNCT
dpc-5083	278	3	 	 	SPACE
dpc-5083	278	4	38373645	38373645	NUM
dpc-5083	278	5	.	.	PUNCT
dpc-5083	279	1	29	29	NUM
dpc-5083	279	2	.	.	PUNCT
dpc-5083	280	1	miller	miller	PROPN
dpc-5083	280	2	mm	mm	PROPN
dpc-5083	280	3	,	,	PUNCT
dpc-5083	280	4	kamath	kamath	PROPN
dpc-5083	280	5	s	s	PROPN
dpc-5083	280	6	,	,	PUNCT
dpc-5083	280	7	hughes	hughes	PROPN
dpc-5083	280	8	m	m	PROPN
dpc-5083	280	9	,	,	PUNCT
dpc-5083	280	10	harter	harter	VERB
dpc-5083	280	11	n	n	PART
dpc-5083	280	12	,	,	PUNCT
dpc-5083	280	13	luu	luu	PROPN
dpc-5083	280	14	m.	m.	PROPN
dpc-5083	280	15	evaluation	evaluation	NOUN
dpc-5083	280	16	of	of	ADP
dpc-5083	280	17	etanercept	etanercept	NOUN
dpc-5083	280	18	for	for	ADP
dpc-5083	280	19	treatment	treatment	NOUN
dpc-5083	280	20	of	of	ADP
dpc-5083	280	21	reactive	reactive	ADJ
dpc-5083	280	22	infectious	infectious	ADJ
dpc-5083	280	23	mucocutaneous	mucocutaneous	ADJ
dpc-5083	280	24	eruption	eruption	NOUN
dpc-5083	280	25	.	.	PUNCT
dpc-5083	281	1	jama	jama	PROPN
dpc-5083	281	2	dermatol	dermatol	NOUN
dpc-5083	281	3	.	.	PUNCT
dpc-5083	282	1	2021;157:230	2021;157:230	X
dpc-5083	282	2	.	.	PUNCT
dpc-5083	282	3	doi	doi	NOUN
dpc-5083	282	4	:	:	PUNCT
dpc-5083	282	5	10.1001	10.1001	NUM
dpc-5083	282	6	/jamadermatol.2020.5166	/jamadermatol.2020.5166	NUM
dpc-5083	282	7	.	.	PUNCT
dpc-5083	283	1	pmid	pmid	NOUN
dpc-5083	283	2	:	:	PUNCT
dpc-5083	283	3	 	 	SPACE
dpc-5083	283	4	33439235	33439235	NUM
dpc-5083	283	5	.	.	PUNCT
dpc-5083	284	1	30	30	NUM
dpc-5083	284	2	.	.	PUNCT
dpc-5083	285	1	berentsen	berentsen	PROPN
dpc-5083	285	2	s.	s.	PROPN
dpc-5083	285	3	new	new	ADJ
dpc-5083	285	4	insights	insight	NOUN
dpc-5083	285	5	in	in	ADP
dpc-5083	285	6	the	the	DET
dpc-5083	285	7	pathogenesis	pathogenesis	NOUN
dpc-5083	285	8	and	and	CCONJ
dpc-5083	285	9	therapy	therapy	NOUN
dpc-5083	285	10	of	of	ADP
dpc-5083	285	11	cold	cold	ADJ
dpc-5083	285	12	agglutinin	agglutinin	NOUN
dpc-5083	285	13	-	-	PUNCT
dpc-5083	285	14	mediated	mediate	VERB
dpc-5083	285	15	autoimmune	autoimmune	ADJ
dpc-5083	285	16	hemolytic	hemolytic	ADJ
dpc-5083	285	17	anemia	anemia	NOUN
dpc-5083	285	18	.	.	PUNCT
dpc-5083	286	1	front	front	ADJ
dpc-5083	286	2	immunol	immunol	NOUN
dpc-5083	286	3	.	.	PUNCT
dpc-5083	287	1	2020;11:590	2020;11:590	X
dpc-5083	287	2	.	.	X
dpc-5083	287	3	doi	doi	NOUN
dpc-5083	287	4	:	:	PUNCT
dpc-5083	287	5	10.3389	10.3389	NUM
dpc-5083	287	6	/	/	SYM
dpc-5083	287	7	fimmu.2020.00590	fimmu.2020.00590	NOUN
dpc-5083	287	8	.	.	PUNCT
dpc-5083	288	1	pmid	pmid	NOUN
dpc-5083	288	2	:	:	PUNCT
dpc-5083	288	3	  	  	SPACE
dpc-5083	288	4	32318071	32318071	NUM
dpc-5083	288	5	.	.	PUNCT
dpc-5083	289	1	31	31	NUM
dpc-5083	289	2	.	.	PUNCT
dpc-5083	289	3	vujic	vujic	PROPN
dpc-5083	289	4	i	i	PROPN
dpc-5083	289	5	,	,	PUNCT
dpc-5083	289	6	shroff	shroff	VERB
dpc-5083	289	7	a	a	PRON
dpc-5083	289	8	,	,	PUNCT
dpc-5083	289	9	grzelka	grzelka	PROPN
dpc-5083	289	10	m	m	PROPN
dpc-5083	289	11	,	,	PUNCT
dpc-5083	289	12	et	et	PROPN
dpc-5083	289	13	al	al	PROPN
dpc-5083	289	14	.	.	PROPN
dpc-5083	289	15	mycoplasma	mycoplasma	PROPN
dpc-5083	289	16	pneumoniae	pneumoniae	ADJ
dpc-5083	289	17	–	–	PUNCT
dpc-5083	289	18	associated	associate	VERB
dpc-5083	289	19	mucositis	mucositis	NOUN
dpc-5083	289	20	–	–	PUNCT
dpc-5083	289	21	case	case	NOUN
dpc-5083	289	22	report	report	NOUN
dpc-5083	289	23	and	and	CCONJ
dpc-5083	289	24	systematic	systematic	ADJ
dpc-5083	289	25	review	review	NOUN
dpc-5083	289	26	of	of	ADP
dpc-5083	289	27	literature	literature	NOUN
dpc-5083	289	28	.	.	PUNCT
dpc-5083	290	1	acad	acad	PROPN
dpc-5083	290	2	dermatol	dermatol	NOUN
dpc-5083	290	3	venereol	venereol	NOUN
dpc-5083	290	4	.	.	PUNCT
dpc-5083	291	1	2015;29:595–8	2015;29:595–8	NUM
dpc-5083	291	2	.	.	PUNCT
dpc-5083	292	1	doi	doi	NOUN
dpc-5083	292	2	:	:	PUNCT
dpc-5083	292	3	10.1111	10.1111	NUM
dpc-5083	292	4	/jdv.12392	/jdv.12392	NOUN
dpc-5083	292	5	.	.	PUNCT
dpc-5083	293	1	pmid	pmid	NOUN
dpc-5083	293	2	:	:	PUNCT
dpc-5083	293	3	 	 	SPACE
dpc-5083	293	4	24665876	24665876	NUM
dpc-5083	293	5	.	.	PUNCT
dpc-5083	294	1	32	32	NUM
dpc-5083	294	2	.	.	PUNCT
dpc-5083	294	3	fan	fan	PROPN
dpc-5083	294	4	q	q	PROPN
dpc-5083	294	5	,	,	PUNCT
dpc-5083	294	6	meng	meng	PROPN
dpc-5083	294	7	j	j	PROPN
dpc-5083	294	8	,	,	PUNCT
dpc-5083	294	9	li	li	PROPN
dpc-5083	294	10	p	p	PROPN
dpc-5083	294	11	,	,	PUNCT
dpc-5083	294	12	et	et	PROPN
dpc-5083	294	13	al	al	PROPN
dpc-5083	294	14	.	.	PUNCT
dpc-5083	294	15	pathogenesis	pathogenesis	PROPN
dpc-5083	294	16	and	and	CCONJ
dpc-5083	294	17	association	association	NOUN
dpc-5083	294	18	of	of	ADP
dpc-5083	294	19	mycoplasma	mycoplasma	NOUN
dpc-5083	294	20	pneumoniae	pneumoniae	ADJ
dpc-5083	294	21	infection	infection	NOUN
dpc-5083	294	22	with	with	ADP
dpc-5083	294	23	cardiac	cardiac	ADJ
dpc-5083	294	24	and	and	CCONJ
dpc-5083	294	25	hepatic	hepatic	ADJ
dpc-5083	294	26	damage	damage	NOUN
dpc-5083	294	27	.	.	PUNCT
dpc-5083	295	1	microbiology	microbiology	NOUN
dpc-5083	295	2	and	and	CCONJ
dpc-5083	295	3	immunology	immunology	NOUN
dpc-5083	295	4	.	.	PUNCT
dpc-5083	296	1	2015;59:375–80	2015;59:375–80	X
dpc-5083	296	2	.	.	PUNCT
dpc-5083	297	1	doi	doi	NOUN
dpc-5083	297	2	:	:	PUNCT
dpc-5083	297	3	10.1111/1348	10.1111/1348	PROPN
dpc-5083	297	4	-	-	PUNCT
dpc-5083	297	5	0421.12267	0421.12267	NOUN
dpc-5083	297	6	.	.	PUNCT
dpc-5083	298	1	pmid	pmid	NOUN
dpc-5083	298	2	:	:	PUNCT
dpc-5083	298	3	 	 	SPACE
dpc-5083	298	4	26011190	26011190	NUM
dpc-5083	298	5	.	.	PUNCT
dpc-5083	299	1	33	33	NUM
dpc-5083	299	2	.	.	PUNCT
dpc-5083	299	3	kamada	kamada	PROPN
dpc-5083	299	4	n	n	CCONJ
dpc-5083	299	5	,	,	PUNCT
dpc-5083	299	6	kinoshita	kinoshita	PROPN
dpc-5083	299	7	k	k	PROPN
dpc-5083	299	8	,	,	PUNCT
dpc-5083	299	9	togawa	togawa	PROPN
dpc-5083	299	10	y	y	PROPN
dpc-5083	299	11	,	,	PUNCT
dpc-5083	299	12	et	et	PROPN
dpc-5083	299	13	al	al	PROPN
dpc-5083	299	14	.	.	PROPN
dpc-5083	299	15	chronic	chronic	ADJ
dpc-5083	299	16	pulmonary	pulmonary	ADJ
dpc-5083	299	17	complications	complication	NOUN
dpc-5083	299	18	associated	associate	VERB
dpc-5083	299	19	with	with	ADP
dpc-5083	299	20	toxic	toxic	ADJ
dpc-5083	299	21	epidermal	epidermal	ADJ
dpc-5083	299	22	necrolysis	necrolysis	NOUN
dpc-5083	299	23	:	:	PUNCT
dpc-5083	299	24	report	report	NOUN
dpc-5083	299	25	of	of	ADP
dpc-5083	299	26	a	a	DET
dpc-5083	299	27	severe	severe	ADJ
dpc-5083	299	28	case	case	NOUN
dpc-5083	299	29	with	with	ADP
dpc-5083	299	30	anti	anti	ADJ
dpc-5083	299	31	-	-	ADJ
dpc-5083	299	32	ro	ro	ADJ
dpc-5083	299	33	/	/	SYM
dpc-5083	299	34	ss	ss	NOUN
dpc-5083	299	35	-	-	PUNCT
dpc-5083	299	36	a	a	NOUN
dpc-5083	299	37	and	and	CCONJ
dpc-5083	299	38	a	a	DET
dpc-5083	299	39	review	review	NOUN
dpc-5083	299	40	of	of	ADP
dpc-5083	299	41	the	the	DET
dpc-5083	299	42	published	publish	VERB
dpc-5083	299	43	work	work	NOUN
dpc-5083	299	44	.	.	PUNCT
dpc-5083	300	1	the	the	DET
dpc-5083	300	2	journal	journal	NOUN
dpc-5083	300	3	of	of	ADP
dpc-5083	300	4	dermatology	dermatology	NOUN
dpc-5083	300	5	.	.	PUNCT
dpc-5083	301	1	2006;33:616–22	2006;33:616–22	X
dpc-5083	301	2	.	.	PUNCT
dpc-5083	301	3	doi	doi	NOUN
dpc-5083	301	4	:	:	PUNCT
dpc-5083	301	5	10.1111	10.1111	NUM
dpc-5083	301	6	/	/	SYM
dpc-5083	301	7	j.1346	j.1346	VERB
dpc-5083	301	8	-	-	PUNCT
dpc-5083	301	9	8138.2006.00142.x	8138.2006.00142.x	NUM
dpc-5083	301	10	.	.	PUNCT
dpc-5083	302	1	pmid	pmid	NOUN
dpc-5083	302	2	:	:	PUNCT
dpc-5083	302	3	 	 	SPACE
dpc-5083	302	4	16958806	16958806	NUM
dpc-5083	302	5	.	.	PUNCT
dpc-5083	303	1	34	34	NUM
dpc-5083	303	2	.	.	PUNCT
dpc-5083	303	3	marquart	marquart	PROPN
dpc-5083	303	4	e	e	PROPN
dpc-5083	303	5	,	,	PUNCT
dpc-5083	303	6	kinaciyan	kinaciyan	ADJ
dpc-5083	303	7	t.	t.	PROPN
dpc-5083	303	8	overlapping	overlap	VERB
dpc-5083	303	9	clinical	clinical	ADJ
dpc-5083	303	10	presentation	presentation	NOUN
dpc-5083	303	11	of	of	ADP
dpc-5083	303	12	mycoplasma	mycoplasma	NOUN
dpc-5083	303	13	-	-	PUNCT
dpc-5083	303	14	induced	induce	VERB
dpc-5083	303	15	rash	rash	NOUN
dpc-5083	303	16	and	and	CCONJ
dpc-5083	303	17	mucositis	mucositis	NOUN
dpc-5083	303	18	and	and	CCONJ
dpc-5083	303	19	drug	drug	NOUN
dpc-5083	303	20	-	-	PUNCT
dpc-5083	303	21	induced	induce	VERB
dpc-5083	303	22	stevens	stevens	PROPN
dpc-5083	303	23	johnson	johnson	PROPN
dpc-5083	303	24	syndrome	syndrome	PROPN
dpc-5083	303	25	:	:	PUNCT
dpc-5083	303	26	a	a	DET
dpc-5083	303	27	case	case	NOUN
dpc-5083	303	28	report	report	NOUN
dpc-5083	303	29	.	.	PUNCT
dpc-5083	304	1	idcases	idcase	NOUN
dpc-5083	304	2	.	.	PUNCT
dpc-5083	305	1	2023;33	2023;33	NUM
dpc-5083	305	2	:	:	PUNCT
dpc-5083	305	3	e01888	e01888	NOUN
dpc-5083	305	4	.	.	PUNCT
dpc-5083	306	1	doi	doi	PROPN
dpc-5083	306	2	:	:	PUNCT
dpc-5083	306	3	 	 	SPACE
dpc-5083	306	4	10.1016	10.1016	NUM
dpc-5083	306	5	/	/	SYM
dpc-5083	306	6	j.idcr.2023.e01888	j.idcr.2023.e01888	PROPN
dpc-5083	306	7	.	.	PUNCT
dpc-5083	307	1	pmid	pmid	NOUN
dpc-5083	307	2	:	:	PUNCT
dpc-5083	307	3	37693950	37693950	NUM
dpc-5083	307	4	.	.	PUNCT
dpc-5083	308	1	35	35	NUM
dpc-5083	308	2	.	.	PUNCT
dpc-5083	309	1	gise	gise	ADJ
dpc-5083	309	2	r	r	PROPN
dpc-5083	309	3	,	,	PUNCT
dpc-5083	309	4	elhusseiny	elhusseiny	PROPN
dpc-5083	309	5	am	am	NOUN
dpc-5083	309	6	,	,	PUNCT
dpc-5083	309	7	scelfo	scelfo	PROPN
dpc-5083	309	8	c	c	NOUN
dpc-5083	309	9	,	,	PUNCT
dpc-5083	309	10	mantagos	mantagos	PROPN
dpc-5083	309	11	is	be	AUX
dpc-5083	309	12	.	.	PUNCT
dpc-5083	310	1	mycoplasma	mycoplasma	NOUN
dpc-5083	310	2	pneumoniae	pneumoniae	ADJ
dpc-5083	310	3	–	–	PUNCT
dpc-5083	310	4	induced	induced	ADJ
dpc-5083	310	5	rash	rash	NOUN
dpc-5083	310	6	and	and	CCONJ
dpc-5083	310	7	mucositis	mucositis	NOUN
dpc-5083	310	8	:	:	PUNCT
dpc-5083	310	9	a	a	DET
dpc-5083	310	10	longitudinal	longitudinal	ADJ
dpc-5083	310	11	perspective	perspective	NOUN
dpc-5083	310	12	and	and	CCONJ
dpc-5083	310	13	proposed	propose	VERB
dpc-5083	310	14	management	management	NOUN
dpc-5083	310	15	criteria	criterion	NOUN
dpc-5083	310	16	.	.	PUNCT
dpc-5083	311	1	american	american	ADJ
dpc-5083	311	2	journal	journal	PROPN
dpc-5083	311	3	of	of	ADP
dpc-5083	311	4	ophthalmology	ophthalmology	NOUN
dpc-5083	311	5	.	.	PUNCT
dpc-5083	312	1	2020;219:351–6	2020;219:351–6	ADJ
dpc-5083	312	2	.	.	PUNCT
dpc-5083	313	1	doi	doi	NOUN
dpc-5083	313	2	:	:	PUNCT
dpc-5083	313	3	10.1016	10.1016	NUM
dpc-5083	313	4	/j.ajo.2020.06.010	/j.ajo.2020.06.010	PUNCT
dpc-5083	313	5	.	.	PUNCT
dpc-5083	314	1	pmid	pmid	NOUN
dpc-5083	314	2	:	:	PUNCT
dpc-5083	314	3	 	 	SPACE
dpc-5083	314	4	32574770	32574770	NUM
dpc-5083	314	5	.	.	PUNCT
dpc-5083	315	1	36	36	NUM
dpc-5083	315	2	.	.	X
dpc-5083	316	1	maredia	maredia	PROPN
dpc-5083	316	2	h	h	PROPN
dpc-5083	316	3	,	,	PUNCT
dpc-5083	316	4	eseonu	eseonu	PROPN
dpc-5083	316	5	a	a	PROPN
dpc-5083	316	6	,	,	PUNCT
dpc-5083	316	7	grossberg	grossberg	PROPN
dpc-5083	316	8	al	al	PROPN
dpc-5083	316	9	,	,	PUNCT
dpc-5083	316	10	cohen	cohen	PROPN
dpc-5083	316	11	ba	ba	PROPN
dpc-5083	316	12	.	.	PUNCT
dpc-5083	317	1	recurrent	recurrent	PROPN
dpc-5083	317	2	mycoplasma	mycoplasma	NOUN
dpc-5083	317	3	pneumoniae	pneumoniae	ADV
dpc-5083	317	4	-	-	PUNCT
dpc-5083	317	5	associated	associated	ADJ
dpc-5083	317	6	reactive	reactive	ADJ
dpc-5083	317	7	infectious	infectious	ADJ
dpc-5083	317	8	mucocutaneous	mucocutaneous	ADJ
dpc-5083	317	9	eruption	eruption	NOUN
dpc-5083	317	10	responsive	responsive	ADJ
dpc-5083	317	11	to	to	ADP
dpc-5083	317	12	systemic	systemic	ADJ
dpc-5083	317	13	steroids	steroid	NOUN
dpc-5083	317	14	:	:	PUNCT
dpc-5083	317	15	a	a	DET
dpc-5083	317	16	case	case	NOUN
dpc-5083	317	17	series	series	NOUN
dpc-5083	317	18	.	.	PUNCT
dpc-5083	318	1	jaad	jaad	PROPN
dpc-5083	318	2	case	case	NOUN
dpc-5083	318	3	rep	rep	PROPN
dpc-5083	318	4	.	.	PROPN
dpc-5083	318	5	2021;11:139–43	2021;11:139–43	PROPN
dpc-5083	318	6	.	.	PUNCT
dpc-5083	318	7	doi	doi	PROPN
dpc-5083	318	8	:	:	PUNCT
dpc-5083	318	9	  	  	SPACE
dpc-5083	318	10	10.1016	10.1016	NUM
dpc-5083	318	11	/	/	SYM
dpc-5083	318	12	j.jdcr	j.jdcr	ADJ
dpc-5083	318	13	.2021.03.009	.2021.03.009	PROPN
dpc-5083	318	14	.	.	PUNCT
dpc-5083	319	1	pmid	pmid	NOUN
dpc-5083	319	2	:	:	PUNCT
dpc-5083	319	3	33997214	33997214	NUM
dpc-5083	319	4	.	.	PUNCT
dpc-5083	320	1	2023;49:572–4	2023;49:572–4	NUM
dpc-5083	320	2	.	.	PUNCT
dpc-5083	320	3	doi	doi	NOUN
dpc-5083	320	4	:	:	PUNCT
dpc-5083	320	5	10.1097	10.1097	NUM
dpc-5083	320	6	/	/	SYM
dpc-5083	320	7	icl.0000000000001042	icl.0000000000001042	PROPN
dpc-5083	320	8	.	.	PUNCT
dpc-5083	321	1	pmid	pmid	NOUN
dpc-5083	321	2	:	:	PUNCT
dpc-5083	321	3	  	  	SPACE
dpc-5083	321	4	37728867	37728867	NUM
dpc-5083	321	5	.	.	PUNCT
dpc-5083	322	1	10	10	NUM
dpc-5083	322	2	.	.	PUNCT
dpc-5083	322	3	song	song	PROPN
dpc-5083	322	4	a	a	PRON
dpc-5083	322	5	,	,	PUNCT
dpc-5083	322	6	nicholson	nicholson	PROPN
dpc-5083	322	7	c	c	PROPN
dpc-5083	322	8	,	,	PUNCT
dpc-5083	322	9	maguiness	maguiness	PROPN
dpc-5083	322	10	s.	s.	PROPN
dpc-5083	322	11	recurrent	recurrent	PROPN
dpc-5083	322	12	reactive	reactive	ADJ
dpc-5083	322	13	infectious	infectious	ADJ
dpc-5083	322	14	mucocutaneous	mucocutaneous	ADJ
dpc-5083	322	15	eruption	eruption	NOUN
dpc-5083	322	16	(	(	PUNCT
dpc-5083	322	17	rime	rime	NOUN
dpc-5083	322	18	)	)	PUNCT
dpc-5083	322	19	in	in	ADP
dpc-5083	322	20	two	two	NUM
dpc-5083	322	21	adolescents	adolescent	NOUN
dpc-5083	322	22	triggered	trigger	VERB
dpc-5083	322	23	by	by	ADP
dpc-5083	322	24	several	several	ADJ
dpc-5083	322	25	distinct	distinct	ADJ
dpc-5083	322	26	pathogens	pathogen	NOUN
dpc-5083	322	27	including	include	VERB
dpc-5083	322	28	sars	sar	NOUN
dpc-5083	322	29	-	-	PUNCT
dpc-5083	322	30	cov-2	cov-2	PART
dpc-5083	322	31	and	and	CCONJ
dpc-5083	322	32	influenza	influenza	NOUN
dpc-5083	322	33	a.	a.	NOUN
dpc-5083	322	34	pediatr	pediatr	PROPN
dpc-5083	322	35	dermatol	dermatol	NOUN
dpc-5083	322	36	.	.	PUNCT
dpc-5083	323	1	2021;38:1222–5	2021;38:1222–5	X
dpc-5083	323	2	.	.	PUNCT
dpc-5083	324	1	doi	doi	PROPN
dpc-5083	324	2	:	:	PUNCT
dpc-5083	324	3	10.1111	10.1111	NUM
dpc-5083	324	4	/pde.14780	/pde.14780	NOUN
dpc-5083	324	5	.	.	PUNCT
dpc-5083	325	1	pmid	pmid	NOUN
dpc-5083	325	2	:	:	PUNCT
dpc-5083	325	3	34515364	34515364	NUM
dpc-5083	325	4	.	.	PUNCT
dpc-5083	326	1	11	11	NUM
dpc-5083	326	2	.	.	PUNCT
dpc-5083	327	1	goyal	goyal	PROPN
dpc-5083	327	2	a	a	PRON
dpc-5083	327	3	,	,	PUNCT
dpc-5083	327	4	hook	hook	NOUN
dpc-5083	327	5	k.	k.	PROPN
dpc-5083	327	6	two	two	NUM
dpc-5083	327	7	pediatric	pediatric	ADJ
dpc-5083	327	8	cases	case	NOUN
dpc-5083	327	9	of	of	ADP
dpc-5083	327	10	influenza	influenza	NOUN
dpc-5083	327	11	b	b	NOUN
dpc-5083	327	12	-	-	PUNCT
dpc-5083	327	13	induced	induced	ADJ
dpc-5083	327	14	rash	rash	NOUN
dpc-5083	327	15	and	and	CCONJ
dpc-5083	327	16	mucositis	mucositis	NOUN
dpc-5083	327	17	:	:	PUNCT
dpc-5083	327	18	stevens	stevens	PROPN
dpc-5083	327	19	-	-	PUNCT
dpc-5083	327	20	johnson	johnson	PROPN
dpc-5083	327	21	syndrome	syndrome	NOUN
dpc-5083	327	22	or	or	CCONJ
dpc-5083	327	23	expansion	expansion	NOUN
dpc-5083	327	24	of	of	ADP
dpc-5083	327	25	the	the	DET
dpc-5083	327	26	mycoplasma	mycoplasma	NOUN
dpc-5083	327	27	pneumoniae	pneumoniae	ADV
dpc-5083	327	28	-	-	PUNCT
dpc-5083	327	29	induced	induce	VERB
dpc-5083	327	30	rash	rash	NOUN
dpc-5083	327	31	with	with	ADP
dpc-5083	327	32	mucositis	mucositis	PROPN
dpc-5083	327	33	(	(	PUNCT
dpc-5083	327	34	mirm	mirm	NOUN
dpc-5083	327	35	)	)	PUNCT
dpc-5083	327	36	spectrum	spectrum	NOUN
dpc-5083	327	37	?	?	PUNCT
dpc-5083	328	1	pediatr	pediatr	ADJ
dpc-5083	328	2	dermatol	dermatol	NOUN
dpc-5083	328	3	.	.	PUNCT
dpc-5083	329	1	2019;36:929–31	2019;36:929–31	X
dpc-5083	329	2	.	.	PUNCT
dpc-5083	329	3	doi	doi	NOUN
dpc-5083	329	4	:	:	PUNCT
dpc-5083	329	5	 	 	SPACE
dpc-5083	329	6	10.1111	10.1111	NUM
dpc-5083	329	7	/	/	SYM
dpc-5083	329	8	pde.13921	pde.13921	PROPN
dpc-5083	329	9	.	.	PUNCT
dpc-5083	330	1	pmid	pmid	NOUN
dpc-5083	330	2	:	:	PUNCT
dpc-5083	330	3	31576583	31576583	NUM
dpc-5083	330	4	.	.	PUNCT
dpc-5083	331	1	12	12	NUM
dpc-5083	331	2	.	.	PUNCT
dpc-5083	332	1	bowe	bowe	PROPN
dpc-5083	332	2	s	s	PROPN
dpc-5083	332	3	,	,	PUNCT
dpc-5083	332	4	o’connor	o’connor	ADV
dpc-5083	332	5	c	c	AUX
dpc-5083	332	6	,	,	PUNCT
dpc-5083	332	7	gleeson	gleeson	NOUN
dpc-5083	332	8	c	c	NOUN
dpc-5083	332	9	,	,	PUNCT
dpc-5083	332	10	murphy	murphy	PROPN
dpc-5083	332	11	m.	m.	PROPN
dpc-5083	332	12	reactive	reactive	ADJ
dpc-5083	332	13	infectious	infectious	ADJ
dpc-5083	332	14	mucocutaneous	mucocutaneous	ADJ
dpc-5083	332	15	eruption	eruption	NOUN
dpc-5083	332	16	in	in	ADP
dpc-5083	332	17	children	child	NOUN
dpc-5083	332	18	diagnosed	diagnose	VERB
dpc-5083	332	19	with	with	ADP
dpc-5083	332	20	covid-19	covid-19	PROPN
dpc-5083	332	21	.	.	PUNCT
dpc-5083	333	1	pediatr	pediatr	ADJ
dpc-5083	333	2	dermatol	dermatol	NOUN
dpc-5083	333	3	.	.	PUNCT
dpc-5083	334	1	2021;38:1385–6	2021;38:1385–6	X
dpc-5083	334	2	.	.	PUNCT
dpc-5083	334	3	doi	doi	PROPN
dpc-5083	334	4	:	:	PUNCT
dpc-5083	334	5	  	  	SPACE
dpc-5083	334	6	10.1111	10.1111	NUM
dpc-5083	334	7	/	/	SYM
dpc-5083	334	8	pde.14801	pde.14801	PROPN
dpc-5083	334	9	.	.	PUNCT
dpc-5083	335	1	pmid	pmid	NOUN
dpc-5083	335	2	:	:	PUNCT
dpc-5083	335	3	34542915	34542915	NUM
dpc-5083	335	4	.	.	PUNCT
dpc-5083	336	1	13	13	NUM
dpc-5083	336	2	.	.	X
dpc-5083	336	3	mcdermid	mcdermid	NOUN
dpc-5083	336	4	a	a	PRON
dpc-5083	336	5	,	,	PUNCT
dpc-5083	336	6	lam	lam	PROPN
dpc-5083	336	7	k	k	PROPN
dpc-5083	336	8	,	,	PUNCT
dpc-5083	336	9	ko	ko	PROPN
dpc-5083	336	10	yck	yck	PROPN
dpc-5083	336	11	,	,	PUNCT
dpc-5083	336	12	et	et	PROPN
dpc-5083	336	13	al	al	PROPN
dpc-5083	336	14	.	.	PUNCT
dpc-5083	337	1	sars	sars	PROPN
dpc-5083	337	2	-	-	PUNCT
dpc-5083	337	3	cov-2	cov-2	NOUN
dpc-5083	337	4	reactive	reactive	ADJ
dpc-5083	337	5	infectious	infectious	ADJ
dpc-5083	337	6	mucocutaneous	mucocutaneous	ADJ
dpc-5083	337	7	eruptions	eruption	NOUN
dpc-5083	337	8	in	in	ADP
dpc-5083	337	9	  	  	SPACE
dpc-5083	337	10	adults	adult	NOUN
dpc-5083	337	11	treated	treat	VERB
dpc-5083	337	12	with	with	ADP
dpc-5083	337	13	cyclosporine	cyclosporine	NOUN
dpc-5083	337	14	as	as	ADP
dpc-5083	337	15	first	first	ADJ
dpc-5083	337	16	line	line	NOUN
dpc-5083	337	17	treatment	treatment	NOUN
dpc-5083	337	18	.	.	PUNCT
dpc-5083	338	1	j	j	PROPN
dpc-5083	338	2	dtsch	dtsch	PROPN
dpc-5083	338	3	dermatol	dermatol	NOUN
dpc-5083	338	4	ges	ge	NOUN
dpc-5083	338	5	.	.	PROPN
dpc-5083	338	6	2024	2024	NUM
dpc-5083	338	7	.	.	PUNCT
dpc-5083	339	1	doi	doi	NOUN
dpc-5083	339	2	:	:	PUNCT
dpc-5083	339	3	10.1111	10.1111	NUM
dpc-5083	339	4	/	/	SYM
dpc-5083	339	5	ddg.15417	ddg.15417	PROPN
dpc-5083	339	6	.	.	PUNCT
dpc-5083	340	1	pmid	pmid	NOUN
dpc-5083	340	2	:	:	PUNCT
dpc-5083	340	3	38837589	38837589	NUM
dpc-5083	340	4	.	.	PUNCT
dpc-5083	341	1	14	14	NUM
dpc-5083	341	2	.	.	PUNCT
dpc-5083	342	1	miller	miller	PROPN
dpc-5083	342	2	ae	ae	PROPN
dpc-5083	342	3	,	,	PUNCT
dpc-5083	342	4	zhang	zhang	PROPN
dpc-5083	342	5	d	d	PROPN
dpc-5083	342	6	,	,	PUNCT
dpc-5083	342	7	shields	shield	NOUN
dpc-5083	342	8	be	be	VERB
dpc-5083	342	9	,	,	PUNCT
dpc-5083	342	10	et	et	PROPN
dpc-5083	342	11	al	al	PROPN
dpc-5083	342	12	.	.	PUNCT
dpc-5083	343	1	covid-19	covid-19	PROPN
dpc-5083	343	2	associated	associate	VERB
dpc-5083	343	3	severe	severe	ADJ
dpc-5083	343	4	mucocutaneous	mucocutaneous	ADJ
dpc-5083	343	5	blistering	blistering	ADJ
dpc-5083	343	6	eruptions	eruption	NOUN
dpc-5083	343	7	:	:	PUNCT
dpc-5083	343	8	a	a	DET
dpc-5083	343	9	case	case	NOUN
dpc-5083	343	10	series	series	NOUN
dpc-5083	343	11	.	.	PUNCT
dpc-5083	344	1	pediatr	pediatr	ADJ
dpc-5083	344	2	dermatol	dermatol	NOUN
dpc-5083	344	3	.	.	PUNCT
dpc-5083	345	1	2023;40:990–5	2023;40:990–5	NUM
dpc-5083	345	2	.	.	PUNCT
dpc-5083	345	3	  	  	SPACE
dpc-5083	345	4	doi	doi	NOUN
dpc-5083	345	5	:	:	PUNCT
dpc-5083	345	6	  	  	SPACE
dpc-5083	345	7	10.1111	10.1111	NUM
dpc-5083	345	8	/	/	SYM
dpc-5083	345	9	pde.15407	pde.15407	NOUN
dpc-5083	345	10	.	.	PUNCT
dpc-5083	346	1	pmid	pmid	NOUN
dpc-5083	346	2	:	:	PUNCT
dpc-5083	346	3	37526023	37526023	NUM
dpc-5083	346	4	.	.	PUNCT
dpc-5083	347	1	15	15	NUM
dpc-5083	347	2	.	.	PUNCT
dpc-5083	348	1	wu	wu	PROPN
dpc-5083	348	2	d	d	PROPN
dpc-5083	348	3	,	,	PUNCT
dpc-5083	348	4	lee	lee	PROPN
dpc-5083	348	5	ey	ey	PROPN
dpc-5083	348	6	,	,	PUNCT
dpc-5083	348	7	lifton	lifton	PROPN
dpc-5083	348	8	j	j	PROPN
dpc-5083	348	9	,	,	PUNCT
dpc-5083	348	10	et	et	PROPN
dpc-5083	348	11	al	al	PROPN
dpc-5083	348	12	.	.	PROPN
dpc-5083	349	1	severe	severe	ADJ
dpc-5083	349	2	recurrence	recurrence	NOUN
dpc-5083	349	3	of	of	ADP
dpc-5083	349	4	reactive	reactive	ADJ
dpc-5083	349	5	infectious	infectious	ADJ
dpc-5083	349	6	mucocutaneous	mucocutaneous	ADJ
dpc-5083	349	7	eruption	eruption	NOUN
dpc-5083	349	8	with	with	ADP
dpc-5083	349	9	extensive	extensive	ADJ
dpc-5083	349	10	ocular	ocular	ADJ
dpc-5083	349	11	involvement	involvement	NOUN
dpc-5083	349	12	in	in	ADP
dpc-5083	349	13	an	an	DET
dpc-5083	349	14	adult	adult	NOUN
dpc-5083	349	15	due	due	ADP
dpc-5083	349	16	to	to	ADP
dpc-5083	349	17	sars	sar	NOUN
dpc-5083	349	18	-	-	PUNCT
dpc-5083	349	19	cov-2	cov-2	NOUN
dpc-5083	349	20	.	.	PUNCT
dpc-5083	350	1	jaad	jaad	NOUN
dpc-5083	350	2	case	case	PROPN
dpc-5083	350	3	rep	rep	PROPN
dpc-5083	350	4	.	.	PROPN
dpc-5083	350	5	2023;36:1–3	2023;36:1–3	PROPN
dpc-5083	350	6	.	.	PUNCT
dpc-5083	351	1	doi	doi	PROPN
dpc-5083	351	2	:	:	PUNCT
dpc-5083	351	3	 	 	SPACE
dpc-5083	351	4	10.1016	10.1016	NUM
dpc-5083	351	5	/	/	SYM
dpc-5083	351	6	j.jdcr.2022.12.026	j.jdcr.2022.12.026	PROPN
dpc-5083	351	7	.	.	PUNCT
dpc-5083	352	1	pmid	pmid	NOUN
dpc-5083	352	2	:	:	PUNCT
dpc-5083	352	3	36819988	36819988	NUM
dpc-5083	352	4	.	.	PUNCT
dpc-5083	353	1	16	16	NUM
dpc-5083	353	2	.	.	PUNCT
dpc-5083	354	1	van	van	PROPN
dpc-5083	354	2	dam	dam	PROPN
dpc-5083	354	3	v	v	PROPN
dpc-5083	354	4	,	,	PUNCT
dpc-5083	354	5	bonny	bonny	PROPN
dpc-5083	354	6	m	m	PROPN
dpc-5083	354	7	,	,	PUNCT
dpc-5083	354	8	desmet	desmet	PROPN
dpc-5083	354	9	s.	s.	PROPN
dpc-5083	354	10	recurrent	recurrent	PROPN
dpc-5083	354	11	reactive	reactive	ADJ
dpc-5083	354	12	infectious	infectious	ADJ
dpc-5083	354	13	mucocutaneous	mucocutaneous	ADJ
dpc-5083	354	14	eruption	eruption	NOUN
dpc-5083	354	15	in	in	ADP
dpc-5083	354	16	a	a	DET
dpc-5083	354	17	male	male	ADJ
dpc-5083	354	18	adult	adult	NOUN
dpc-5083	354	19	patient	patient	NOUN
dpc-5083	354	20	associated	associate	VERB
dpc-5083	354	21	with	with	ADP
dpc-5083	354	22	mycoplasma	mycoplasma	NOUN
dpc-5083	354	23	pneumoniae	pneumoniae	NOUN
dpc-5083	354	24	,	,	PUNCT
dpc-5083	354	25	sars	sar	NOUN
dpc-5083	354	26	-	-	PUNCT
dpc-5083	354	27	cov-2	cov-2	NOUN
dpc-5083	354	28	and	and	CCONJ
dpc-5083	354	29	rhinovirus	rhinovirus	NOUN
dpc-5083	354	30	.	.	PUNCT
dpc-5083	355	1	bmj	bmj	PROPN
dpc-5083	355	2	case	case	NOUN
dpc-5083	355	3	rep	rep	PROPN
dpc-5083	355	4	.	.	PROPN
dpc-5083	355	5	2023;16	2023;16	NUM
dpc-5083	355	6	.	.	PUNCT
dpc-5083	356	1	doi	doi	NOUN
dpc-5083	356	2	:	:	PUNCT
dpc-5083	356	3	  	  	SPACE
dpc-5083	356	4	10.1136	10.1136	NUM
dpc-5083	356	5	/	/	SYM
dpc-5083	356	6	bcr-2023	bcr-2023	NOUN
dpc-5083	356	7	-	-	PUNCT
dpc-5083	356	8	254975	254975	NUM
dpc-5083	356	9	.	.	PUNCT
dpc-5083	357	1	pmid	pmid	NOUN
dpc-5083	357	2	:	:	PUNCT
dpc-5083	357	3	37258050	37258050	NUM
dpc-5083	357	4	.	.	PUNCT
dpc-5083	358	1	17	17	NUM
dpc-5083	358	2	.	.	X
dpc-5083	358	3	ortiz	ortiz	PROPN
dpc-5083	358	4	eg	eg	PROPN
dpc-5083	358	5	,	,	PUNCT
dpc-5083	358	6	junkins	junkins	PROPN
dpc-5083	358	7	-	-	PUNCT
dpc-5083	358	8	hopkins	hopkins	PROPN
dpc-5083	358	9	jm	jm	PROPN
dpc-5083	358	10	.	.	PROPN
dpc-5083	358	11	reactive	reactive	ADJ
dpc-5083	358	12	infectious	infectious	ADJ
dpc-5083	358	13	mucocutaneous	mucocutaneous	ADJ
dpc-5083	358	14	eruption	eruption	NOUN
dpc-5083	358	15	due	due	ADP
dpc-5083	358	16	to	to	ADP
dpc-5083	358	17	covid-19	covid-19	PROPN
dpc-5083	358	18	with	with	ADP
dpc-5083	358	19	erythema	erythema	ADJ
dpc-5083	358	20	-	-	PUNCT
dpc-5083	358	21	multiforme	multiforme	NOUN
dpc-5083	358	22	-	-	PUNCT
dpc-5083	358	23	like	like	ADJ
dpc-5083	358	24	lesions	lesion	NOUN
dpc-5083	358	25	and	and	CCONJ
dpc-5083	358	26	myeloid	myeloid	ADJ
dpc-5083	358	27	cells	cell	NOUN
dpc-5083	358	28	.	.	PUNCT
dpc-5083	359	1	j	j	PROPN
dpc-5083	359	2	cutan	cutan	PROPN
dpc-5083	359	3	pathol	pathol	PROPN
dpc-5083	359	4	.	.	PUNCT
dpc-5083	360	1	2023;50:321–5	2023;50:321–5	NUM
dpc-5083	360	2	.	.	PUNCT
dpc-5083	361	1	doi	doi	NOUN
dpc-5083	361	2	:	:	PUNCT
dpc-5083	361	3	 	 	SPACE
dpc-5083	361	4	10.1111	10.1111	NUM
dpc-5083	361	5	/	/	SYM
dpc-5083	361	6	cup.14339	cup.14339	PROPN
dpc-5083	361	7	.	.	PUNCT
dpc-5083	362	1	pmid	pmid	NOUN
dpc-5083	362	2	:	:	PUNCT
dpc-5083	362	3	36194075	36194075	NUM
dpc-5083	362	4	.	.	PUNCT
dpc-5083	363	1	18	18	NUM
dpc-5083	363	2	.	.	X
dpc-5083	363	3	mahama	mahama	PROPN
dpc-5083	363	4	a	a	DET
dpc-5083	363	5	,	,	PUNCT
dpc-5083	363	6	kojder	kojder	NOUN
dpc-5083	363	7	p	p	NOUN
dpc-5083	363	8	,	,	PUNCT
dpc-5083	363	9	thibodeaux	thibodeaux	PROPN
dpc-5083	363	10	q	q	NOUN
dpc-5083	363	11	,	,	PUNCT
dpc-5083	363	12	ruth	ruth	PROPN
dpc-5083	363	13	j.	j.	PROPN
dpc-5083	363	14	reactive	reactive	PROPN
dpc-5083	363	15	infectious	infectious	ADJ
dpc-5083	363	16	mucocutaneous	mucocutaneous	ADJ
dpc-5083	363	17	eruption	eruption	NOUN
dpc-5083	363	18	following	follow	VERB
dpc-5083	363	19	covid-19	covid-19	PROPN
dpc-5083	363	20	in	in	ADP
dpc-5083	363	21	an	an	DET
dpc-5083	363	22	adolescent	adolescent	ADJ
dpc-5083	363	23	boy	boy	NOUN
dpc-5083	363	24	:	:	PUNCT
dpc-5083	363	25	case	case	NOUN
dpc-5083	363	26	report	report	NOUN
dpc-5083	363	27	and	and	CCONJ
dpc-5083	363	28	review	review	NOUN
dpc-5083	363	29	of	of	ADP
dpc-5083	363	30	the	the	DET
dpc-5083	363	31	literature	literature	NOUN
dpc-5083	363	32	.	.	PUNCT
dpc-5083	364	1	pediatr	pediatr	ADJ
dpc-5083	364	2	dermatol	dermatol	NOUN
dpc-5083	364	3	.	.	PUNCT
dpc-5083	365	1	2023;40:162–5	2023;40:162–5	NUM
dpc-5083	365	2	.	.	PUNCT
dpc-5083	366	1	doi	doi	NOUN
dpc-5083	366	2	:	:	PUNCT
dpc-5083	366	3	 	 	SPACE
dpc-5083	366	4	10.1111	10.1111	NUM
dpc-5083	366	5	/	/	SYM
dpc-5083	366	6	pde.15122	pde.15122	NOUN
dpc-5083	366	7	.	.	PUNCT
dpc-5083	367	1	pmid	pmid	NOUN
dpc-5083	367	2	:	:	PUNCT
dpc-5083	367	3	36042536	36042536	NUM
dpc-5083	367	4	.	.	PUNCT
dpc-5083	368	1	19	19	NUM
dpc-5083	368	2	.	.	PUNCT
dpc-5083	368	3	ryder	ryder	PROPN
dpc-5083	368	4	cy	cy	PROPN
dpc-5083	368	5	,	,	PUNCT
dpc-5083	368	6	pedersen	pedersen	PROPN
dpc-5083	368	7	ea	ea	PROPN
dpc-5083	368	8	,	,	PUNCT
dpc-5083	368	9	mancuso	mancuso	PROPN
dpc-5083	368	10	jb	jb	PROPN
dpc-5083	368	11	.	.	PROPN
dpc-5083	369	1	reactive	reactive	ADJ
dpc-5083	369	2	infectious	infectious	ADJ
dpc-5083	369	3	mucocutaneous	mucocutaneous	ADJ
dpc-5083	369	4	eruption	eruption	NOUN
dpc-5083	369	5	secondary	secondary	ADJ
dpc-5083	369	6	to	to	ADP
dpc-5083	369	7	sars	sar	NOUN
dpc-5083	369	8	-	-	PUNCT
dpc-5083	369	9	cov-2	cov-2	NOUN
dpc-5083	369	10	.	.	PUNCT
dpc-5083	370	1	jaad	jaad	NOUN
dpc-5083	370	2	case	case	PROPN
dpc-5083	370	3	rep	rep	PROPN
dpc-5083	370	4	.	.	PROPN
dpc-5083	370	5	2021;18:103–5	2021;18:103–5	NUM
dpc-5083	370	6	.	.	PUNCT
dpc-5083	371	1	doi	doi	NOUN
dpc-5083	371	2	:	:	PUNCT
dpc-5083	371	3	 	 	SPACE
dpc-5083	371	4	10.1016	10.1016	NUM
dpc-5083	371	5	/	/	SYM
dpc-5083	371	6	j.jdcr.2021.10.007	j.jdcr.2021.10.007	PROPN
dpc-5083	371	7	.	.	PUNCT
dpc-5083	372	1	pmid	pmid	NOUN
dpc-5083	372	2	:	:	PUNCT
dpc-5083	372	3	34692963	34692963	NUM
dpc-5083	372	4	.	.	PUNCT
dpc-5083	373	1	20	20	NUM
dpc-5083	373	2	.	.	PUNCT
dpc-5083	374	1	lowell	lowell	PROPN
dpc-5083	374	2	ja	ja	PROPN
dpc-5083	374	3	,	,	PUNCT
dpc-5083	374	4	wright	wright	PROPN
dpc-5083	374	5	j	j	PROPN
dpc-5083	374	6	,	,	PUNCT
dpc-5083	374	7	eisenberg	eisenberg	PROPN
dpc-5083	374	8	s	s	PROPN
dpc-5083	374	9	,	,	PUNCT
dpc-5083	374	10	teperman	teperman	PROPN
dpc-5083	374	11	j	j	PROPN
dpc-5083	374	12	,	,	PUNCT
dpc-5083	374	13	dastagir	dastagir	PROPN
dpc-5083	374	14	m.	m.	NOUN
dpc-5083	374	15	rash	rash	NOUN
dpc-5083	374	16	from	from	ADP
dpc-5083	374	17	the	the	DET
dpc-5083	374	18	past	past	NOUN
dpc-5083	374	19	:	:	PUNCT
dpc-5083	374	20	a	a	DET
dpc-5083	374	21	case	case	NOUN
dpc-5083	374	22	of	of	ADP
dpc-5083	374	23	recurrent	recurrent	ADJ
dpc-5083	374	24	reactive	reactive	ADJ
dpc-5083	374	25	infectious	infectious	ADJ
dpc-5083	374	26	mucocutaneous	mucocutaneous	ADJ
dpc-5083	374	27	eruption	eruption	NOUN
dpc-5083	374	28	triggered	trigger	VERB
dpc-5083	374	29	by	by	ADP
dpc-5083	374	30	common	common	ADJ
dpc-5083	374	31	coronavirus	coronavirus	NOUN
dpc-5083	374	32	.	.	PUNCT
dpc-5083	375	1	jaad	jaad	NOUN
dpc-5083	375	2	case	case	NOUN
dpc-5083	375	3	reports	report	VERB
dpc-5083	375	4	.	.	PUNCT
dpc-5083	376	1	2024;47:26–9	2024;47:26–9	X
dpc-5083	376	2	.	.	PUNCT
dpc-5083	376	3	doi	doi	NOUN
dpc-5083	376	4	:	:	PUNCT
dpc-5083	376	5	10.1016	10.1016	NUM
dpc-5083	376	6	/	/	SYM
dpc-5083	376	7	j.jdcr.2024.02.013	j.jdcr.2024.02.013	PROPN
dpc-5083	376	8	.	.	PUNCT
dpc-5083	377	1	pmid	pmid	NOUN
dpc-5083	377	2	:	:	PUNCT
dpc-5083	377	3	 	 	SPACE
dpc-5083	377	4	38576904	38576904	NUM
dpc-5083	377	5	.	.	PUNCT
dpc-5083	378	1	21	21	NUM
dpc-5083	378	2	.	.	PUNCT
dpc-5083	378	3	sanfilippo	sanfilippo	PROPN
dpc-5083	378	4	e	e	PROPN
dpc-5083	378	5	,	,	PUNCT
dpc-5083	378	6	habeshian	habeshian	ADJ
dpc-5083	378	7	k	k	NOUN
dpc-5083	378	8	,	,	PUNCT
dpc-5083	378	9	cotton	cotton	NOUN
dpc-5083	378	10	ch	ch	NOUN
dpc-5083	378	11	,	,	PUNCT
dpc-5083	378	12	kirkorian	kirkorian	PROPN
dpc-5083	378	13	ay	ay	PROPN
dpc-5083	378	14	.	.	PUNCT
dpc-5083	378	15	severe	severe	ADJ
dpc-5083	378	16	reactive	reactive	ADJ
dpc-5083	378	17	infectious	infectious	ADJ
dpc-5083	378	18	mucocutaneous	mucocutaneous	ADJ
dpc-5083	378	19	eruption	eruption	NOUN
dpc-5083	378	20	mimicking	mimic	VERB
dpc-5083	378	21	drug	drug	NOUN
dpc-5083	378	22	induced	induce	VERB
dpc-5083	378	23	epidermal	epidermal	ADJ
dpc-5083	378	24	necrolysis	necrolysis	NOUN
dpc-5083	378	25	triggered	trigger	VERB
dpc-5083	378	26	by	by	ADP
dpc-5083	378	27	norovirus	noroviru	NOUN
dpc-5083	378	28	.	.	PUNCT
dpc-5083	379	1	pediatr	pediatr	ADJ
dpc-5083	379	2	dermatol	dermatol	NOUN
dpc-5083	379	3	.	.	PUNCT
dpc-5083	380	1	2024;41:84–6	2024;41:84–6	NUM
dpc-5083	380	2	.	.	PUNCT
dpc-5083	381	1	doi	doi	NOUN
dpc-5083	381	2	:	:	PUNCT
dpc-5083	381	3	10.1111	10.1111	NUM
dpc-5083	381	4	/	/	SYM
dpc-5083	381	5	pde.15370	pde.15370	NUM
dpc-5083	381	6	.	.	PUNCT
dpc-5083	382	1	pmid	pmid	NOUN
dpc-5083	382	2	:	:	PUNCT
dpc-5083	382	3	37317663	37317663	NUM
dpc-5083	382	4	.	.	PUNCT
dpc-5083	383	1	22	22	NUM
dpc-5083	383	2	.	.	PUNCT
dpc-5083	384	1	guzmán	guzmán	PROPN
dpc-5083	384	2	tena	tena	PROPN
dpc-5083	384	3	p	p	X
dpc-5083	384	4	,	,	PUNCT
dpc-5083	384	5	rodríguez	rodríguez	PROPN
dpc-5083	384	6	ramos	ramos	PROPN
dpc-5083	384	7	m	m	PROPN
dpc-5083	384	8	,	,	PUNCT
dpc-5083	384	9	lloret	lloret	ADJ
dpc-5083	384	10	ruiz	ruiz	PROPN
dpc-5083	384	11	c	c	PROPN
dpc-5083	384	12	,	,	PUNCT
dpc-5083	384	13	vázquez	vázquez	NOUN
dpc-5083	384	14	álvarez	álvarez	NOUN
dpc-5083	384	15	ml	ml	PROPN
dpc-5083	384	16	.	.	PUNCT
dpc-5083	384	17	reactive	reactive	ADJ
dpc-5083	384	18	infectious	infectious	ADJ
dpc-5083	384	19	mucocutaneous	mucocutaneous	ADJ
dpc-5083	384	20	eruption	eruption	NOUN
dpc-5083	384	21	(	(	PUNCT
dpc-5083	384	22	rime	rime	NOUN
dpc-5083	384	23	):	):	PUNCT
dpc-5083	384	24	expanding	expand	VERB
dpc-5083	384	25	the	the	DET
dpc-5083	384	26	spectrum	spectrum	NOUN
dpc-5083	384	27	of	of	ADP
dpc-5083	384	28	mucocutaneous	mucocutaneous	ADJ
dpc-5083	384	29	exanthems	exanthem	NOUN
dpc-5083	384	30	.	.	PUNCT
dpc-5083	385	1	actas	actas	PROPN
dpc-5083	385	2	dermosifiliogr	dermosifiliogr	NOUN
dpc-5083	385	3	.	.	PUNCT
dpc-5083	386	1	2023	2023	NUM
dpc-5083	386	2	:	:	PUNCT
dpc-5083	386	3	s0001	s0001	VERB
dpc-5083	386	4	-	-	PUNCT
dpc-5083	386	5	7310(23)00937	7310(23)00937	NUM
dpc-5083	386	6	-	-	SYM
dpc-5083	386	7	7	7	NUM
dpc-5083	386	8	.	.	PUNCT
dpc-5083	386	9	doi	doi	NOUN
dpc-5083	386	10	:	:	PUNCT
dpc-5083	386	11	 	 	SPACE
dpc-5083	386	12	10.1016	10.1016	NUM
dpc-5083	386	13	/	/	SYM
dpc-5083	386	14	j.ad.2024.10.044	j.ad.2024.10.044	PROPN
dpc-5083	386	15	.	.	PUNCT
dpc-5083	387	1	pmid	pmid	NOUN
dpc-5083	387	2	:	:	PUNCT
dpc-5083	387	3	38061456	38061456	NUM
dpc-5083	387	4	.	.	PUNCT
dpc-5083	388	1	8	8	NUM
dpc-5083	388	2	review	review	NOUN
dpc-5083	388	3	|	|	ADV
dpc-5083	388	4	dermatol	dermatol	ADJ
dpc-5083	388	5	pract	pract	NOUN
dpc-5083	388	6	concept	concept	NOUN
dpc-5083	388	7	.	.	PUNCT
dpc-5083	389	1	2025;15(3):5083	2025;15(3):5083	NUM
dpc-5083	389	2	pediatr	pediatr	ADJ
dpc-5083	389	3	dermatol	dermatol	NOUN
dpc-5083	389	4	.	.	PUNCT
dpc-5083	390	1	2020;37:769–70	2020;37:769–70	PROPN
dpc-5083	390	2	.	.	PUNCT
dpc-5083	391	1	doi	doi	PROPN
dpc-5083	391	2	:	:	PUNCT
dpc-5083	391	3	  	  	SPACE
dpc-5083	391	4	10.1111	10.1111	NUM
dpc-5083	391	5	/	/	SYM
dpc-5083	391	6	pde.14209	pde.14209	NOUN
dpc-5083	391	7	.	.	PUNCT
dpc-5083	392	1	pmid	pmid	NOUN
dpc-5083	392	2	:	:	PUNCT
dpc-5083	392	3	32500927	32500927	NUM
dpc-5083	392	4	.	.	PUNCT
dpc-5083	393	1	39	39	NUM
dpc-5083	393	2	.	.	PUNCT
dpc-5083	394	1	vassallo	vassallo	PROPN
dpc-5083	394	2	c	c	PROPN
dpc-5083	394	3	,	,	PUNCT
dpc-5083	394	4	ruffo	ruffo	PROPN
dpc-5083	394	5	di	di	PROPN
dpc-5083	394	6	calabria	calabria	PROPN
dpc-5083	394	7	v	v	PROPN
dpc-5083	394	8	,	,	PUNCT
dpc-5083	394	9	isoletta	isoletta	NOUN
dpc-5083	394	10	e	e	NOUN
dpc-5083	394	11	,	,	PUNCT
dpc-5083	394	12	et	et	PROPN
dpc-5083	394	13	al	al	PROPN
dpc-5083	394	14	.	.	PROPN
dpc-5083	395	1	clinical	clinical	ADJ
dpc-5083	395	2	and	and	CCONJ
dpc-5083	395	3	microbiological	microbiological	ADJ
dpc-5083	395	4	characteristics	characteristic	NOUN
dpc-5083	395	5	of	of	ADP
dpc-5083	395	6	reactive	reactive	ADJ
dpc-5083	395	7	infectious	infectious	ADJ
dpc-5083	395	8	mucocutaneous	mucocutaneous	ADJ
dpc-5083	395	9	eruption	eruption	NOUN
dpc-5083	395	10	:	:	PUNCT
dpc-5083	395	11	a	a	DET
dpc-5083	395	12	case	case	NOUN
dpc-5083	395	13	series	series	NOUN
dpc-5083	395	14	of	of	ADP
dpc-5083	395	15	5	5	NUM
dpc-5083	395	16	patients	patient	NOUN
dpc-5083	395	17	.	.	PUNCT
dpc-5083	396	1	jaad	jaad	NOUN
dpc-5083	396	2	case	case	NOUN
dpc-5083	396	3	rep	rep	PROPN
dpc-5083	396	4	.	.	PROPN
dpc-5083	396	5	2021;17:152–6	2021;17:152–6	PROPN
dpc-5083	396	6	.	.	PUNCT
dpc-5083	397	1	doi	doi	PROPN
dpc-5083	397	2	:	:	PUNCT
dpc-5083	397	3	  	  	SPACE
dpc-5083	397	4	10.1016	10.1016	NUM
dpc-5083	397	5	/	/	SYM
dpc-5083	397	6	j.jdcr.2021.09.029	j.jdcr.2021.09.029	PROPN
dpc-5083	397	7	.	.	PUNCT
dpc-5083	398	1	pmid	pmid	NOUN
dpc-5083	398	2	:	:	PUNCT
dpc-5083	398	3	34754894	34754894	NUM
dpc-5083	398	4	.	.	PUNCT
dpc-5083	399	1	37	37	NUM
dpc-5083	399	2	.	.	PUNCT
dpc-5083	399	3	calvano	calvano	PROPN
dpc-5083	399	4	ra	ra	PROPN
dpc-5083	399	5	,	,	PUNCT
dpc-5083	399	6	scacchi	scacchi	PROPN
dpc-5083	399	7	mf	mf	PROPN
dpc-5083	399	8	,	,	PUNCT
dpc-5083	399	9	sojo	sojo	PROPN
dpc-5083	399	10	mm	mm	PROPN
dpc-5083	399	11	,	,	PUNCT
dpc-5083	399	12	et	et	PROPN
dpc-5083	399	13	al	al	PROPN
dpc-5083	399	14	.	.	PROPN
dpc-5083	399	15	toxic	toxic	ADJ
dpc-5083	399	16	epidermal	epidermal	ADJ
dpc-5083	399	17	necrolysis	necrolysis	NOUN
dpc-5083	399	18	associated	associate	VERB
dpc-5083	399	19	with	with	ADP
dpc-5083	399	20	acute	acute	ADJ
dpc-5083	399	21	infection	infection	NOUN
dpc-5083	399	22	by	by	ADP
dpc-5083	399	23	mycoplasma	mycoplasma	NOUN
dpc-5083	399	24	pneumoniae	pneumoniae	NOUN
dpc-5083	399	25	.	.	PUNCT
dpc-5083	400	1	arch	arch	ADJ
dpc-5083	400	2	argent	argent	ADJ
dpc-5083	400	3	pediatr	pediatr	NOUN
dpc-5083	400	4	.	.	PUNCT
dpc-5083	401	1	2013	2013	NUM
dpc-5083	401	2	jan	jan	PROPN
dpc-5083	401	3	-	-	PUNCT
dpc-5083	401	4	feb;111(1):e24	feb;111(1):e24	NUM
dpc-5083	401	5	-	-	PUNCT
dpc-5083	401	6	7	7	NUM
dpc-5083	401	7	.	.	PUNCT
dpc-5083	401	8	doi	doi	NOUN
dpc-5083	401	9	:	:	PUNCT
dpc-5083	401	10	10.5546	10.5546	NUM
dpc-5083	401	11	/	/	SYM
dpc-5083	401	12	aap.2013.e24	aap.2013.e24	NOUN
dpc-5083	401	13	.	.	PUNCT
dpc-5083	401	14	pmid	pmid	NOUN
dpc-5083	401	15	:	:	PUNCT
dpc-5083	401	16	23381713	23381713	NUM
dpc-5083	401	17	.	.	PUNCT
dpc-5083	402	1	38	38	NUM
dpc-5083	402	2	.	.	PUNCT
dpc-5083	403	1	agnihotri	agnihotri	PROPN
dpc-5083	403	2	g	g	PROPN
dpc-5083	403	3	,	,	PUNCT
dpc-5083	403	4	loucks	louck	NOUN
dpc-5083	403	5	e	e	NOUN
dpc-5083	403	6	,	,	PUNCT
dpc-5083	403	7	ashack	ashack	NOUN
dpc-5083	403	8	k	k	NOUN
dpc-5083	403	9	,	,	PUNCT
dpc-5083	403	10	tsoukas	tsoukas	PROPN
dpc-5083	403	11	m.	m.	NOUN
dpc-5083	403	12	mycoplasma	mycoplasma	PROPN
dpc-5083	403	13	pneumoniae	pneumoniae	ADV
dpc-5083	403	14	-	-	PUNCT
dpc-5083	403	15	associated	associate	VERB
dpc-5083	403	16	mucositis	mucositis	NOUN
dpc-5083	403	17	complicated	complicate	VERB
dpc-5083	403	18	by	by	ADP
dpc-5083	403	19	herpes	herpe	NOUN
dpc-5083	403	20	simplex	simplex	NOUN
dpc-5083	403	21	virus	virus	NOUN
dpc-5083	403	22	dissemination	dissemination	NOUN
dpc-5083	403	23	and	and	CCONJ
dpc-5083	403	24	staphylococcus	staphylococcus	NOUN
dpc-5083	403	25	epidermidis	epidermidis	NOUN
dpc-5083	403	26	bacteremia	bacteremia	NOUN
dpc-5083	403	27	.	.	PUNCT